Daftar Isi WHO 2

1 Central Nervous System Tumours (5th ed.
)
2 1.
3 Forewords and Introductions
4 WHO Classification of Tumours: Editorial Board (/chaptercontent/45/260) How to cite this volume (/chaptercontent/45/261)
5 Foreword with changes from the book, including corrigenda (/chaptercontent/45/262) ICD-O coding of CNS tumours
6 ICCR datasets: Central nervous system (/chaptercontent/45/264) Introduction to CNS tumours (/chaptercontent/45/1)
7 2.
8 Gliomas, glioneuronal tumours, and neuronal tumours
9 Gliomas, glioneuronal tumours, and neuronal tumours: Introduction (/chaptercontent/45/216)
10 Gliomas, glioneuronal tumours, and neuronal tumours
11 Adult-type diffuse gliomas
12 Astrocytoma, IDH-mutant (/chaptercontent/45/5)
13 Oligodendroglioma, IDH-mutant and 1p/19q-codeleted (/chaptercontent/45/6) Glioblastoma, IDH-wildtype (/chaptercontent/45/7)
14 Paediatric-type diffuse low-grade gliomas
15 Diffuse astrocytoma, MYB- or MYBL1-altered (/chaptercontent/45/241) Angiocentric glioma (/chaptercontent/45/24)
16 Polymorphous low-grade neuroepithelial tumour of the young (/chaptercontent/45/26) Diffuse low-grade glioma, MAPK pathway-altered
(/chaptercontent/45/254)
17 Paediatric-type diffuse high-grade gliomas
18 Diffuse midline glioma, H3 K27-altered (/chaptercontent/45/8)
19 Diffuse hemispheric glioma, H3 G34-mutant (/chaptercontent/45/9)
20 Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype (/chaptercontent/45/218) Infant-type hemispheric glioma
21 (/chaptercontent/45/219)
Circumscribed astrocytic gliomas
22 Pilocytic astrocytoma (/chaptercontent/45/19)
23 High-grade astrocytoma with piloid features (/chaptercontent/45/27) Pleomorphic xanthoastrocytoma (/chaptercontent/45/20)
24 Subependymal giant cell astrocytoma (/chaptercontent/45/21) Chordoid glioma (/chaptercontent/45/23)
25 Astroblastoma, MN1-altered (/chaptercontent/45/22)
26 Glioneuronal and neuronal tumours Ganglioglioma (/chaptercontent/45/35) Gangliocytoma (/chaptercontent/45/34)
27 Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma (/chaptercontent/45/36) Dysembryoplastic neuroepithelial tumour
28 Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (/chaptercontent/45/236)
29 Papillary glioneuronal tumour (/chaptercontent/45/39)
30 Rosette-forming glioneuronal tumour (/chaptercontent/45/38) Myxoid glioneuronal tumour (/chaptercontent/45/40)
31 Diffuse leptomeningeal glioneuronal tumour (/chaptercontent/45/41) Multinodular and vacuolating neuronal tumour (/chaptercontent/45/33)
32 Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) (/chaptercontent/45/32) Central neurocytoma (/chaptercontent/45/29)
33 Extraventricular neurocytoma (/chaptercontent/45/30) Cerebellar liponeurocytoma (/chaptercontent/45/31)
34 Ependymal tumours
35 Ependymal tumours: Introduction (/chaptercontent/45/247) Supratentorial ependymoma (/chaptercontent/45/44)
36 Supratentorial ependymoma, ZFTA fusion-positive (/chaptercontent/45/229) Supratentorial ependymoma, YAP1 fusion-positive
(/chaptercontent/45/230) Posterior fossa ependymoma (/chaptercontent/45/49)
37 Posterior fossa group A (PFA) ependymoma (/chaptercontent/45/231) Posterior fossa group B (PFB) ependymoma (/chaptercontent/45/232) Spinal
ependymoma (/chaptercontent/45/233)
38 Spinal ependymoma, MYCN-amplified (/chaptercontent/45/51) Myxopapillary ependymoma (/chaptercontent/45/52)
39 Subependymoma (/chaptercontent/45/53)
40 3.
41 Choroid plexus tumours
42 Choroid plexus papilloma (/chaptercontent/45/55)
43 Atypical choroid plexus papilloma (/chaptercontent/45/56) Choroid plexus carcinoma (/chaptercontent/45/57)
44 4.
45 Embryonal tumours
46 Medulloblastoma
47 Medulloblastoma: Introduction (/chaptercontent/45/60)
48 Medulloblastomas, molecularly defined
49 Medulloblastoma, WNT-activated (/chaptercontent/45/62)
50 Medulloblastoma, SHH-activated and TP53-wildtype (/chaptercontent/45/64) Medulloblastoma, SHH-activated and TP53-mutant
(/chaptercontent/45/63) Medulloblastoma, non-WNT/non-SHH (/chaptercontent/45/65)
51 Medulloblastomas, histologically defined
52 Medulloblastoma, histologically defined (/chaptercontent/45/67)
53 Other CNS embryonal tumours
54 Other CNS embryonal tumours: Introduction (/chaptercontent/45/242) Atypical teratoid/rhabdoid tumour (/chaptercontent/45/72)
55 Cribriform neuroepithelial tumour (/chaptercontent/45/235)
56 Embryonal tumour with multilayered rosettes (/chaptercontent/45/73) CNS neuroblastoma, FOXR2-activated (/chaptercontent/45/75)
57 CNS tumour with BCOR internal tandem duplication (/chaptercontent/45/76) CNS embryonal tumour NEC/NOS (/chaptercontent/45/257)
58 5.
59 Pineal tumours
60 Pineal tumours: Introduction (/chaptercontent/45/258) Pineocytoma (/chaptercontent/45/78)
61 Pineal parenchymal tumour of intermediate differentiation (/chaptercontent/45/79) Pineoblastoma (/chaptercontent/45/80)
62 Papillary tumour of the pineal region (/chaptercontent/45/81)
63 Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant (/chaptercontent/45/224)
64 6.
65 Cranial and paraspinal nerve tumours
66 Cranial and paraspinal nerve tumours: Introduction (/chaptercontent/45/243) Schwannoma (/chaptercontent/45/83)
67 Neurofibroma (/chaptercontent/45/84) Perineurioma (/chaptercontent/45/85)
68 Hybrid nerve sheath tumours (/chaptercontent/45/86)
69 Malignant melanotic nerve sheath tumour (/chaptercontent/45/87) Malignant peripheral nerve sheath tumour (/chaptercontent/45/88)
70 Cauda equina neuroendocrine tumour (previously paraganglioma) (/chaptercontent/45/42)
71 7.
72 Meningioma
73 Meningioma (/chaptercontent/45/91)
74 8.
75 Mesenchymal, non-meningothelial tumours involving the CNS
76 Mesenchymal, non-meningothelial tumours involving the CNS: Introduction (/chaptercontent/45/244)
77 Soft tissue tumours
78 Fibroblastic and myofibroblastic tumours
79 Solitary fibrous tumour (/chaptercontent/45/120)
80 Vascular tumours
81 Haemangiomas and vascular malformations (/chaptercontent/45/125) Haemangioblastoma (/chaptercontent/45/126)
82 Skeletal muscle tumours
83 Rhabdomyosarcoma (/chaptercontent/45/135)
84 Tumours of uncertain differentiation
85 Intracranial mesenchymal tumour, FET::CREB fusion-positive (/chaptercontent/45/123) CIC-rearranged sarcoma (/chaptercontent/45/250)
86 Primary intracranial sarcoma, DICER1-mutant (/chaptercontent/45/141) Ewing sarcoma (/chaptercontent/45/139)
87 Chondro-osseous tumours
88 Chondrogenic tumours
89 Mesenchymal chondrosarcoma (/chaptercontent/45/144) Chondrosarcoma (/chaptercontent/45/145)
90 Notochordal tumours
91 Chordoma (/chaptercontent/45/151)
92 9.
93 Melanocytic tumours
94 Melanocytic tumours: Introduction (/chaptercontent/45/245)
95 Diffuse meningeal melanocytic neoplasms
96 Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis (/chaptercontent/45/154)
97 Circumscribed meningeal melanocytic neoplasms
98 Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma (/chaptercontent/45/156)
99 10.
100 Haematolymphoid tumours involving the CNS
101 Haematolymphoid tumours involving the CNS: Introduction (/chaptercontent/45/228)
102 Lymphomas
103 CNS lymphomas
104 Primary diffuse large B-cell lymphoma of the CNS (/chaptercontent/45/162) Immunodeficiency-associated CNS lymphomas
(/chaptercontent/45/163) Lymphomatoid granulomatosis (/chaptercontent/45/166)
105 Intravascular large B-cell lymphoma (/chaptercontent/45/167)
106 Miscellaneous rare lymphomas in the CNS
107 MALT lymphoma of the dura (/chaptercontent/45/172)
108 Other low-grade B-cell lymphomas of the CNS (/chaptercontent/45/169) Anaplastic large cell lymphoma (ALK+/ALK−) (/chaptercontent/45/171) T-
cell and NK/T-cell lymphomas (/chaptercontent/45/170)
109 Histiocytic tumours
110 Erdheim-Chester disease (/chaptercontent/45/174) Rosai-Dorfman disease (/chaptercontent/45/175) Juvenile xanthogranuloma
Langerhans cell histiocytosis (/chaptercontent/45/177) Histiocytic sarcoma (/chaptercontent/45/178)
112 11.
113 Germ cell tumours
114 Germ cell tumours of the CNS (/chaptercontent/45/240)
115 12.
116 Tumours of the sellar region
117 Tumours of the sellar region: Introduction (number corrected was 12.0.0.1) (/chaptercontent/45/256)
118 Adamantinomatous craniopharyngioma (/chaptercontent/45/188) Papillary craniopharyngioma (/chaptercontent/45/252)
119 Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma (/chaptercontent/45/189)
120 Pituitary adenoma / pituitary neuroendocrine tumour (/chaptercontent/45/191) Pituitary blastoma (/chaptercontent/45/246)
121 13.
122 Metastases to the CNS
123 Metastases to the brain and spinal cord parenchyma (/chaptercontent/45/193) Metastases to the meninges (/chaptercontent/45/194)
124 14.
125 Genetic tumour syndromes involving the CNS
126 Genetic tumour syndromes of the nervous system: Introduction (/chaptercontent/45/227) Neurofibromatosis type 1 (/chaptercontent/45/196)
127 Neurofibromatosis type 2 (/chaptercontent/45/197) Schwannomatosis (/chaptercontent/45/198)
128 Von Hippel-Lindau syndrome (/chaptercontent/45/199) Tuberous sclerosis (/chaptercontent/45/200)
129 Li-Fraumeni syndrome (/chaptercontent/45/201) Cowden syndrome (/chaptercontent/45/202)
130 Constitutional mismatch repair deficiency syndrome (/chaptercontent/45/203) Familial adenomatous polyposis 1 (/chaptercontent/45/204)
131 Naevoid basal cell carcinoma syndrome (/chaptercontent/45/206)
132 Rhabdoid tumour predisposition syndrome (/chaptercontent/45/207) Carney complex (/chaptercontent/45/209)
133 DICER1 syndrome (/chaptercontent/45/210)
134 Familial paraganglioma syndromes (/chaptercontent/45/211) Melanoma-astrocytoma syndrome (/chaptercontent/45/212) Familial retinoblastoma
135 BAP1 tumour predisposition syndrome (/chaptercontent/45/214) Fanconi anaemia (/chaptercontent/45/215)
136 ELP1-medulloblastoma syndrome (/chaptercontent/45/239)
137 Terms of use (http://publications.iarc.fr/Terms-Of-Use)
138 Head and Neck Tumours (5th ed.)
139 1.
141 Website beta version (/chaptercontent/52/372)
143 Foreword with changes from the book, including corrigenda (/chaptercontent/52/364) ICD-O coding of head and neck tumours
144 TNM staging of head and neck tumours (/chaptercontent/52/369) ICCR datasets: Head and neck (/chaptercontent/52/370)
145 2.
146 Nasal, paranasal, and skull base tumours
147 Nasal, paranasal, and skull base tumours: Introduction (/chaptercontent/52/2)
148 Hamartomas
149 Respiratory epithelial adenomatoid hamartoma (/chaptercontent/52/4) Seromucinous hamartoma (/chaptercontent/52/5)
150 Nasal chondromesenchymal hamartoma (/chaptercontent/52/26)
151 Respiratory epithelial lesions
152 Sinonasal papillomas
153 Sinonasal papilloma, inverted type (/chaptercontent/52/9)
154 Sinonasal papilloma, oncocytic type (/chaptercontent/52/10) Sinonasal papilloma, exophytic type (/chaptercontent/52/11)
155 Carcinomas
156 Keratinizing squamous cell carcinoma (/chaptercontent/52/13)
157 Non-keratinizing squamous cell carcinoma (/chaptercontent/52/14) NUT carcinoma (/chaptercontent/52/19)
158 SWI/SNF complex-deficient sinonasal carcinoma (/chaptercontent/52/18) Sinonasal lymphoepithelial carcinoma (/chaptercontent/52/16)
159 Sinonasal undifferentiated carcinoma (/chaptercontent/52/17) Teratocarcinosarcoma (/chaptercontent/52/27)
160 HPV-associated multiphenotypic sinonasal carcinoma (/chaptercontent/52/320)
161 Adenocarcinomas
162 Intestinal-type sinonasal adenocarcinoma (/chaptercontent/52/21)
163 Non-intestinal-type sinonasal adenocarcinoma (/chaptercontent/52/22)
164 Mesenchymal tumours of the sinonasal tract
165 Sinonasal tract angiofibroma (/chaptercontent/52/196)
166 Sinonasal glomangiopericytoma (/chaptercontent/52/211) Biphenotypic sinonasal sarcoma (/chaptercontent/52/227) Chordoma
Other sinonasal tumours
168 Sinonasal ameloblastoma (/chaptercontent/52/25)
169 Adamantinomatous craniopharyngioma (/chaptercontent/52/33)
170 Meningioma of the sinonasal tract, ear, and temporal bone (/chaptercontent/52/24) Olfactory neuroblastoma (/chaptercontent/52/262)
171 3.
172 Nasopharyngeal tumours
173 Nasopharyngeal tumours: Introduction (/chaptercontent/52/29)
174 Hamartomas
175 Hairy polyp (/chaptercontent/52/31)
176 Salivary gland anlage tumour (/chaptercontent/52/75)
177 Carcinomas
178 Low-grade nasopharyngeal papillary adenocarcinoma (/chaptercontent/52/38) Nasopharyngeal carcinoma (/chaptercontent/52/37)
179 4.
180 Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours
181 Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours: Introduction (/chaptercontent/52/40)
182 Precursor lesions
183 Squamous papilloma and papillomatosis (/chaptercontent/52/43) Laryngeal and hypopharyngeal epithelial dysplasia (/chaptercontent/52/42)
184 Squamous cell carcinomas
185 Conventional squamous cell carcinoma (/chaptercontent/52/45)
186 Verrucous carcinoma of the hypopharynx, larynx, trachea, and parapharyngeal space (/chaptercontent/52/46)
187 Basaloid squamous cell carcinoma (/chaptercontent/52/47) Papillary squamous cell carcinoma (/chaptercontent/52/48) Spindle cell squamous
carcinoma (/chaptercontent/52/49) Adenosquamous carcinoma (/chaptercontent/52/50)
188 Lymphoepithelial carcinoma of the larynx (/chaptercontent/52/51)
189 Mesenchymal tumours unique to the hypopharynx, larynx, trachea, and parapharyngeal space
190 Laryngeal cartilaginous tumours (/chaptercontent/52/323)
191 5.
192 Salivary gland tumours
193 Salivary gland tumours: Introduction (/chaptercontent/52/53)
194 Non-neoplastic epithelial lesions
195 Nodular oncocytic hyperplasia (/chaptercontent/52/56) Lymphoepithelial sialadenitis (/chaptercontent/52/57)
196 Benign epithelial tumours
197 Pleomorphic adenoma (/chaptercontent/52/63) Basal cell adenoma (/chaptercontent/52/65) Warthin tumour (/chaptercontent/52/66) Oncocytoma
198 Salivary gland myoepithelioma (/chaptercontent/52/64) Canalicular adenoma (/chaptercontent/52/73)
199 Cystadenoma of the salivary glands (/chaptercontent/52/69) Ductal papillomas (/chaptercontent/52/71)
200 Sialadenoma papilliferum (/chaptercontent/52/70) Lymphadenoma (/chaptercontent/52/68)
201 Sebaceous adenoma (/chaptercontent/52/355)
202 Intercalated duct adenoma and hyperplasia (/chaptercontent/52/59) Striated duct adenoma (/chaptercontent/52/60)
203 Sclerosing polycystic adenoma (/chaptercontent/52/74) Keratocystoma (/chaptercontent/52/61)
204 Malignant epithelial tumours
205 Mucoepidermoid carcinoma (/chaptercontent/52/77) Adenoid cystic carcinoma (/chaptercontent/52/78) Acinic cell carcinoma
Secretory carcinoma (/chaptercontent/52/89) Microsecretory adenocarcinoma (/chaptercontent/52/91) Polymorphous adenocarcinoma
(/chaptercontent/52/80) Hyalinizing clear cell carcinoma (/chaptercontent/52/81) Basal cell adenocarcinoma (/chaptercontent/52/82) Intraductal
carcinoma (/chaptercontent/52/83)
207 Salivary duct carcinoma (/chaptercontent/52/85) Myoepithelial carcinoma (/chaptercontent/52/86)
208 Epithelial-myoepithelial carcinoma (/chaptercontent/52/87) Mucinous adenocarcinoma (/chaptercontent/52/325)
209 Sclerosing microcystic adenocarcinoma (/chaptercontent/52/326) Carcinoma ex pleomorphic adenoma (/chaptercontent/52/88)
210 Carcinosarcoma of the salivary glands (/chaptercontent/52/354) Sebaceous adenocarcinoma (/chaptercontent/52/90) Lymphoepithelial carcinoma
211 Squamous cell carcinoma (/chaptercontent/52/94) Sialoblastoma (/chaptercontent/52/95)
212 Salivary carcinoma NOS and emerging entities (/chaptercontent/52/84)
213 Mesenchymal tumours specific to the salivary glands
214 Sialolipoma (/chaptercontent/52/72)
215 6.
216 Oral cavity and mobile tongue tumours
217 Oral cavity and mobile tongue tumours: Introduction (/chaptercontent/52/350)
218 Non-neoplastic lesions
219 Necrotizing sialometaplasia (/chaptercontent/52/347) Multifocal epithelial hyperplasia (/chaptercontent/52/102) Oral melanoacanthoma
220 Epithelial tumours
221 Papillomas
222 Squamous papilloma (/chaptercontent/52/99)
223 Oral potentially malignant disorders and oral epithelial dysplasia Oral potentially malignant disorders (/chaptercontent/52/103) Oral epithelial
dysplasia (/chaptercontent/52/106)
224 Proliferative verrucous leukoplakia (/chaptercontent/52/104) Submucous fibrosis (/chaptercontent/52/100)
225 HPV-associated oral epithelial dysplasia (/chaptercontent/52/101)
227 Oral squamous cell carcinoma (/chaptercontent/52/108)
228 Verrucous carcinoma of the oral cavity and mobile tongue (/chaptercontent/52/109) Carcinoma cuniculatum (/chaptercontent/52/110)
229 Tumours of uncertain histogenesis
230 Congenital granular cell epulis (/chaptercontent/52/112) Granular cell tumour (/chaptercontent/52/224)
231 Ectomesenchymal chondromyxoid tumour (/chaptercontent/52/113) Melanotic neuroectodermal tumour of infancy (/chaptercontent/52/169)
232 7.
233 Oropharyngeal tumours (base of tongue, tonsils, adenoids)
234 Oropharyngeal tumours (base of tongue, tonsils, adenoids): Introduction (/chaptercontent/52/115)
235 Benign oropharyngeal lesions
236 Hamartomatous polyps (/chaptercontent/52/105)
238 Squamous cell carcinoma
239 Squamous cell carcinoma, HPV-associated (/chaptercontent/52/118) Squamous cell carcinoma, HPV-independent (/chaptercontent/52/119)
240 8.
241 Odontogenic and maxillofacial bone tumours
242 Odontogenic and maxillofacial bone tumours: Introduction (/chaptercontent/52/121)
243 Cysts of the jaws
244 Radicular cyst (/chaptercontent/52/123)
245 Inflammatory collateral cysts (/chaptercontent/52/124) Surgical ciliated cyst (/chaptercontent/52/331)
246 Nasopalatine duct cyst (/chaptercontent/52/132) Gingival cysts (/chaptercontent/52/128)
247 Dentigerous cyst (/chaptercontent/52/125)
248 Orthokeratinized odontogenic cyst (/chaptercontent/52/131)
249 Lateral periodontal cyst and botryoid odontogenic cyst (/chaptercontent/52/127) Calcifying odontogenic cyst (/chaptercontent/52/130)
250 Glandular odontogenic cyst (/chaptercontent/52/129) Odontogenic keratocyst (/chaptercontent/52/126)
251 Odontogenic tumours
252 Benign epithelial odontogenic tumours
253 Adenomatoid odontogenic tumour (/chaptercontent/52/141) Squamous odontogenic tumour (/chaptercontent/52/139)
254 Calcifying epithelial odontogenic tumour (/chaptercontent/52/140) Ameloblastoma, unicystic (/chaptercontent/52/136)
255 Ameloblastoma, extraosseous/peripheral (/chaptercontent/52/137) Ameloblastoma, conventional (/chaptercontent/52/332)
256 Adenoid ameloblastoma (/chaptercontent/52/333) Metastasizing ameloblastoma (/chaptercontent/52/138)
257 Benign mixed epithelial and mesenchymal odontogenic tumours
258 Odontoma (/chaptercontent/52/156)
259 Primordial odontogenic tumour (/chaptercontent/52/154) Ameloblastic fibroma (/chaptercontent/52/153)
260 Dentinogenic ghost cell tumour (/chaptercontent/52/157)
261 Benign mesenchymal odontogenic tumours Odontogenic fibroma (/chaptercontent/52/159) Cementoblastoma (/chaptercontent/52/161)
262 Cemento-ossifying fibroma (/chaptercontent/52/162) Odontogenic myxoma (/chaptercontent/52/160)
263 Malignant odontogenic tumours
264 Sclerosing odontogenic carcinoma (/chaptercontent/52/145) Ameloblastic carcinoma (/chaptercontent/52/143)
265 Clear cell odontogenic carcinoma (/chaptercontent/52/146) Ghost cell odontogenic carcinoma (/chaptercontent/52/147)
266 Primary intraosseous carcinoma NOS (/chaptercontent/52/144) Odontogenic carcinosarcoma (/chaptercontent/52/149) Odontogenic sarcomas
267 Giant cell lesions and bone cysts
268 Central giant cell granuloma (/chaptercontent/52/185)
269 Peripheral giant cell granuloma (/chaptercontent/52/186) Cherubism (/chaptercontent/52/187)
270 Aneurysmal bone cyst (/chaptercontent/52/188) Simple bone cyst (/chaptercontent/52/189)
271 Bone and cartilage tumours
272 Fibro-osseous tumours and dysplasias
273 Cemento-osseous dysplasia (/chaptercontent/52/182)
274 Segmental odontomaxillary dysplasia (/chaptercontent/52/335) Fibrous dysplasia (/chaptercontent/52/181)
275 Juvenile trabecular ossifying fibroma (/chaptercontent/52/164) Psammomatoid ossifying fibroma (/chaptercontent/52/163) Familial gigantiform
cementoma (/chaptercontent/52/180)
276 Benign maxillofacial bone and cartilage tumours Osteoma (/chaptercontent/52/168) Osteochondroma (/chaptercontent/52/183) Osteoblastoma
277 Chondroblastoma (/chaptercontent/52/170)
278 Chondromyxoid fibroma (/chaptercontent/52/171)
279 Desmoplastic fibroma of bone (/chaptercontent/52/174)
280 Malignant maxillofacial bone and cartilage tumours
281 Osteosarcoma of the jaw (/chaptercontent/52/178)
282 The chondrosarcoma family of tumours (/chaptercontent/52/176) Mesenchymal chondrosarcoma (/chaptercontent/52/177)
283 Rhabdomyosarcoma with TFCP2 rearrangement (/chaptercontent/52/134)
284 9.
285 Ear tumours
286 Ear tumours: Introduction (/chaptercontent/52/291)
287 Tumours of the external auditory canal
288 Chondrodermatitis nodularis chronica helicis (/chaptercontent/52/348) Cystic chondromalacia (/chaptercontent/52/349)
289 Exostosis (osteoma) of the ear (/chaptercontent/52/353) Ceruminous adenoma (/chaptercontent/52/293)
290 Ceruminous adenocarcinoma (/chaptercontent/52/294)
291 Squamous cell carcinoma of the external auditory canal (/chaptercontent/52/295)
292 Tumours of the middle and inner ear
293 Otosclerosis (/chaptercontent/52/297)
294 Cholesteatoma (/chaptercontent/52/298) Middle ear papilloma (/chaptercontent/52/352)
295 Vestibular schwannoma (/chaptercontent/52/344)
296 Middle ear neuroendocrine tumour (/chaptercontent/52/280) Endolymphatic sac tumour (/chaptercontent/52/299)
297 Middle ear squamous cell carcinoma (/chaptercontent/52/301) Middle ear adenocarcinoma (/chaptercontent/52/300)
298 10.
300 Soft tissue tumours: Introduction (/chaptercontent/52/191)
301 Adipocytic tumours
302 Lipomas (/chaptercontent/52/193) Liposarcomas (/chaptercontent/52/194)
304 Nodular fasciitis (/chaptercontent/52/198)
305 Desmoid fibromatosis (/chaptercontent/52/199) Solitary fibrous tumour (/chaptercontent/52/200)
306 Low-grade myofibroblastic sarcoma (/chaptercontent/52/202) Inflammatory myofibroblastic tumour (/chaptercontent/52/201)
307 Vascular tumours
308 Haemangioma (/chaptercontent/52/205)
309 Epithelioid haemangioma (/chaptercontent/52/203) Lymphangioma (/chaptercontent/52/206)
310 Epithelioid haemangioendothelioma (/chaptercontent/52/207) Kaposi sarcoma (/chaptercontent/52/208)
311 Angiosarcoma (/chaptercontent/52/209)
312 Pericytic (perivascular) tumours
313 Myofibroma (/chaptercontent/52/197)
314 Smooth muscle tumours
315 Leiomyoma (/chaptercontent/52/213)
316 EBV-associated smooth muscle tumour (/chaptercontent/52/338)
317 Smooth muscle tumour of uncertain malignant potential (/chaptercontent/52/339) Leiomyosarcoma (/chaptercontent/52/214)
319 Rhabdomyoma (/chaptercontent/52/216)
320 Rhabdomyosarcomas (/chaptercontent/52/217)
322 Chondroma (/chaptercontent/52/219)
323 Peripheral nerve sheath tumours
324 Neurofibroma (/chaptercontent/52/222) Schwannoma (/chaptercontent/52/223) Neuromas (/chaptercontent/52/340)
325 Malignant peripheral nerve sheath tumour (/chaptercontent/52/225)
327 Phosphaturic mesenchymal tumour (/chaptercontent/52/341) Myxoma (/chaptercontent/52/356)
328 Extraskeletal myxoid chondrosarcoma (/chaptercontent/52/220) Synovial sarcoma (/chaptercontent/52/228)
329 GLI1-altered soft tissue tumour (/chaptercontent/52/337) Undifferentiated sarcoma (/chaptercontent/52/229)
330 Undifferentiated small round cell sarcomas of bone and soft tissue
331 Ewing sarcoma (/chaptercontent/52/231)
332 11.
333 Haematolymphoid proliferations and neoplasia
334 Haematolymphoid proliferations and neoplasia: Introduction (/chaptercontent/52/233)
335 Reactive haematolymphoid and related lesions
336 Reactive lymphoid hyperplasia (/chaptercontent/52/235)
337 EBV-positive mucocutaneous ulcer (/chaptercontent/52/357) IgG4-related disease (/chaptercontent/52/236)
338 Myeloid tumours
339 Extramedullary myeloid sarcoma (/chaptercontent/52/238)
340 B-cell lymphomas
341 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) (/chaptercontent/52/248)
342 Mantle cell lymphoma (/chaptercontent/52/240) Follicular lymphoma (/chaptercontent/52/241)
343 Paediatric-type follicular lymphoma (/chaptercontent/52/360)
344 Large B-cell lymphoma with IRF4 rearrangement (/chaptercontent/52/361) Diffuse large B-cell lymphoma (/chaptercontent/52/242)
345 Burkitt lymphoma (/chaptercontent/52/246) Plasmacytoma (/chaptercontent/52/243)
346 Plasmablastic lymphoma (/chaptercontent/52/244)
347 T/NK-cell tumours
348 T-lymphoblastic leukaemia/lymphoma (/chaptercontent/52/249)
349 Primary mucosal CD30-positive T-cell lymphoproliferative disorder (/chaptercontent/52/250) Extranodal NK/T-cell lymphoma
Hodgkin lymphoma
351 Hodgkin lymphoma (/chaptercontent/52/253)
352 Histiocytic and dendritic cell tumours
353 Juvenile xanthogranuloma (/chaptercontent/52/255) Erdheim-Chester disease (/chaptercontent/52/256) Rosai-Dorfman disease
Langerhans cell histiocytosis (/chaptercontent/52/258) Follicular dendritic cell sarcoma (/chaptercontent/52/259)
355 12.
356 Melanocytic tumours
357 Melanocytic tumours: Introduction (/chaptercontent/52/261) Mucosal melanoma (/chaptercontent/52/263)
358 13.
359 Tumours and tumour-like lesions of the neck and lymph nodes
360 Tumours and tumour-like lesions of the neck and lymph nodes: Introduction (/chaptercontent/52/265)
361 Cysts and cyst-like lesions
362 Ranula (/chaptercontent/52/267) Lymphoepithelial cyst (/chaptercontent/52/342) Branchial cleft cyst (/chaptercontent/52/268) Thyroglossal duct
cyst (/chaptercontent/52/269)
363 Dermoid and teratoid cysts (/chaptercontent/52/270)
364 Other tumours of the neck and lymph nodes
365 Branchioma (/chaptercontent/52/272)
366 Heterotopia-associated carcinoma (/chaptercontent/52/273)
367 Squamous carcinoma of unknown primary site (/chaptercontent/52/274)
368 14.
370 Germ cell tumours of the head and neck (/chaptercontent/52/366)
371 15.
372 Metastasis
373 Metastases to the head and neck region (/chaptercontent/52/343)
374 16.
375 Neuroendocrine neoplasms and paraganglioma
376 Neuroendocrine neoplasms and paraganglioma: Introduction (/chaptercontent/52/276)
377 Neuroendocrine neoplasms
378 Neuroendocrine tumours
379 Neuroendocrine tumour (/chaptercontent/52/279)
380 Ectopic or invasive PitNET / pituitary adenoma (/chaptercontent/52/281)
381 Neuroendocrine carcinomas
382 Small cell neuroendocrine carcinoma (/chaptercontent/52/284) Large cell neuroendocrine carcinoma (/chaptercontent/52/285) Merkel cell
383 Paraganglion tumours
384 Head and neck paraganglioma (/chaptercontent/52/289)
385 17.
386 Genetic tumour syndromes involving the head and neck
387 Genetic tumour syndromes involving the head and neck: Introduction (/chaptercontent/52/303) Naevoid basal cell carcinoma syndrome (Gorlin
syndrome) (/chaptercontent/52/304)
388 Neurofibromatosis type 1 (/chaptercontent/52/306)
389 Familial adenomatous polyposis and Gardner syndrome (/chaptercontent/52/308) Brooke-Spiegler syndrome (/chaptercontent/52/309)
390 Cowden syndrome (/chaptercontent/52/345)
391 Familial paraganglioma syndromes (/chaptercontent/52/310) Multiple endocrine neoplasia type 2 (/chaptercontent/52/318)
392 Hyperparathyroidism-jaw tumour syndrome (/chaptercontent/52/311) Li-Fraumeni syndrome (/chaptercontent/52/313)
393 Fanconi anaemia (/chaptercontent/52/314)
394 Dyskeratosis congenita (/chaptercontent/52/315) Ataxia-telangiectasia (/chaptercontent/52/316)
395 Bloom syndrome (/chaptercontent/52/317)
396 Von Hippel-Lindau syndrome (/chaptercontent/52/319) Tuberous sclerosis (/chaptercontent/52/346)
398 Thoracic Tumours (5th ed.)
399 1.
402 Foreword with changes from the book, including corrigenda (/chaptercontent/35/331) ICD-O coding of thoracic tumours
403 TNM staging of thoracic tumours (/chaptercontent/35/337) ICCR datasets: Thorax (/chaptercontent/35/336)
404 2.
405 Tumours of the lung
406 Tumours of the lung: Introduction (/chaptercontent/35/2) Small diagnostic samples (/chaptercontent/35/313)
408 Papillomas
409 Bronchial papillomas (/chaptercontent/35/5)
410 Adenomas
411 Sclerosing pneumocytoma (/chaptercontent/35/11) Alveolar adenoma (/chaptercontent/35/12)
412 Papillary adenoma of the lung (/chaptercontent/35/13)
413 Bronchiolar adenoma / ciliated muconodular papillary tumour (/chaptercontent/35/14) Mucinous cystadenoma of the lung (/chaptercontent/35/15)
414 Mucous gland adenoma of the lung (/chaptercontent/35/16)
415 Precursor glandular lesions
416 Atypical adenomatous hyperplasia of the lung (/chaptercontent/35/18) Adenocarcinoma in situ of the lung (/chaptercontent/35/19)
417 Adenocarcinomas
418 Minimally invasive adenocarcinoma of the lung (/chaptercontent/35/35) Invasive non-mucinous adenocarcinoma of the lung
(/chaptercontent/35/23) Invasive mucinous adenocarcinoma of the lung (/chaptercontent/35/29)
419 Colloid adenocarcinoma of the lung (/chaptercontent/35/31) Fetal adenocarcinoma of the lung (/chaptercontent/35/32)
420 Enteric-type adenocarcinoma of the lung (/chaptercontent/35/33)
421 Squamous precursor lesions
422 Squamous dysplasia and carcinoma in situ of the lung (/chaptercontent/35/81)
424 Squamous cell carcinoma of the lung (/chaptercontent/35/41) Lymphoepithelial carcinoma of the lung (/chaptercontent/35/314)
425 Large cell carcinomas
426 Large cell carcinoma of the lung (/chaptercontent/35/46)
427 Adenosquamous carcinoma
428 Adenosquamous carcinoma of the lung (/chaptercontent/35/47)
429 Sarcomatoid carcinomas
430 Pleomorphic carcinoma of the lung (/chaptercontent/35/312)
431 Pulmonary blastoma (/chaptercontent/35/52)
432 Carcinosarcoma of the lung (/chaptercontent/35/51)
433 Other epithelial tumours
434 NUT carcinoma of the lung (see NUT carcinoma of the thorax) (/chaptercontent/35/54) Thoracic SMARCA4-deficient undifferentiated tumour
435 Salivary gland-type tumours
436 Pleomorphic adenoma of the lung (/chaptercontent/35/57)
437 Adenoid cystic carcinoma of the lung (/chaptercontent/35/58)
438 Epithelial-myoepithelial carcinoma of the lung (/chaptercontent/35/59) Mucoepidermoid carcinoma of the lung (/chaptercontent/35/60)
439 Hyalinizing clear cell carcinoma of the lung (/chaptercontent/35/61) Myoepithelioma and myoepithelial carcinoma of the lung
Lung neuroendocrine neoplasms
441 Lung neuroendocrine neoplasms: Introduction (/chaptercontent/35/307)
442 Precursor lesion
443 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (/chaptercontent/35/67)
445 Carcinoid/neuroendocrine tumour of the lung (/chaptercontent/35/69)
447 Small cell lung carcinoma (/chaptercontent/35/72)
448 Large cell neuroendocrine carcinoma of the lung (/chaptercontent/35/74)
449 Tumours of ectopic tissues
450 Melanoma of the lung (/chaptercontent/35/85) Meningioma of the lung (/chaptercontent/35/86)
451 Mesenchymal tumours specific to the lung
452 Pulmonary hamartoma (/chaptercontent/35/90) Pulmonary chondroma (/chaptercontent/35/91)
453 Diffuse pulmonary lymphangiomatosis (/chaptercontent/35/98) Pleuropulmonary blastoma (/chaptercontent/35/93)
454 Pulmonary artery intimal sarcoma (/chaptercontent/35/94)
455 Congenital peribronchial myofibroblastic tumour (/chaptercontent/35/334)
456 Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion (/chaptercontent/35/95)
457 PEComatous tumours
458 Lymphangioleiomyomatosis of the lung (/chaptercontent/35/97) PEComa of the lung (/chaptercontent/35/290)
459 Haematolymphoid tumours
460 Haematolymphoid tumours of the lung: Introduction (/chaptercontent/35/101) MALT lymphoma of the lung (/chaptercontent/35/102)
461 Pulmonary diffuse large B-cell lymphoma (/chaptercontent/35/103) Lymphomatoid granulomatosis of the lung (/chaptercontent/35/104)
Intravascular large B-cell lymphoma of the lung (/chaptercontent/35/105) Pulmonary Langerhans cell histiocytosis (/chaptercontent/35/106)
462 Pulmonary Erdheim-Chester disease (/chaptercontent/35/107)
463 3.
464 Tumours of the pleura and pericardium
465 Tumours of the pleura and pericardium: Introduction (/chaptercontent/35/109)
466 Mesothelial tumours
467 Benign and preinvasive mesothelial tumours
468 Adenomatoid tumour of the pleura (/chaptercontent/35/112)
469 Well-differentiated papillary mesothelial tumour of the pleura (/chaptercontent/35/116) Mesothelioma in situ (/chaptercontent/35/114)
470 Mesothelioma
471 Localized pleural mesothelioma (/chaptercontent/35/115) Diffuse pleural mesothelioma (/chaptercontent/35/117)
473 Haematolymphoid tumours of the pleura and pericardium: Introduction (/chaptercontent/35/127) Primary effusion lymphoma
Diffuse large B-cell lymphoma associated with chronic inflammation of the pleura (/chaptercontent/35/129)
475 4.
476 Tumours of the heart
477 Tumours of the heart: Introduction (/chaptercontent/35/131) Benign tumours
478 Papillary fibroelastoma (/chaptercontent/35/138) Cardiac myxoma (/chaptercontent/35/137)
479 Cardiac fibroma (/chaptercontent/35/144)
480 Cardiac rhabdomyoma (/chaptercontent/35/133)
481 Adult cellular rhabdomyoma (/chaptercontent/35/136)
482 Cardiac lipoma and lipomatous hypertrophy of the atrial septum (/chaptercontent/35/145) Lipomatous hamartoma of the atrioventricular valve
483 Hamartoma of mature cardiac myocytes (/chaptercontent/35/135) Mesenchymal cardiac hamartoma (/chaptercontent/35/305)
484 Cardiac haemangiomas (/chaptercontent/35/139)
485 Conduction system hamartoma (/chaptercontent/35/134)
486 Cystic tumour of the atrioventricular node (/chaptercontent/35/146)
487 Malignant tumours
488 Cardiac angiosarcoma (/chaptercontent/35/157) Cardiac leiomyosarcoma (/chaptercontent/35/161)
489 Cardiac undifferentiated pleomorphic sarcoma (/chaptercontent/35/158) Other sarcomas that may involve the heart (/chaptercontent/35/164)
491 Haematolymphoid tumours of the heart: Introduction (/chaptercontent/35/167) Cardiac diffuse large B-cell lymphoma (/chaptercontent/35/168)
492 Cardiac fibrin-associated diffuse large B-cell lymphoma (/chaptercontent/35/169)
493 5.
494 Mesenchymal tumours of the thorax
495 Mesenchymal tumours of the thorax: Introduction (/chaptercontent/35/171) Mesenchymal tumours
497 Lipoma of the thorax (/chaptercontent/35/174)
498 Thymolipoma (/chaptercontent/35/175) Liposarcoma of the thorax (/chaptercontent/35/176)
500 Desmoid fibromatosis of the thorax (/chaptercontent/35/182) Solitary fibrous tumour of the thorax (/chaptercontent/35/183)
501 Calcifying fibrous tumour of the thorax (/chaptercontent/35/189) Inflammatory myofibroblastic tumour of the thorax (/chaptercontent/35/185)
Myxofibrosarcoma of the thorax (/chaptercontent/35/186)
503 Haemangioma of the thorax (/chaptercontent/35/191) Lymphangioma of the thorax (/chaptercontent/35/192)
504 Epithelioid haemangioendothelioma of the thorax (/chaptercontent/35/193) Angiosarcoma of the thorax (/chaptercontent/35/194)
506 Rhabdomyosarcoma of the thorax (/chaptercontent/35/199)
507 Peripheral nerve sheath and neural tumours
508 Paraganglioma of the thorax (/chaptercontent/35/151) Granular cell tumour of the thorax (/chaptercontent/35/147) Schwannoma of the thorax
509 Malignant peripheral nerve sheath tumour of the thorax (/chaptercontent/35/293) Peripheral neuroblastic tumours of the thorax
Tumours of uncertain differentiation
511 Synovial sarcoma of the thorax (/chaptercontent/35/210)
512 Undifferentiated small round cell sarcomas of the thorax (/chaptercontent/35/215)
513 6.
514 Tumours of the thymus
516 Thymoma
517 Thymoma: Introduction (/chaptercontent/35/292)
518 Type A thymoma (including atypical subtype) (/chaptercontent/35/219) Type AB thymoma (/chaptercontent/35/220)
519 Type B1 thymoma (/chaptercontent/35/221) Type B2 thymoma (/chaptercontent/35/222) Type B3 thymoma (/chaptercontent/35/223)
520 Micronodular thymoma with lymphoid stroma (/chaptercontent/35/224) Metaplastic thymoma (/chaptercontent/35/225)
521 Lipofibroadenoma of the thymus (/chaptercontent/35/229) Thymic carcinoma: Introduction (/chaptercontent/35/298)
522 Squamous cell carcinoma of the thymus (/chaptercontent/35/231) Basaloid carcinoma of the thymus (/chaptercontent/35/232) Lymphoepithelial
carcinoma of the thymus (/chaptercontent/35/234) NUT carcinoma of the thorax (/chaptercontent/35/243)
523 Clear cell carcinoma of the thymus (/chaptercontent/35/235)
524 Low-grade papillary adenocarcinoma of the thymus (/chaptercontent/35/238) Mucoepidermoid carcinoma of the thymus (/chaptercontent/35/233)
525 Thymic carcinoma with adenoid cystic carcinoma-like features (/chaptercontent/35/239)
526 Enteric-type adenocarcinoma of the thymus (/chaptercontent/35/241) Adenocarcinoma NOS of the thymus (/chaptercontent/35/242)
527 Adenosquamous carcinoma of the thymus (/chaptercontent/35/246) Sarcomatoid carcinoma of the thymus (/chaptercontent/35/236)
528 Undifferentiated carcinoma of the thymus (/chaptercontent/35/244) Thymic carcinoma NOS (/chaptercontent/35/248)
529 Thymic neuroendocrine neoplasms
530 Thymic neuroendocrine neoplasms: Introduction (/chaptercontent/35/300)
532 Carcinoid/neuroendocrine tumour of the thymus (/chaptercontent/35/252)
534 Small cell carcinoma of the thymus (/chaptercontent/35/257)
535 Large cell neuroendocrine carcinoma of the thymus (/chaptercontent/35/255)
536 7.
537 Germ cell tumours of the mediastinum
538 Germ cell tumours of the mediastinum: Introduction (/chaptercontent/35/301) Seminoma of the mediastinum (/chaptercontent/35/262)
539 Embryonal carcinoma of the mediastinum (/chaptercontent/35/263) Yolk sac tumour of the mediastinum (/chaptercontent/35/264)
540 Choriocarcinoma of the mediastinum (/chaptercontent/35/265) Teratoma of the mediastinum (/chaptercontent/35/266)
541 Mixed germ cell tumours of the mediastinum (/chaptercontent/35/269)
542 Mediastinal germ cell tumours with somatic-type solid malignancy (/chaptercontent/35/270) Mediastinal germ cell tumours with associated
haematological malignancy (/chaptercontent/35/272)
543 8.
544 Haematolymphoid tumours of the mediastinum
545 Haematolymphoid tumours of the mediastinum: Introduction (/chaptercontent/35/275) Primary mediastinal large B-cell lymphoma
MALT lymphoma of the mediastinum (/chaptercontent/35/277)
547 Mediastinal T-lymphoblastic leukaemia/lymphoma (/chaptercontent/35/278) Classic Hodgkin lymphoma of the mediastinum
(/chaptercontent/35/279) Mediastinal grey zone lymphoma (/chaptercontent/35/280)
548 Follicular dendritic cell sarcoma of the mediastinum (/chaptercontent/35/281) Myeloid sarcoma of the mediastinum (/chaptercontent/35/282)
549 9.
550 Ectopic tumours of thyroid and parathyroid origin
551 Ectopic thyroid tumours (/chaptercontent/35/326)
552 Ectopic parathyroid tumours (/chaptercontent/35/327)
553 10.
554 Metastases
555 Metastasis to the lung (/chaptercontent/35/87) Metastasis to the pleura (/chaptercontent/35/324)
556 Metastasis to the thymus and mediastinal lymph nodes (/chaptercontent/35/325) Metastasis to the heart and pericardium (/chaptercontent/35/323)
557 11.
558 Genetic tumour syndromes involving the thorax
559 Genetic tumour syndromes involving the thorax: Introduction (/chaptercontent/35/309) Li-Fraumeni syndrome (/chaptercontent/35/285)
560 BAP1 tumour predisposition syndrome (/chaptercontent/35/289) Carney complex (/chaptercontent/35/310)
562 Digestive System Tumours (5th ed.)
563 1.
566 Foreword with changes from the book, including corrigenda (/chaptercontent/31/277) ICD-O coding of digestive system tumours
567 TNM staging of digestive system tumours (/chaptercontent/31/281) ICCR datasets: Digestive tract (/chaptercontent/31/282)
568 Introduction to tumours of the digestive system (/chaptercontent/31/1)
569 Classification of neuroendocrine neoplasms of the digestive system (/chaptercontent/31/139)
570 2.
571 Tumours of the oesophagus
572 Tumours of the oesophagus: Introduction (/chaptercontent/31/3) Epithelial tumours
573 Benign epithelial tumours and precursors
574 Oesophageal squamous papilloma (/chaptercontent/31/6) Barrett dysplasia (/chaptercontent/31/8)
575 Oesophageal squamous dysplasia (/chaptercontent/31/9)
577 Adenocarcinoma of the oesophagus and oesophagogastric junction NOS (/chaptercontent/31/11) Oesophageal adenoid cystic carcinoma
578 Oesophageal adenosquamous and mucoepidermoid carcinomas (/chaptercontent/31/13) Oesophageal squamous cell carcinoma NOS
579 Oesophageal undifferentiated carcinoma (/chaptercontent/31/15) Oesophageal neuroendocrine neoplasms (/chaptercontent/31/140)
580 3.
581 Tumours of the stomach
582 Tumours of the stomach: Introduction (/chaptercontent/31/17)
583 Gastritis and metaplasia: precursors of gastric neoplasms (/chaptercontent/31/260) Epithelial tumours
585 Fundic gland polyps (/chaptercontent/31/20) Gastric hyperplastic polyps (/chaptercontent/31/21) Gastric dysplasia (/chaptercontent/31/23)
586 Intestinal-type gastric adenoma (/chaptercontent/31/25) Foveolar-type adenoma (/chaptercontent/31/245) Gastric pyloric gland adenoma
(/chaptercontent/31/26) Oxyntic gland adenoma (/chaptercontent/31/27)
588 Gastric adenocarcinoma (/chaptercontent/31/29)
589 Gastric squamous cell carcinoma (/chaptercontent/31/30)
590 Gastric adenosquamous carcinoma (/chaptercontent/31/31) Gastric undifferentiated carcinoma (/chaptercontent/31/32) Gastroblastoma
591 Gastric neuroendocrine neoplasms (/chaptercontent/31/141)
592 4.
593 Tumours of the small intestine and ampulla
594 Tumours of the small intestine and ampulla: Introduction (/chaptercontent/31/34) Epithelial tumours
596 Non-ampullary adenoma (/chaptercontent/31/37) Ampullary adenoma (/chaptercontent/31/250)
598 Non-ampullary adenocarcinoma (/chaptercontent/31/39) Ampullary adenocarcinoma (/chaptercontent/31/251)
599 Small intestinal and ampullary neuroendocrine neoplasms (/chaptercontent/31/142)
600 5.
601 Tumours of the appendix
602 Tumours of the appendix: Introduction (/chaptercontent/31/42) Epithelial tumours
603 Appendiceal serrated lesions and polyps (/chaptercontent/31/46) Appendiceal mucinous neoplasm (/chaptercontent/31/48)
604 Appendiceal adenocarcinoma (/chaptercontent/31/51)
605 Appendiceal goblet cell adenocarcinoma (/chaptercontent/31/52) Appendiceal neuroendocrine neoplasms (/chaptercontent/31/143)
606 6.
607 Tumours of the colon and rectum
608 Tumours of the colon and rectum: Introduction (/chaptercontent/31/54) Epithelial tumours
610 Colorectal serrated lesions and polyps (/chaptercontent/31/57) Conventional colorectal adenoma (/chaptercontent/31/59)
611 Inflammatory bowel disease-associated dysplasia of the colorectum (/chaptercontent/31/60)
613 Colorectal adenocarcinoma (/chaptercontent/31/62)
614 Colorectal neuroendocrine neoplasms (/chaptercontent/31/144)
615 7.
616 Tumours of the anal canal
617 Tumours of the anal canal: Introduction (/chaptercontent/31/65) Epithelial tumours
619 Inflammatory cloacogenic polyp (/chaptercontent/31/68) Anal condyloma (/chaptercontent/31/253)
620 Anal squamous dysplasia (intraepithelial neoplasia) (/chaptercontent/31/70)
622 Anal squamous cell carcinoma (/chaptercontent/31/72) Anal adenocarcinoma (/chaptercontent/31/73)
623 Anal neuroendocrine neoplasms (/chaptercontent/31/259)
624 8.
625 Tumours of the liver and intrahepatic bile ducts
626 Tumours of the liver and intrahepatic bile ducts: Introduction (/chaptercontent/31/75) Epithelial tumours
627 Benign hepatocellular tumours
628 Focal nodular hyperplasia of the liver (/chaptercontent/31/79) Hepatocellular adenoma (/chaptercontent/31/78)
629 Malignant hepatocellular tumours and precursors
630 Hepatocellular carcinoma (/chaptercontent/31/82) Hepatoblastoma (/chaptercontent/31/83)
631 Benign biliary tumours and precursors
632 Bile duct adenoma (/chaptercontent/31/85) Biliary adenofibroma (/chaptercontent/31/86)
633 Biliary intraepithelial neoplasia (See chapter 9) (/chaptercontent/31/272)
634 Intraductal papillary neoplasm of the bile ducts (See chapter 9) (/chaptercontent/31/273) Mucinous cystic neoplasm of the liver and biliary system
635 Malignant biliary tumours
636 Intrahepatic cholangiocarcinoma (/chaptercontent/31/90)
637 Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma (/chaptercontent/31/91)
638 Hepatic neuroendocrine neoplasms (/chaptercontent/31/258)
639 9.
640 Tumours of the gallbladder and extrahepatic bile ducts
641 Tumours of the gallbladder and extrahepatic bile ducts: Introduction (/chaptercontent/31/102) Epithelial tumours
643 Pyloric gland adenoma of the gallbladder (/chaptercontent/31/105) Biliary intraepithelial neoplasia (/chaptercontent/31/108)
644 Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm) (/chaptercontent/31/106)
645 Intraductal papillary neoplasm of the bile ducts (/chaptercontent/31/275)
647 Carcinoma of the gallbladder (/chaptercontent/31/110)
648 Carcinoma of the extrahepatic bile ducts (/chaptercontent/31/249)
649 Neuroendocrine neoplasms of the gallbladder and bile ducts (/chaptercontent/31/157)
650 10.
651 Tumours of the pancreas
652 Tumours of the pancreas: Introduction (/chaptercontent/31/114) Epithelial tumours
654 Acinar cystic transformation of the pancreas (/chaptercontent/31/117) Serous neoplasms of the pancreas (/chaptercontent/31/118)
655 Pancreatic intraepithelial neoplasia (/chaptercontent/31/120)
656 Pancreatic intraductal papillary mucinous neoplasm (/chaptercontent/31/121) Pancreatic intraductal oncocytic papillary neoplasm
(/chaptercontent/31/122) Pancreatic intraductal tubulopapillary neoplasm (/chaptercontent/31/123)
657 Pancreatic mucinous cystic neoplasm (/chaptercontent/31/124)
659 Pancreatic ductal adenocarcinoma (/chaptercontent/31/126) Pancreatic acinar cell carcinoma (/chaptercontent/31/130)
660 Pancreatoblastoma (/chaptercontent/31/127)
661 Solid pseudopapillary neoplasm of the pancreas (/chaptercontent/31/128)
662 Pancreatic neuroendocrine neoplasms
663 Pancreatic neuroendocrine neoplasms: Introduction (/chaptercontent/31/276) Non-functioning pancreatic neuroendocrine tumours
(/chaptercontent/31/147) Functioning pancreatic neuroendocrine tumours
664 Insulinoma (/chaptercontent/31/148) Gastrinoma (/chaptercontent/31/151) VIPoma (/chaptercontent/31/152)
665 Glucagonoma (/chaptercontent/31/149)
666 Somatostatinoma (/chaptercontent/31/150)
667 ACTH-producing neuroendocrine tumour (/chaptercontent/31/154)
668 Serotonin-producing neuroendocrine tumour (/chaptercontent/31/153) Pancreatic neuroendocrine carcinoma (/chaptercontent/31/155)
669 Pancreatic MiNENs (/chaptercontent/31/156)
670 11.
671 Haematolymphoid tumours of the digestive system
672 Haematolymphoid tumours of the digestive system: Introduction (/chaptercontent/31/165) Haematolymphoid tumours
673 Site-specific haematolymphoid tumours
674 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract (/chaptercontent/31/168)
675 Duodenal-type follicular lymphoma (/chaptercontent/31/169)
676 Enteropathy-associated T-cell lymphoma (/chaptercontent/31/170) Monomorphic epitheliotropic intestinal T-cell lymphoma
(/chaptercontent/31/171) Intestinal T-cell lymphoma NOS (/chaptercontent/31/172)
677 Indolent T-cell lymphoproliferative disorder of the GI tract (/chaptercontent/31/173) Hepatosplenic T-cell lymphoma (/chaptercontent/31/174)
678 EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract (/chaptercontent/31/175)
679 Haematolymphoid tumours occurring with some frequency in the digestive system
680 Diffuse large B-cell lymphoma (/chaptercontent/31/177) Follicular lymphoma (/chaptercontent/31/178)
681 Mantle cell lymphoma (/chaptercontent/31/179) Burkitt lymphoma (/chaptercontent/31/180)
682 Plasmablastic lymphoma (/chaptercontent/31/181)
683 Posttransplant lymphoproliferative disorders (/chaptercontent/31/182) Extranodal NK/T-cell lymphoma (/chaptercontent/31/183)
684 Systemic mastocytosis (/chaptercontent/31/184) Langerhans cell histiocytosis (/chaptercontent/31/246) Follicular dendritic cell sarcoma
(/chaptercontent/31/247) Histiocytic sarcoma (/chaptercontent/31/248)
685 12.
686 Mesenchymal tumours of the digestive system
687 Mesenchymal tumours of the digestive system: Introduction (/chaptercontent/31/187) Mesenchymal tumours
688 Gastrointestinal stromal tumour
689 Gastrointestinal stromal tumour (/chaptercontent/31/206)
690 Adipose tissue and (myo)fibroblastic tumours
691 Inflammatory myofibroblastic tumour (/chaptercontent/31/190) Desmoid fibromatosis (/chaptercontent/31/191)
692 Solitary fibrous tumour (/chaptercontent/31/192) Lipoma (/chaptercontent/31/193)
693 Inflammatory fibroid polyp (/chaptercontent/31/194) Plexiform fibromyxoma (/chaptercontent/31/195)
694 Smooth muscle and skeletal muscle tumours Leiomyoma (/chaptercontent/31/197) Leiomyosarcoma (/chaptercontent/31/198)
696 Vascular and perivascular tumours
697 Haemangioma (/chaptercontent/31/201)
698 Epithelioid haemangioendothelioma (prev Vascular Tumours in Liver) (/chaptercontent/31/93) Kaposi sarcoma (/chaptercontent/31/202)
699 Angiosarcoma (/chaptercontent/31/203) Glomus tumour (/chaptercontent/31/204)
700 Lymphangioma and lymphangiomatosis (/chaptercontent/31/205)
701 Neural tumours
702 Schwannoma (/chaptercontent/31/208) Granular cell tumour (/chaptercontent/31/209) Perineurioma (/chaptercontent/31/210)
703 Ganglioneuroma and ganglioneuromatosis (/chaptercontent/31/211)
705 PEComa, including angiomyolipoma (/chaptercontent/31/95) Mesenchymal hamartoma of the liver (/chaptercontent/31/214)
706 Calcifying nested stromal-epithelial tumour of the liver (/chaptercontent/31/96) Synovial sarcoma (/chaptercontent/31/215)
707 Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumour (/chaptercontent/31/216)
708 Embryonal sarcoma of the liver (/chaptercontent/31/218)
709 13.
710 Other tumours of the digestive system
711 Other tumours of the digestive system
712 Mucosal melanoma of the digestive system (/chaptercontent/31/223) Germ cell tumours of the digestive system (/chaptercontent/31/98)
713 Digestive system metastases (/chaptercontent/31/224)
714 14.
715 Genetic tumour syndromes of the digestive system
716 Genetic tumour syndromes of the digestive system: Introduction (/chaptercontent/31/226) Genetics
717 Genetic tumour syndromes of the digestive system
718 Lynch syndrome (/chaptercontent/31/231)
719 Familial adenomatous polyposis 1 (/chaptercontent/31/232) GAPPS and other fundic gland polyposes (/chaptercontent/31/229) Other
adenomatous polyposes (/chaptercontent/31/233)
720 Serrated polyposis (/chaptercontent/31/234)
721 Hereditary diffuse gastric cancer (/chaptercontent/31/230) Familial pancreatic cancer (/chaptercontent/31/235) Juvenile polyposis syndrome
722 Peutz-Jeghers syndrome (/chaptercontent/31/243) Cowden syndrome (/chaptercontent/31/244)
723 Other genetic tumour syndromes (/chaptercontent/31/239)
725 Urinary and Male Genital Tumours (5th ed.)
726 1.
729 Foreword with changes from the book, including corrigenda (/chaptercontent/36/332) ICD-O coding of urinary and male genital tumours
730 TNM staging of urological tumours (/chaptercontent/36/337) ICCR datasets: Urinary / Male genital (/chaptercontent/36/338)
731 Introduction to urinary and male genital tumours (/chaptercontent/36/1)
732 2.
733 Tumours of the kidney
734 Renal cell tumours
735 Renal cell tumours: Introduction (/chaptercontent/36/4)
736 Clear cell renal tumours
737 Clear cell renal cell carcinoma (/chaptercontent/36/13)
738 Multilocular cystic renal neoplasm of low malignant potential (/chaptercontent/36/14)
739 Papillary renal tumours
740 Renal papillary adenoma (/chaptercontent/36/6)
741 Papillary renal cell carcinoma (/chaptercontent/36/7)
742 Oncocytic and chromophobe renal tumours
743 Oncocytoma of the kidney (/chaptercontent/36/17)
744 Chromophobe renal cell carcinoma (/chaptercontent/36/18) Other oncocytic tumours of the kidney (/chaptercontent/36/204)
745 Collecting duct tumours
746 Collecting duct carcinoma (/chaptercontent/36/21)
747 Other renal tumours
748 Clear cell papillary renal cell tumour (/chaptercontent/36/15) Mucinous tubular and spindle cell carcinoma (/chaptercontent/36/8) Tubulocystic renal
cell carcinoma (/chaptercontent/36/10)
749 Acquired cystic disease-associated renal cell carcinoma (/chaptercontent/36/11) Eosinophilic solid and cystic renal cell carcinoma
Renal cell carcinoma NOS (/chaptercontent/36/27)
751 Molecularly defined renal carcinomas
752 TFE3-rearranged renal cell carcinomas (/chaptercontent/36/25) TFEB-altered renal cell carcinomas (/chaptercontent/36/26)
753 ELOC (formerly TCEB1)-mutated renal cell carcinoma (/chaptercontent/36/211) Fumarate hydratase-deficient renal cell carcinoma
Succinate dehydrogenase-deficient renal cell carcinoma (/chaptercontent/36/19) ALK-rearranged renal cell carcinomas (/chaptercontent/36/311)
755 SMARCB1-deficient renal medullary carcinoma (/chaptercontent/36/22)
756 Metanephric tumours
757 Metanephric adenoma (/chaptercontent/36/48) Metanephric adenofibroma (/chaptercontent/36/49)
758 Metanephric stromal tumour (/chaptercontent/36/50)
759 Mixed epithelial and stromal renal tumours
760 Mixed epithelial and stromal tumour of the kidney (/chaptercontent/36/29) Paediatric cystic nephroma (/chaptercontent/36/45)
761 Renal mesenchymal tumours
762 Adult renal mesenchymal tumours
763 Classic angiomyolipoma / PEComa of the kidney (/chaptercontent/36/32)
764 Epithelioid angiomyolipoma / epithelioid PEComa of the kidney (/chaptercontent/36/33) Renal haemangioblastoma (/chaptercontent/36/243)
765 Juxtaglomerular cell tumour (/chaptercontent/36/34)
766 Renomedullary interstitial cell tumour (/chaptercontent/36/35)
767 Paediatric renal mesenchymal tumours
768 Ossifying renal tumour of infancy (/chaptercontent/36/38) Congenital mesoblastic nephroma (/chaptercontent/36/37) Rhabdoid tumour of the kidney
769 Clear cell sarcoma of the kidney (/chaptercontent/36/40)
770 Embryonal neoplasms of the kidney
771 Nephroblastic tumours
772 Nephrogenic rests (/chaptercontent/36/43)
773 Cystic partially differentiated nephroblastoma (/chaptercontent/36/46) Nephroblastoma (/chaptercontent/36/44)
774 Miscellaneous renal tumours
775 Germ cell tumours of the kidney (/chaptercontent/36/53)
776 3.
777 Tumours of the urinary tract
778 Tumours of the urinary tract: Introduction (/chaptercontent/36/66)
779 Urothelial tumours
780 Non-invasive urothelial neoplasms
781 Urothelial papilloma (/chaptercontent/36/69) Inverted urothelial papilloma (/chaptercontent/36/70)
782 Papillary urothelial neoplasm of low malignant potential (/chaptercontent/36/71) Non-invasive papillary urothelial carcinoma, low-grade
(/chaptercontent/36/72) Non-invasive papillary urothelial carcinoma, high-grade (/chaptercontent/36/73) Urothelial carcinoma in situ
783 Invasive urothelial neoplasms
784 Invasive urothelial carcinoma (/chaptercontent/36/76)
785 Squamous cell neoplasms of the urinary tract
786 Squamous papilloma of the urothelial tract (/chaptercontent/36/79)
787 Squamous cell carcinomas of the urinary tract
788 Verrucous carcinoma of the bladder (/chaptercontent/36/81)
789 Pure squamous carcinoma of the urothelial tract (/chaptercontent/36/82)
790 Glandular neoplasms
791 Adenomas
792 Villous adenoma (/chaptercontent/36/85)
793 Adenocarcinomas
794 Adenocarcinoma NOS (/chaptercontent/36/87)
795 Urachal and diverticular neoplasms
796 Urachal carcinoma (/chaptercontent/36/88)
797 Diverticular carcinoma (/chaptercontent/36/330)
798 Urethral neoplasms
799 Urethral accessory gland carcinomas
800 Littre gland adenocarcinoma of the urethra (/chaptercontent/36/227) Skene gland adenocarcinoma of the urethra (/chaptercontent/36/228)
801 Cowper gland adenocarcinoma of the urethra (/chaptercontent/36/103)
802 Tumours of Mullerian type
803 Clear cell adenocarcinoma of the urinary tract (/chaptercontent/36/90) Endometrioid carcinoma of the urinary tract (/chaptercontent/36/91)
804 4.
805 Tumours of the prostate
806 Tumours of the prostate: Introduction (/chaptercontent/36/95)
807 Epithelial tumours of the prostate
808 Glandular neoplasms of the prostate
809 Prostatic cystadenoma (/chaptercontent/36/331)
810 High-grade prostatic intraepithelial neoplasia (/chaptercontent/36/98) Intraductal carcinoma of the prostate (/chaptercontent/36/99)
811 Prostatic acinar adenocarcinoma (/chaptercontent/36/100) Prostatic ductal adenocarcinoma (/chaptercontent/36/101)
812 Treatment-related neuroendocrine prostatic carcinoma (/chaptercontent/36/326)
813 Squamous neoplasms of the prostate
814 Adenosquamous carcinoma of the prostate (/chaptercontent/36/105) Squamous cell carcinoma of the prostate (/chaptercontent/36/106)
815 Adenoid cystic (basal cell) carcinoma of the prostate (/chaptercontent/36/107)
816 Mesenchymal tumours unique to the prostate
817 Stromal tumours of the prostate
818 Prostatic stromal tumour of uncertain malignant potential (/chaptercontent/36/110) Prostatic stromal sarcoma (/chaptercontent/36/111)
819 5.
820 Tumours of the seminal vesicle
821 Tumours of the seminal vesicle: Introduction (/chaptercontent/36/318)
822 Epithelial tumours of the seminal vesicle
823 Glandular neoplasms of the seminal vesicle
824 Cystadenoma of the seminal vesicle (/chaptercontent/36/321)
825 Adenocarcinoma of the seminal vesicle (/chaptercontent/36/322)
826 Squamous neoplasms of the seminal vesicle
827 Squamous cell carcinoma of the seminal vesicle (/chaptercontent/36/324)
828 Other tumours of the seminal vesicle
829 Mixed epithelial and stromal tumour of the seminal vesicle (/chaptercontent/36/327)
830 6.
831 Tumours of the testis
832 Tumours of the testis: Introduction (/chaptercontent/36/113)
833 Germ cell tumours derived from germ cell neoplasia in situ
834 Non-invasive germ cell neoplasia
835 Germ cell neoplasia in situ (/chaptercontent/36/116)
836 Specific forms of intratubular germ cell neoplasia (/chaptercontent/36/117) Gonadoblastoma (/chaptercontent/36/157)
837 The germinoma family of tumours
838 Seminoma (/chaptercontent/36/119)
839 Non-seminomatous germ cell tumours
840 Embryonal carcinoma (/chaptercontent/36/121)
841 Yolk sac tumour, postpubertal-type (/chaptercontent/36/122) Choriocarcinoma (/chaptercontent/36/124)
842 Placental site trophoblastic tumour (/chaptercontent/36/125) Epithelioid trophoblastic tumour (/chaptercontent/36/126)
843 Cystic trophoblastic tumour (/chaptercontent/36/127) Teratoma, postpubertal-type (/chaptercontent/36/316)
844 Teratoma with somatic-type malignancy (/chaptercontent/36/129)
845 Mixed germ cell tumours of the testis
846 Mixed germ cell tumours (/chaptercontent/36/134)
847 Germ cell tumours of unknown type
848 Regressed germ cell tumours (/chaptercontent/36/136)
849 Germ cell tumours unrelated to germ cell neoplasia in situ Spermatocytic tumour (/chaptercontent/36/138) Teratoma, prepubertal-type
850 Yolk sac tumour, prepubertal-type (/chaptercontent/36/142)
851 Testicular neuroendocrine tumour, prepubertal-type (/chaptercontent/36/130) Mixed teratoma and yolk sac tumour, prepubertal-type
852 Sex cord stromal tumours of the testis
853 Leydig cell tumour
854 Leydig cell tumour (/chaptercontent/36/145)
855 Sertoli cell tumours
856 Sertoli cell tumour (/chaptercontent/36/147)
857 Large cell calcifying Sertoli cell tumour (/chaptercontent/36/219)
858 Granulosa cell tumours
859 Adult granulosa cell tumour (/chaptercontent/36/149) Juvenile granulosa cell tumour (/chaptercontent/36/150)
860 The fibroma thecoma family of tumours
861 Tumours in the fibroma thecoma group (/chaptercontent/36/152)
862 Mixed and other sex cord stromal tumours
863 Mixed sex cord stromal tumour (/chaptercontent/36/154) Signet ring stromal tumour (/chaptercontent/36/133) Myoid gonadal stromal tumour
(/chaptercontent/36/222) Sex cord stromal tumour NOS (/chaptercontent/36/155)
864 7.
865 Tumours of the testicular adnexa
866 Tumours of the testicular adnexa: Introduction (/chaptercontent/36/170)
867 Ovarian-type tumours of the collecting ducts and rete testis
868 Serous cystadenoma (/chaptercontent/36/160)
869 Serous tumour of borderline malignancy (/chaptercontent/36/161) Serous cystadenocarcinoma (/chaptercontent/36/162)
870 Mucinous cystadenoma (/chaptercontent/36/163) Mucinous borderline tumour (/chaptercontent/36/164) Mucinous cystadenocarcinoma
(/chaptercontent/36/165) Endometrioid tumours (/chaptercontent/36/166)
871 Clear cell adenocarcinoma (/chaptercontent/36/167) Brenner tumour (/chaptercontent/36/168)
872 Tumours of the collecting ducts and rete testis
873 Adenoma of the collecting ducts and rete testis (/chaptercontent/36/172)
874 Adenocarcinoma of the collecting ducts and rete testis (/chaptercontent/36/173)
875 Paratesticular mesothelial tumours
876 Adenomatoid tumour (/chaptercontent/36/176)
877 Well-differentiated papillary mesothelial tumour (/chaptercontent/36/178) Mesothelioma (/chaptercontent/36/177)
878 Tumours of the epididymis
879 Cystadenoma of the epididymis (/chaptercontent/36/182)
880 Papillary cystadenoma of the epididymis (/chaptercontent/36/183) Adenocarcinoma of the epididymis (/chaptercontent/36/184)
881 Squamous cell carcinoma of the epididymis (/chaptercontent/36/185) Melanotic neuroectodermal tumour of the epididymis
8.
883 Tumours of the penis and scrotum
884 Tumours of the penis and scrotum: Introduction (/chaptercontent/36/191)
885 Benign and precursor squamous lesions
886 Condyloma acuminatum (/chaptercontent/36/193)
887 Squamous cell carcinoma precursors, HPV-associated
888 Penile intraepithelial neoplasia, HPV-associated (/chaptercontent/36/195)
889 Squamous cell carcinoma precursors, HPV-independent
890 Differentiated penile intraepithelial neoplasia, HPV-independent (/chaptercontent/36/201)
891 Invasive epithelial tumours of the penis and scrotum
892 Invasive squamous epithelial tumours
893 HPV-associated squamous cell carcinoma (/chaptercontent/36/203) HPV-independent squamous cell carcinoma (/chaptercontent/36/208)
Squamous cell carcinoma NOS (/chaptercontent/36/209)
895 Penile adenosquamous and mucoepidermoid carcinomas (/chaptercontent/36/212) Extramammary Paget disease (/chaptercontent/36/215)
896 Other scrotal tumours
897 Basal cell carcinoma of the scrotum (/chaptercontent/36/312)
898 9.
900 Neuroendocrine neoplasms: Introduction (/chaptercontent/36/56)
902 Well-differentiated neuroendocrine tumour (/chaptercontent/36/58)
904 Small cell neuroendocrine carcinoma (/chaptercontent/36/61) Large cell neuroendocrine carcinoma (/chaptercontent/36/60) Mixed neuroendocrine
neoplasms (/chaptercontent/36/62)
905 Paragangliomas
906 Paraganglioma (/chaptercontent/36/64)
907 10.
908 Mesenchymal tumours
909 Mesenchymal tumours: Introduction (/chaptercontent/36/231)
911 The angiofibroma family of tumours (/chaptercontent/36/314) Solitary fibrous tumour (/chaptercontent/36/234)
912 Inflammatory myofibroblastic tumour (/chaptercontent/36/236)
914 Haemangioma (/chaptercontent/36/240) Angiosarcoma (/chaptercontent/36/245)
916 Glomus tumour (/chaptercontent/36/247) Myointimoma (/chaptercontent/36/248) Myopericytoma (/chaptercontent/36/329)
917 Extrarenal PEComa (/chaptercontent/36/249)
919 Leiomyoma (/chaptercontent/36/252) Leiomyosarcoma (/chaptercontent/36/253)
923 Synovial sarcoma (/chaptercontent/36/264)
924 Extrarenal rhabdoid tumour (/chaptercontent/36/268)
925 Desmoplastic small round cell tumour (/chaptercontent/36/313)
926 11.
928 Haematolymphoid tumours: Introduction (/chaptercontent/36/271)
929 Mature B-cell lymphomas
930 Extranodal marginal zone lymphoma of MALT (/chaptercontent/36/275) Diffuse large B-cell lymphoma (/chaptercontent/36/277)
931 Plasmacytoma (/chaptercontent/36/278)
932 Histiocytic tumours
933 Juvenile xanthogranuloma (/chaptercontent/36/282)
934 12.
935 Melanocytic lesions
936 Mucosal melanoma (/chaptercontent/36/287)
937 13.
938 Metastases in the genitourinary system
939 Metastases in the genitourinary system: Introduction (/chaptercontent/36/289) Metastasis to the urinary tract (/chaptercontent/36/291)
940 Metastasis to the kidney (/chaptercontent/36/290)
941 Metastasis to the testis and paratestis (/chaptercontent/36/292)
942 14.
943 Genetic tumour syndromes of the urinary and male genital tracts
944 Genetic tumour syndromes of the urinary and male genital tracts: Introduction (/chaptercontent/36/295)
945 Von Hippel-Lindau syndrome (/chaptercontent/36/297) Birt-Hogg-Dube syndrome (/chaptercontent/36/298)
946 Hereditary papillary renal carcinoma (/chaptercontent/36/299)
947 Hereditary leiomyomatosis and renal cell carcinoma syndrome (/chaptercontent/36/300) Succinate dehydrogenase-deficient tumour syndromes
948 BAP1 tumour predisposition syndrome (/chaptercontent/36/303)
949 Hereditary phaeochromocytoma-paraganglioma syndromes (/chaptercontent/36/304) Tuberous sclerosis (/chaptercontent/36/305)
950 Genitourinary system and Lynch syndrome (/chaptercontent/36/307)
951 Hereditary tumour syndromes associated with homologous recombination pathway mutations (/chaptercontent/36/308)
952 Carney complex (/chaptercontent/36/309)
953 Peutz-Jeghers syndrome (/chaptercontent/36/310)
955 Female Genital Tumours (5th ed.)
956 1.
959 Foreword with changes from the book, including corrigenda (/chaptercontent/34/534) ICD-O coding of female genital tumours
960 TNM staging of female genital tumours (/chaptercontent/34/539) ICCR datasets: Female reproductive organs (/chaptercontent/34/540)
General introduction (/chaptercontent/34/526)
961 2.
962 Tumours of the ovary
963 Tumours of the ovary: Introduction (/chaptercontent/34/2) Serous tumours
964 Benign serous tumours
965 Serous cystadenoma, adenofibroma, and surface papilloma of the ovary (/chaptercontent/34/5)
966 Borderline serous tumours
967 Serous borderline tumour of the ovary (/chaptercontent/34/9)
968 Malignant serous tumours
969 Low-grade serous carcinoma of the ovary (/chaptercontent/34/12) High-grade serous carcinoma of the ovary (/chaptercontent/34/13)
970 Mucinous tumours
971 Benign mucinous tumours
972 Mucinous cystadenoma and adenofibroma (/chaptercontent/34/16)
973 Borderline mucinous tumours
974 Mucinous borderline tumour (/chaptercontent/34/19)
975 Malignant mucinous tumours
976 Mucinous carcinoma of the ovary (/chaptercontent/34/21)
977 Endometrioid tumours
978 Benign endometrioid tumours
979 Endometrioid cystadenoma and adenofibroma (/chaptercontent/34/24)
980 Borderline endometrioid tumours
981 Endometrioid borderline tumour (/chaptercontent/34/27)
982 Malignant endometrioid tumours
983 Endometrioid carcinoma of the ovary (/chaptercontent/34/29)
984 Clear cell tumours
985 Benign clear cell tumours
986 Clear cell cystadenoma and adenofibroma (/chaptercontent/34/32)
987 Borderline clear cell tumours
988 Clear cell borderline tumour (/chaptercontent/34/35)
989 Malignant clear cell tumours
990 Clear cell carcinoma of the ovary (/chaptercontent/34/37)
991 Seromucinous tumours
992 Benign seromucinous tumours
993 Seromucinous cystadenoma and adenofibroma (/chaptercontent/34/47)
994 Borderline seromucinous tumours
995 Seromucinous borderline tumour (/chaptercontent/34/50)
996 Malignant seromucinous tumours
997 Seromucinous carcinoma (/chaptercontent/34/52)
998 Brenner tumours
999 Benign Brenner tumours
1000 Brenner tumour (/chaptercontent/34/40)
1001 Borderline Brenner tumours
1002 Borderline Brenner tumour (/chaptercontent/34/42)
1003 Malignant Brenner tumours
1004 Malignant Brenner tumour (/chaptercontent/34/44)
1005 Other carcinomas
1006 Mesonephric-like adenocarcinoma (/chaptercontent/34/111)
1007 Undifferentiated and dedifferentiated carcinomas of the ovary (/chaptercontent/34/55) Carcinosarcoma of the ovary (/chaptercontent/34/64)
1008 Mixed carcinoma of the ovary (/chaptercontent/34/10)
1009 Mesenchymal tumours
1010 Endometrioid stromal sarcoma of the ovary (/chaptercontent/34/57) Smooth muscle tumours of the ovary (/chaptercontent/34/59) Ovarian myxoma
1011 Other ovarian mesenchymal tumours (/chaptercontent/34/60)
1012 Mixed epithelial and mesenchymal tumours
1013 Mixed malignant epithelial and mesenchymal tumours
1014 Adenosarcoma of the ovary (/chaptercontent/34/63)
1015 Sex cord-stromal tumours
1016 Pure stromal tumours
1017 Ovarian fibroma (/chaptercontent/34/67) Thecoma (/chaptercontent/34/69)
1018 Luteinized thecoma associated with sclerosing peritonitis (/chaptercontent/34/70) Sclerosing stromal tumour (/chaptercontent/34/71)
1019 Microcystic stromal tumour (/chaptercontent/34/72) Signet-ring stromal tumour (/chaptercontent/34/73) Leydig cell tumour (/chaptercontent/34/74)
1020 Steroid cell tumour (/chaptercontent/34/75) Ovarian fibrosarcoma (/chaptercontent/34/68)
1021 Pure sex cord tumours
1022 Adult granulosa cell tumour (/chaptercontent/34/77) Juvenile granulosa cell tumour (/chaptercontent/34/78) Sertoli cell tumour
Sex cord tumour with annular tubules (/chaptercontent/34/80)
1024 Mixed sex cord-stromal tumours
1025 Sertoli-Leydig cell tumour (/chaptercontent/34/82)
1026 Sex cord-stromal tumour NOS (/chaptercontent/34/83) Gynandroblastoma (/chaptercontent/34/17)
1028 Mature teratoma of the ovary (/chaptercontent/34/90) Immature teratoma of the ovary (/chaptercontent/34/91) Dysgerminoma
Yolk sac tumour (/chaptercontent/34/87)
1030 Embryonal carcinoma (/chaptercontent/34/88)
1031 Non-gestational choriocarcinoma (/chaptercontent/34/89) Mixed germ cell tumour of the ovary (/chaptercontent/34/92)
1032 Monodermal teratomas and somatic-type tumours arising from a dermoid cyst
1033 Struma ovarii (/chaptercontent/34/94) Ovarian carcinoid (/chaptercontent/34/95)
1034 Neuroectodermal-type tumours (/chaptercontent/34/96) Monodermal cystic teratoma (/chaptercontent/34/98)
1035 Somatic neoplasms arising from teratomas (/chaptercontent/34/99)
1036 Germ cell-sex cord-stromal tumours
1037 Gonadoblastoma (/chaptercontent/34/102)
1038 Mixed germ cell-sex cord-stromal tumour, unclassified (/chaptercontent/34/103)
1039 Miscellaneous tumours
1040 Rete cystadenoma, adenoma, and adenocarcinoma (/chaptercontent/34/106) Wolffian tumour of the ovary (/chaptercontent/34/108)
1041 Solid pseudopapillary tumour (/chaptercontent/34/516)
1042 Small cell carcinoma of the ovary, hypercalcaemic type (/chaptercontent/34/109) Wilms tumour (/chaptercontent/34/110)
1043 Mesothelial tumours (see Tumours of the peritoneum) Tumour-like lesions
1044 Follicle cyst (/chaptercontent/34/116)
1045 Corpus luteum cyst (/chaptercontent/34/117)
1046 Large solitary luteinized follicle cyst (/chaptercontent/34/118) Hyperreactio luteinalis (/chaptercontent/34/119)
1047 Pregnancy luteoma (/chaptercontent/34/120)
1048 Stromal hyperplasia and hyperthecosis (/chaptercontent/34/121) Fibromatosis and massive oedema (/chaptercontent/34/123) Leydig cell
hyperplasia (/chaptercontent/34/125)
1049 Metastases
1050 Metastases to the ovary (/chaptercontent/34/509)
1051 3.
1052 Endometriosis and related conditions
1053 Endometriosis and derived tumours (/chaptercontent/34/131)
1054 4.
1055 Tumours of the peritoneum
1056 Tumours of the peritoneum: Introduction (/chaptercontent/34/520)
1058 Adenomatoid tumour (/chaptercontent/34/136)
1059 Well-differentiated papillary mesothelial tumour (/chaptercontent/34/137) Mesothelioma (/chaptercontent/34/138)
1061 Epithelial tumours of Mullerian type
1062 Serous borderline tumour of the peritoneum (/chaptercontent/34/141)
1063 Low-grade serous carcinoma of the peritoneum (/chaptercontent/34/142) High-grade serous carcinoma of the peritoneum (/chaptercontent/34/143)
1064 Mesenchymal tumours specific to peritoneum
1066 Leiomyomatosis peritonealis disseminata (/chaptercontent/34/147)
1067 Miscellaneous primary tumours
1068 Desmoid fibromatosis (/chaptercontent/34/149)
1069 Calcifying fibrous tumour (/chaptercontent/34/151)
1070 Extragastrointestinal stromal tumour (/chaptercontent/34/152)
1071 Solitary fibrous tumour of the peritoneum (/chaptercontent/34/153)
1072 Endometrioid stromal sarcoma of the peritoneum (/chaptercontent/34/97) Desmoplastic small round cell tumour (/chaptercontent/34/144)
1073 Tumour-like lesions
1074 Mesothelial hyperplasia (/chaptercontent/34/155) Peritoneal inclusion cysts (/chaptercontent/34/156)
1075 Transitional cell metaplasia (/chaptercontent/34/157)
1076 Endosalpingiosis of the peritoneum (/chaptercontent/34/158) Histiocytic nodule (/chaptercontent/34/159)
1077 Ectopic decidua (/chaptercontent/34/160) Splenosis (/chaptercontent/34/161)
1078 Other tumour-like lesions of the peritoneum (/chaptercontent/34/162)
1079 Metastases
1080 Carcinomas and sarcomas metastatic to the peritoneum (/chaptercontent/34/164) Pseudomyxoma peritonei (/chaptercontent/34/165)
1081 Gliomatosis (/chaptercontent/34/167)
1082 5.
1083 Tumours of the fallopian tube
1084 Tumours of the fallopian tube: Introduction (/chaptercontent/34/521)
1086 Benign serous tumours
1087 Serous adenofibroma and papilloma of the fallopian tube (/chaptercontent/34/172)
1088 Borderline serous tumours
1089 Serous borderline tumour of the fallopian tube (/chaptercontent/34/176)
1091 High-grade serous carcinoma of the fallopian tube (/chaptercontent/34/177) Endometrioid carcinoma of the fallopian tube (/chaptercontent/34/178)
1092 Carcinosarcoma of the fallopian tube (/chaptercontent/34/194)
1094 Paratubal cysts (/chaptercontent/34/170) Tubal hyperplasia (/chaptercontent/34/183)
1095 Tubo-ovarian abscess (/chaptercontent/34/184)
1096 Salpingitis isthmica nodosa (/chaptercontent/34/185) Metaplastic papillary lesion (/chaptercontent/34/186)
1097 Placental site nodule occurring in the fallopian tube (/chaptercontent/34/187) Mucinous metaplasia (/chaptercontent/34/188)
1098 Endosalpingiosis of the fallopian tube (/chaptercontent/34/190)
1100 Adenosarcoma of the fallopian tube (/chaptercontent/34/193)
1102 Teratoma of the fallopian tube (/chaptercontent/34/203)
1103 6.
1104 Tumours of the broad ligament and other uterine ligaments
1105 Tumours of the broad ligament and other uterine ligaments: Introduction (/chaptercontent/34/522)
1106 Mesenchymal and mixed tumours
1107 Leiomyoma of the broad ligament and other uterine ligaments (/chaptercontent/34/206)
1108 Adenomyoma of the broad ligament and other uterine ligaments (/chaptercontent/34/207) Adenosarcoma of the broad ligament and other uterine
ligaments (/chaptercontent/34/208)
1109 Leiomyosarcoma of the broad ligament and other uterine ligaments (/chaptercontent/34/209) Other mesenchymal and mixed tumours of the broad
ligament and other uterine ligaments (/chaptercontent/34/210)
1111 Wolffian tumour of the broad ligament and other uterine ligaments (/chaptercontent/34/212) Papillary cystadenoma (/chaptercontent/34/213)
1112 Ependymoma (/chaptercontent/34/214)
1114 Adrenocortical remnants (/chaptercontent/34/216)
1115 7.
1116 Tumours of the uterine corpus
1117 Tumours of the uterine corpus: Introduction (/chaptercontent/34/523)
1118 Endometrial epithelial tumours and precursors
1119 Precursor lesions
1120 Endometrial hyperplasia without atypia (/chaptercontent/34/220)
1121 Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia (/chaptercontent/34/221)
1122 Endometrial carcinomas
1123 Endometrioid carcinoma of the uterine corpus (/chaptercontent/34/223) Serous carcinoma of the uterine corpus (/chaptercontent/34/225)
1124 Clear cell carcinoma of the uterine corpus (/chaptercontent/34/226)
1125 Undifferentiated and dedifferentiated carcinomas of the uterine corpus (/chaptercontent/34/227) Mixed carcinoma of the uterine corpus
1126 Other endometrial carcinomas (/chaptercontent/34/124)
1127 Carcinosarcoma of the uterine corpus (/chaptercontent/34/260)
1130 Endometrial polyp (/chaptercontent/34/231)
1131 Endometrial metaplasia (/chaptercontent/34/232)
1132 Arias-Stella reaction of the uterine corpus (/chaptercontent/34/233)
1133 Mesenchymal tumours of the uterus
1135 Uterine leiomyoma (/chaptercontent/34/237) Intravenous leiomyomatosis (/chaptercontent/34/239)
1136 Smooth muscle tumour of uncertain malignant potential of the uterine corpus (/chaptercontent/34/241)
1137 Metastasizing leiomyoma (/chaptercontent/34/240) Uterine leiomyosarcoma (/chaptercontent/34/242)
1138 Endometrial stromal and related tumours
1139 Endometrial stromal nodule (/chaptercontent/34/244)
1140 Low-grade endometrial stromal sarcoma (/chaptercontent/34/245) High-grade endometrial stromal sarcoma (/chaptercontent/34/246)
Undifferentiated uterine sarcoma (/chaptercontent/34/247)
1141 Miscellaneous mesenchymal tumours
1142 Uterine tumour resembling ovarian sex cord tumour (/chaptercontent/34/248) Perivascular epithelioid cell tumour (PEComa)
(/chaptercontent/34/251) Inflammatory myofibroblastic tumour (/chaptercontent/34/252)
1143 Other mesenchymal tumours of the uterus (/chaptercontent/34/253)
1146 Adenomyoma of the uterine corpus (/chaptercontent/34/256) Atypical polypoid adenomyoma (/chaptercontent/34/257)
1147 Adenosarcoma of the uterine corpus (/chaptercontent/34/259)
1149 Central primitive neuroectodermal tumour / CNS embryonal tumour (/chaptercontent/34/263) Germ cell tumours of the uterine corpus
1150 8.
1151 Gestational trophoblastic disease
1152 Gestational trophoblastic disease: Introduction (/chaptercontent/34/524)
1154 Non-neoplastic lesions
1155 Exaggerated placental site reaction (/chaptercontent/34/274) Placental site nodule and plaque (/chaptercontent/34/275)
1156 Abnormal (non-molar) villous lesions (/chaptercontent/34/276)
1157 Molar pregnancies
1158 Molar pregnancies
1159 Partial hydatidiform mole (/chaptercontent/34/479)
1160 Complete hydatidiform mole (/chaptercontent/34/279)
1161 Invasive and metastatic hydatidiform moles (/chaptercontent/34/480)
1162 Gestational trophoblastic neoplasms
1163 Gestational trophoblastic neoplasms
1164 Epithelioid trophoblastic tumour (/chaptercontent/34/269)
1165 Placental site trophoblastic tumour (/chaptercontent/34/270) Gestational choriocarcinoma (/chaptercontent/34/271) Mixed trophoblastic tumour
1166 9.
1167 Tumours of the uterine cervix
1168 Tumours of the uterine cervix: Introduction (/chaptercontent/34/518)
1169 Squamous epithelial tumours
1170 Mimics of squamous precursor lesions
1171 Squamous metaplasia (/chaptercontent/34/283)
1172 Atrophy of the uterine cervix (/chaptercontent/34/286)
1173 Squamous cell tumours and precursors
1174 Condyloma acuminatum (see Tumours of the vulva) (/chaptercontent/34/284) Squamous intraepithelial lesions of the uterine cervix
1175 Squamous cell carcinoma, HPV-associated, of the uterine cervix (/chaptercontent/34/127) Squamous cell carcinoma, HPV-independent, of the
uterine cervix (/chaptercontent/34/289) Squamous cell carcinoma NOS of the uterine cervix (/chaptercontent/34/529)
1176 Glandular tumours and precursors
1177 Benign glandular lesions
1178 Endocervical polyp (/chaptercontent/34/291)
1179 Mullerian papilloma of the uterine cervix (/chaptercontent/34/292) Nabothian cyst (/chaptercontent/34/293)
1180 Tunnel clusters (/chaptercontent/34/294) Microglandular hyperplasia (/chaptercontent/34/295)
1181 Lobular endocervical glandular hyperplasia (/chaptercontent/34/296) Diffuse laminar endocervical hyperplasia (/chaptercontent/34/297)
Mesonephric remnants and hyperplasia (/chaptercontent/34/298)
1182 Arias-Stella reaction of the uterine cervix (/chaptercontent/34/299) Endocervicosis of the uterine cervix (/chaptercontent/34/300) Tuboendometrioid
metaplasia (/chaptercontent/34/301)
1183 Ectopic prostate tissue (/chaptercontent/34/302)
1184 Adenocarcinomas
1185 Adenocarcinoma in situ, HPV-associated, of the uterine cervix (/chaptercontent/34/496) Adenocarcinoma, HPV-associated, of the uterine cervix
1186 Adenocarcinoma in situ, HPV-independent, of the uterine cervix (/chaptercontent/34/505)
1187 Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix (/chaptercontent/34/508)
1188 Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix (/chaptercontent/34/507) Adenocarcinoma, HPV-independent,
mesonephric type, of the uterine cervix (/chaptercontent/34/175)
1189 Other adenocarcinomas of the uterine cervix (/chaptercontent/34/528)
1191 Carcinosarcoma of the uterine cervix (/chaptercontent/34/322)
1192 Adenosquamous and mucoepidermoid carcinomas of the uterine cervix (/chaptercontent/34/309) Adenoid basal carcinoma of the uterine cervix
1193 Carcinoma of the uterine cervix, unclassifiable (/chaptercontent/34/313)
1196 Adenomyoma of the uterine cervix (/chaptercontent/34/320) Adenosarcoma of the uterine cervix (/chaptercontent/34/321)
1198 Germ cell tumours of the uterine cervix (/chaptercontent/34/324)
1199 10.
1200 Tumours of the vagina
1201 Tumours of the vagina: Introduction (/chaptercontent/34/519)
1203 Benign squamous lesions
1204 Condyloma acuminatum (see Tumours of the vulva) (/chaptercontent/34/329) Squamous papilloma of the vagina (/chaptercontent/34/330)
1205 Atrophy of the vagina (/chaptercontent/34/331) Tubulosquamous polyp (/chaptercontent/34/332)
1207 Squamous intraepithelial lesions of the vagina (/chaptercontent/34/335)
1208 Squamous cell carcinoma, HPV-associated, of the vagina (/chaptercontent/34/336) Squamous cell carcinoma, HPV-independent, of the vagina
(/chaptercontent/34/489) Squamous cell carcinoma NOS of the vagina (/chaptercontent/34/531)
1209 Benign glandular lesions
1210 Villous adenoma (/chaptercontent/34/338)
1211 Mullerian papilloma of the vagina (/chaptercontent/34/339) Vaginal adenosis (/chaptercontent/34/340)
1212 Endocervicosis of the vagina (/chaptercontent/34/342) Cysts of the vagina (/chaptercontent/34/343)
1213 Glandular tumours
1214 Adenocarcinoma, HPV-associated, of the vagina (/chaptercontent/34/317) Endometrioid carcinoma of the vagina (/chaptercontent/34/345)
1215 Clear cell carcinoma of the vagina (/chaptercontent/34/346)
1216 Mucinous carcinoma, gastric type, of the vagina (/chaptercontent/34/347) Mucinous carcinoma, intestinal type, of the vagina
(/chaptercontent/34/285) Mesonephric adenocarcinoma of the vagina (/chaptercontent/34/348)
1217 Carcinosarcoma of the vagina (/chaptercontent/34/358)
1219 Mixed tumour of the vagina (/chaptercontent/34/350)
1220 Adenocarcinoma of Skene gland origin (/chaptercontent/34/392)
1221 Adenosquamous carcinoma of the vagina (/chaptercontent/34/351) Adenoid basal carcinoma of the vagina (/chaptercontent/34/352)
1223 Adenosarcoma of the vagina (/chaptercontent/34/357)
1225 Germ cell tumours of the vagina (/chaptercontent/34/360)
1226 11.
1227 Tumours of the vulva
1228 Tumours of the vulva: Introduction (/chaptercontent/34/525)
1230 Benign squamous lesions
1231 Seborrhoeic keratosis (/chaptercontent/34/370)
1234 Squamous intraepithelial lesions, HPV-associated, of the vulva (/chaptercontent/34/488) Vulvar intraepithelial neoplasia, HPV-independent
1235 Squamous cell carcinoma, HPV-associated, of the vulva (/chaptercontent/34/373)
1236 Squamous cell carcinoma, HPV-independent, of the vulva (/chaptercontent/34/500) Squamous cell carcinoma NOS of the vulva
Basal cell carcinoma (/chaptercontent/34/374)
1238 Glandular tumours and cysts
1239 Mammary-type glandular lesions
1240 Papillary hidradenoma (/chaptercontent/34/376) Chondroid syringoma (/chaptercontent/34/377) Fibroadenoma (/chaptercontent/34/378)
1241 Phyllodes tumour (/chaptercontent/34/393)
1242 Adenocarcinoma of mammary gland type (/chaptercontent/34/391) Bartholin gland lesions
1243 Bartholin gland cyst (/chaptercontent/34/381)
1244 Bartholin gland hyperplasia, adenoma, and adenomyoma (/chaptercontent/34/512) Bartholin gland carcinomas (/chaptercontent/34/382)
1245 Other cysts of the vulva (/chaptercontent/34/383)
1246 Adenocarcinomas of other types
1247 Paget disease (/chaptercontent/34/395)
1248 Carcinomas of sweat gland origin (/chaptercontent/34/396) Adenocarcinoma of intestinal type (/chaptercontent/34/397)
1250 Germ cell tumours of the vulva (/chaptercontent/34/399)
1251 12.
1252 Neuroendocrine neoplasia
1253 Neuroendocrine neoplasia: Introduction (/chaptercontent/34/533)
1254 Neuroendocrine tumour
1256 Neuroendocrine carcinoma
1257 Small cell neuroendocrine carcinoma (/chaptercontent/34/406) Large cell neuroendocrine carcinoma (/chaptercontent/34/407)
1258 Mixed neuroendocrine-non-neuroendocrine neoplasms
1259 Carcinoma admixed with neuroendocrine carcinoma (/chaptercontent/34/409)
1260 13.
1261 Haematolymphoid proliferations and neoplasia
1262 Haematolymphoid proliferations and neoplasia: Introduction (/chaptercontent/34/515)
1263 Reactive lymphoid hyperplasia
1264 Florid reactive lymphoid hyperplasia (/chaptercontent/34/234)
1265 Lymphomas
1266 Diffuse large B-cell lymphoma (/chaptercontent/34/411)
1267 Extranodal marginal zone lymphoma (/chaptercontent/34/482) Follicular lymphoma (/chaptercontent/34/484)
1268 Burkitt lymphoma (/chaptercontent/34/412)
1269 Myeloid leukaemia
1270 Myeloid sarcoma (/chaptercontent/34/494)
1271 14.
1272 Mesenchymal tumours of the lower genital tract
1273 Mesenchymal tumours of the lower genital tract: Introduction (/chaptercontent/34/517)
1275 Lipoma (/chaptercontent/34/415)
1276 Lipoblastoma-like tumour of the vulva (/chaptercontent/34/527) Liposarcoma (/chaptercontent/34/416)
1278 Postoperative spindle cell nodule (/chaptercontent/34/316) Fibroepithelial stromal polyp (/chaptercontent/34/418)
1279 Prepubertal fibroma (/chaptercontent/34/502)
1280 Superficial myofibroblastoma (/chaptercontent/34/420) Myofibroblastoma (/chaptercontent/34/419)
1281 Cellular angiofibroma (/chaptercontent/34/421)
1282 Angiomyofibroblastoma (/chaptercontent/34/422)
1283 Solitary fibrous tumour of the lower genital tract (/chaptercontent/34/423) Dermatofibrosarcoma protuberans (/chaptercontent/34/424)
1284 NTRK-rearranged spindle cell neoplasm (emerging) (/chaptercontent/34/425)
1286 Kaposi sarcoma (/chaptercontent/34/429) Angiosarcoma (/chaptercontent/34/430)
1288 Leiomyoma of the lower genital tract (/chaptercontent/34/432)
1289 Smooth muscle tumour of uncertain malignant potential of the lower genital tract (/chaptercontent/34/501)
1290 Leiomyosarcoma of the lower genital tract (/chaptercontent/34/433)
1295 Benign peripheral nerve sheath tumours (/chaptercontent/34/478) Granular cell tumour (/chaptercontent/34/438)
1297 Superficial angiomyxoma (/chaptercontent/34/427)
1298 Deep (aggressive) angiomyxoma (/chaptercontent/34/428) Epithelioid sarcoma (/chaptercontent/34/441)
1299 Alveolar soft part sarcoma (/chaptercontent/34/442)
1300 Undifferentiated small round cell sarcomas
1302 15.
1303 Melanocytic lesions
1304 Naevi
1305 Acquired melanocytic naevus (/chaptercontent/34/450) Congenital melanocytic naevus (/chaptercontent/34/451) Blue naevus
Atypical melanocytic naevus of genital type (/chaptercontent/34/454)
1307 Dysplastic melanocytic naevus (/chaptercontent/34/455)
1308 Melanoma
1309 Mucosal melanoma (/chaptercontent/34/457)
1310 16.
1311 Metastasis
1312 Metastasis to the lower female genital tract (/chaptercontent/34/461)
1313 17.
1314 Genetic tumour syndromes of the female genital tract
1315 BRCA1/2-associated hereditary breast and ovarian cancer syndrome (/chaptercontent/34/463) Lynch syndrome (/chaptercontent/34/464)
1316 Cowden syndrome (/chaptercontent/34/465)
1317 Li-Fraumeni syndrome (/chaptercontent/34/466)
1318 Peutz-Jeghers syndrome (/chaptercontent/34/467) Ataxia-telangiectasia (/chaptercontent/34/468)
1319 Carney complex (/chaptercontent/34/469)
1320 DICER1 syndrome (/chaptercontent/34/470) Ovarian dysgenesis (/chaptercontent/34/471)
1321 Von Hippel-Lindau syndrome (/chaptercontent/34/472)
1322 Hereditary leiomyomatosis and renal cell carcinoma (/chaptercontent/34/473)
1323 Other genetic tumour syndromes of the female genital tract (/chaptercontent/34/475)
1325 Eye and Orbit Tumours (5th ed.)
1326 1.
1330 Foreword (/chaptercontent/65/344)
1331 ICD-O coding of tumours of the eye and orbit (/chaptercontent/65/351) ICCR datasets: Ophthalmic (/chaptercontent/65/360)
1332 Introduction to tumours of the eye and orbit (/chaptercontent/65/97)
1333 2.
1334 Tumours of the conjunctiva and caruncle
1335 Introduction (/chaptercontent/65/2)
1336 Tumour-like lesions and choristomas of the conjunctiva (/chaptercontent/65/3)
1337 Cysts of the conjunctiva and caruncle (/chaptercontent/65/4) Epithelial conjunctival inclusion cyst (/chaptercontent/65/5)
1338 Reactive, epithelial, and degenerative conjunctival lesions (/chaptercontent/65/6) Reactive epithelial hyperplasia of the conjunctiva
Papillary and follicular conjunctivitis (/chaptercontent/65/8) Pterygium and pingueculum (/chaptercontent/65/333)
1340 Choristomas of the conjunctiva (/chaptercontent/65/9)
1341 Epibulbar choristoma (dermoid; dermolipoma; complex choristoma) (/chaptercontent/65/10) Epibulbar osseous choristoma (/chaptercontent/65/11)
1342 Epithelial tumours of the conjunctiva (/chaptercontent/65/12)
1343 Benign epithelial conjunctival tumours (/chaptercontent/65/13)
1344 Conjunctival squamous cell papilloma (/chaptercontent/65/14) Conjunctival oncocytoma (/chaptercontent/65/16)
1345 Hereditary benign intraepithelial dyskeratosis (/chaptercontent/65/18)
1346 Premalignant and malignant epithelial tumours of the conjunctiva (/chaptercontent/65/19) Conjunctival squamous intraepithelial neoplasia
1347 Conjunctival squamous cell carcinoma (/chaptercontent/65/21) Adenosquamous carcinoma (/chaptercontent/65/22)
1348 Melanocytic conjunctival tumours (/chaptercontent/65/23)
1349 Benign melanocytic conjunctival tumours (/chaptercontent/65/24)
1350 Benign epithelial melanosis of the conjunctiva (/chaptercontent/65/25)
1351 Junctional, compound and subepithelial conjunctival naevi (/chaptercontent/65/26) Inflamed juvenile conjunctival naevus (/chaptercontent/65/27)
1352 Blue naevus of the conjunctiva (/chaptercontent/65/28)
1353 WNT-activated deep penetrating/plexiform melanocytoma (naevus) (/chaptercontent/65/334) Combined naevus (/chaptercontent/65/336)
1354 Premalignant and malignant melanocytic conjunctival tumours (/chaptercontent/65/30) Conjunctival melanocytic intraepithelial lesions
1355 Conjunctival melanoma (/chaptercontent/65/32)
1356 3.
1357 Tumours of the eyelid
1359 Tumour-like lesions, hamartomas and choristomas of the eyelid (/chaptercontent/65/35)
1360 Eyelid cysts (/chaptercontent/65/36)
1361 Epidermal inclusion cyst (/chaptercontent/65/39) Intratarsal cyst (/chaptercontent/65/40)
1362 Choristomas of the eyelid (/chaptercontent/65/41)
1363 Phakomatous choristoma (/chaptercontent/65/43)
1364 Epithelial tumours of the eyelid (/chaptercontent/65/45)
1365 Benign and premalignant epithelial tumours of the eyelid (/chaptercontent/65/46) Molluscum contagiosum (/chaptercontent/65/42)
1366 Verruca vulgaris (/chaptercontent/65/47)
1367 Squamous cell papilloma (/chaptercontent/65/48) Seborrheic keratosis (/chaptercontent/65/49) Inverted follicular keratosis (/chaptercontent/65/50)
Actinic keratosis (/chaptercontent/65/51)
1368 Malignant epithelial tumours of the eyelid (/chaptercontent/65/52) Basal cell carcinoma (/chaptercontent/65/53)
1369 Squamous cell carcinoma (/chaptercontent/65/54) Merkel cell carcinoma (/chaptercontent/65/55)
1370 Adnexal tumours of the eyelid (/chaptercontent/65/56)
1371 Benign adnexal tumours of the eyelid (/chaptercontent/65/57) Ductal hidrocystoma (/chaptercontent/65/37)
1372 Sebaceous hyperplasia, adenoma, and sebaceoma (/chaptercontent/65/58) Syringoma (/chaptercontent/65/59)
1373 Mixed tumour (/chaptercontent/65/361) Tubular adenoma (/chaptercontent/65/362)
1374 Syringocystadenoma papilliferum (/chaptercontent/65/60) Pilomatricoma (/chaptercontent/65/61)
1375 Trichilemmoma (/chaptercontent/65/62)
1376 Malignant adnexal tumours of the eyelid (/chaptercontent/65/63) Sebaceous carcinoma (/chaptercontent/65/64)
1377 Adenoid cystic carcinoma (/chaptercontent/65/65)
1378 Signet-ring cell/histiocytoid carcinoma (/chaptercontent/65/66) Mucinous carcinoma (/chaptercontent/65/337)
1379 Endocrine mucin-producing sweat gland carcinoma (/chaptercontent/65/38) Microcystic adnexal carcinoma (/chaptercontent/65/67)
1380 Apocrine carcinoma (/chaptercontent/65/68)
1381 Melanocytic eyelid tumours (/chaptercontent/65/69)
1382 Benign and premalignant melanocytic eyelid tumours (/chaptercontent/65/70) Naevi of the eyelid (/chaptercontent/65/338)
1383 Spitz naevus (/chaptercontent/65/29)
1384 In-situ cutaneous melanoma (/chaptercontent/65/71) Malignant melanocytic eyelid tumours (/chaptercontent/65/72)
1385 Invasive cutaneous melanoma (/chaptercontent/65/73)
1386 4.
1387 Tumours of the uveal tract
1389 Iris tumours (/chaptercontent/65/76)
1390 Benign lesions and hamartomas of the iris (/chaptercontent/65/77) Ectopic tissue (/chaptercontent/65/78)
1391 Implantation cyst (/chaptercontent/65/79)
1392 Pigmented epithelial cyst (/chaptercontent/65/357) Lisch nodule (/chaptercontent/65/82)
1393 Melanocytic tumours of the iris (/chaptercontent/65/80) Ocular melanocytosis (/chaptercontent/65/81)
1394 Iris naevus (/chaptercontent/65/83) Iris melanoma (/chaptercontent/65/84)
1395 Ciliary body and choroid tumours (/chaptercontent/65/85)
1396 Benign melanocytic lesions of the choroid and ciliary body (/chaptercontent/65/86) Choroidal and ciliary body naevi (/chaptercontent/65/87)
1397 Uveal melanocytoma (/chaptercontent/65/88)
1398 Bilateral diffuse uveal melanocytic proliferation (/chaptercontent/65/89)
1399 Malignant melanocytic tumours of the choroid and ciliary body (/chaptercontent/65/90) Choroidal and ciliary body melanomas
5.
1401 Tumours of the retina and neuroepithelium
1403 Tumours of the neurosensory retina (/chaptercontent/65/94)
1404 Benign retinal tumours (/chaptercontent/65/95) Astrocytic tumours (/chaptercontent/65/96)
1405 Nodular and massive retinal gliosis (/chaptercontent/65/98)
1406 Premalignant and malignant retinal tumours (/chaptercontent/65/99) Retinocytoma (/chaptercontent/65/100)
1407 Retinoblastoma (/chaptercontent/65/101)
1408 Tumours of the retinal pigment epithelium (/chaptercontent/65/102)
1409 Reactive and hamartomatous lesions of the retinal pigment epithelium (/chaptercontent/65/103) Hamartoma of the retinal pigment epithelium
1410 Congenital hypertrophy of the retinal pigment epithelium (/chaptercontent/65/104) Reactive hyperplasia of the retinal pigment epithelium
1411 Benign and malignant tumours of the retinal pigment epithelium (/chaptercontent/65/107)
1412 Adenoma and adenocarcinoma of the retinal pigment epithelium (/chaptercontent/65/108)
1413 Tumours of the iris and ciliary body neuroepithelium (/chaptercontent/65/109)
1414 Reactive and cystic lesions of the iris and ciliary body pigment epithelium (/chaptercontent/65/110) Reactive epithelial hyperplasia of the ciliary
epithelium (/chaptercontent/65/113)
1415 Nodular hyperplasia of the ciliary epithelium (/chaptercontent/65/112) Glioneuronal hamartoma of the ciliary body (/chaptercontent/65/117)
1416 Benign and malignant tumours of the iris and ciliary body pigment epithelium (/chaptercontent/65/114)
1417 Adenoma and adenocarcinoma of the ciliary body (/chaptercontent/65/115) Medulloepithelioma of the ciliary body (/chaptercontent/65/116)
1418 6.
1419 Tumours of the optic disc and optic nerve
1421 Primary tumours of the optic disc and optic nerve (/chaptercontent/65/120)
1422 Malformations of the optic disc and optic nerve (/chaptercontent/65/365) Optic nerve choristoma (/chaptercontent/65/355)
1423 Primary neural tumours of the optic disc and optic nerve (/chaptercontent/65/121) Gliomas of the optic nerve (/chaptercontent/65/122)
1424 Pigment epithelial tumours of the optic disc and optic nerve (/chaptercontent/65/123) Medulloepithelioma of the optic disc and optic nerve
1425 Meningeal tumours of the optic nerve (/chaptercontent/65/125) Meningioma of the optic nerve (/chaptercontent/65/126)
1426 Melanocytic tumours of the optic disc and optic nerve (/chaptercontent/65/127) Melanocytoma of the optic disc and optic nerve
7.
1428 Tumours of the lacrimal gland
1430 Epithelial tumours of the lacrimal gland (/chaptercontent/65/131)
1431 Cysts of the lacrimal gland (/chaptercontent/65/366) Dacryops cyst (/chaptercontent/65/151)
1432 Benign and premalignant epithelial tumours of the lacrimal gland (/chaptercontent/65/132) Pleomorphic adenoma of the lacrimal gland
1433 Lacrimal gland oncocytoma (/chaptercontent/65/134) Myoepithelioma (/chaptercontent/65/135)
1434 Intraductal carcinoma (/chaptercontent/65/137)
1435 Malignant epithelial tumours of the lacrimal gland (/chaptercontent/65/138) Carcinoma ex pleomorphic adenoma (/chaptercontent/65/295)
1436 Adenoid cystic carcinoma (/chaptercontent/65/139)
1437 Primary ductal adenocarcinoma of the lacrimal gland (/chaptercontent/65/140) Secretory carcinoma (/chaptercontent/65/141)
1438 Mucoepidermoid carcinoma (/chaptercontent/65/142)
1439 Epithelial-myoepithelial carcinoma (/chaptercontent/65/143) Acinic cell carcinoma (/chaptercontent/65/145)
1440 Adenocarcinoma, NOS (/chaptercontent/65/144)
1441 8.
1442 Tumours of the lacrimal drainage system
1444 Epithelial tumours of the lacrimal drainage system (/chaptercontent/65/152)
1445 Benign and premalignant epithelial tumours of the lacrimal drainage system (/chaptercontent/65/153) Papillomas (squamous and inverted)
1446 Malignant epithelial tumours of the lacrimal drainage system (/chaptercontent/65/155) Squamous cell carcinoma (/chaptercontent/65/156)
1447 Lymphoepithelial carcinoma (/chaptercontent/65/160) Mucoepidermoid carcinoma (/chaptercontent/65/158)
1448 Other salivary gland-type carcinomas of the lacrimal drainage system (/chaptercontent/65/159) Adenocarcinoma NOS of the lacrimal drainage
system (/chaptercontent/65/157)
1449 Melanocytic tumours of the lacrimal drainage system (/chaptercontent/65/162)
1450 Melanoma involving the lacrimal drainage system (/chaptercontent/65/164)
1451 9.
1452 Tumours of the orbit
1454 Teratomas, hamartomas and choristomas (/chaptercontent/65/167)
1455 Choristomas and cysts (/chaptercontent/65/168)
1456 Orbital dermoid cysts and other orbital cysts (/chaptercontent/65/169) Vascular malformations (name to be discussed) (/chaptercontent/65/210)
1457 Cavernous vascular malformation (/chaptercontent/65/340)
1458 Combined lymphatic-venous malformation of the orbit (/chaptercontent/65/171) Orbital venous malformation (/chaptercontent/65/111)
1459 Arteriovenous malformation (/chaptercontent/65/172) Hamartomas (/chaptercontent/65/170)
1460 Orbital glial heterotopia (/chaptercontent/65/173) Mesenchymal hamartoma of the orbit (/chaptercontent/65/174)
1461 Germ cell tumours (/chaptercontent/65/175) Teratoma (/chaptercontent/65/177)
1462 Yolk sac tumour (/chaptercontent/65/178)
1463 Melanocytic tumours of the orbit (/chaptercontent/65/345)
1464 Primary orbital melanoma (/chaptercontent/65/346)
1465 10.
1468 Reactive lymphoid lesions (/chaptercontent/65/199)
1469 Reactive lymphoid lesions (/chaptercontent/65/200)
1470 Reactive lymphoid hyperplasia (/chaptercontent/65/201) IgG4-related disease (/chaptercontent/65/202)
1471 Intraocular haematolymphoid proliferations (/chaptercontent/65/195)
1472 Primary choroidal lymphoma (/chaptercontent/65/197)
1473 Primary vitreoretinal large B-cell lymphoma (/chaptercontent/65/198)
1474 Ocular adnexal lymphomas (/chaptercontent/65/203)
1475 B-cell lymphomas (/chaptercontent/65/204)
1476 Extranodal marginal zone lymphoma (/chaptercontent/65/205) Follicular lymphoma (/chaptercontent/65/206)
1477 Mantle cell lymphoma (/chaptercontent/65/207)
1478 Chronic lymphocytic leukaemia/small lymphocytic lymphoma (/chaptercontent/65/208) Diffuse large B-cell lymphoma (/chaptercontent/65/209)
1479 Plasmacytoma (/chaptercontent/65/211) T/NK cell lymphomas (/chaptercontent/65/213)
1480 CD30 positive lymphoproliferative disorders (/chaptercontent/65/216) T-cell lymphomas (/chaptercontent/65/214)
1481 Extranodal lymphoma of mature NK or T-cell lineage (/chaptercontent/65/215)
1482 Myeloid tumours (/chaptercontent/65/217)
1484 Extramedullary myeloid sarcoma (/chaptercontent/65/218)
1485 Histiocytic and dendritic cell tumours (/chaptercontent/65/219)
1486 Histiocytic tumours (/chaptercontent/65/368)
1487 Juvenile xanthogranuloma (/chaptercontent/65/220) Rosai-Dorfman disease (/chaptercontent/65/223)
1488 Erdheim-Chester disease (/chaptercontent/65/222) Langerhans cell tumours (/chaptercontent/65/221) Xanthelasma (/chaptercontent/65/224)
1489 Adult orbital xanthogranulomatous disease (/chaptercontent/65/364)
1490 11.
1491 Soft Tissue and Bone Tumours
1493 Soft tissue tumours (/chaptercontent/65/227)
1494 Fibrous, fibroblastic tumours (/chaptercontent/65/228)
1495 Conjunctival stromal tumour and ocular surface fibroma (/chaptercontent/65/341) Fibrous histiocytoma (/chaptercontent/65/356)
1496 Nodular and proliferative fasciitis, proliferative myositis (/chaptercontent/65/229) Solitary fibrous tumour (/chaptercontent/65/231)
1497 Inflammatory myofibroblastic tumour (/chaptercontent/65/232) Dermatofibrosarcoma protuberans (/chaptercontent/65/235) Angiomyxoma
1498 Adipocytic tumours (/chaptercontent/65/236)
1499 Benign lipomatous tumours (/chaptercontent/65/237) Malignant adipocytic tumours (/chaptercontent/65/241)
1500 Skeletal muscle tumours (/chaptercontent/65/245)
1501 Rhabdomyosarcoma family (/chaptercontent/65/247) Smooth muscle tumours (/chaptercontent/65/253)
1502 Leiomyoma (/chaptercontent/65/254) Mesectodermal leiomyoma (/chaptercontent/65/255) Leiomyosarcoma (/chaptercontent/65/256)
1503 Peripheral nerve sheath tumours (/chaptercontent/65/257) Schwannoma (/chaptercontent/65/258)
1504 Neurofibroma (/chaptercontent/65/259)
1505 Solitary circumscribed neuroma (/chaptercontent/65/343) Granular cell tumour (/chaptercontent/65/260)
1506 Malignant peripheral nerve sheath tumour (/chaptercontent/65/261) Vascular tumours (/chaptercontent/65/262)
1507 Masson tumour (/chaptercontent/65/263) Infantile haemangioma (/chaptercontent/65/264)
1508 Lobular capillary haemangioma (/chaptercontent/65/358) Lymphangiectasia (/chaptercontent/65/265)
1509 Epithelioid haemangioma (/chaptercontent/65/266) Haemangioblastoma (/chaptercontent/65/267)
1511 Perivascular tumours (/chaptercontent/65/270) Glomus tumour (/chaptercontent/65/271)
1512 Myopericytoma, including myofibroma (/chaptercontent/65/272) Tumours of uncertain derivation (/chaptercontent/65/275)
1513 PEComa (/chaptercontent/65/274)
1514 Epithelioid sarcoma (/chaptercontent/65/277) Synovial sarcoma (/chaptercontent/65/278)
1516 Tumours of orbital bone (/chaptercontent/65/281)
1517 Osteogenic tumours of orbital bone (/chaptercontent/65/282) Osteoma (/chaptercontent/65/283)
1518 Osteoblastoma (/chaptercontent/65/285) Osteosarcoma (/chaptercontent/65/286)
1519 Chondrogenic tumours of orbital bone (/chaptercontent/65/287) Soft tissue chondroma (/chaptercontent/65/288) Mesenchymal chondrosarcoma
1520 Fibrous, fibroblastic tumours of orbital bone (/chaptercontent/65/292) Fibrous dysplasia (/chaptercontent/65/293)
1521 Vascular tumours of orbital bone (/chaptercontent/65/296) Haemangioma of bone (/chaptercontent/65/297)
1522 Epithelioid haemangioendothelioma (/chaptercontent/65/298) Angiosarcoma of bone (/chaptercontent/65/299)
1523 Osteoclast-rich giant cell tumours of orbital bone (/chaptercontent/65/300) Aneurysmal bone cyst (/chaptercontent/65/301)
1524 Giant cell tumour of bone (/chaptercontent/65/302) Other tumours of orbital bone (/chaptercontent/65/303)
1526 12.
1527 Metastases to the eye and surrounding structures
1529 Metastases to ocular adnexal structures (/chaptercontent/65/318) Metastases to intra-ocular structures (/chaptercontent/65/310)
1530 13.
1531 Genetic Tumour Syndromes
1533 Retinoblastoma syndrome (/chaptercontent/65/321)
1534 BAP1 tumour predisposition syndrome (/chaptercontent/65/322) Von Hippel Lindau syndrome (/chaptercontent/65/323)
1535 Sturge Weber syndrome (/chaptercontent/65/342)
1536 Neurofibromatosis type 1 (NF1) (/chaptercontent/65/324) Goldenhar syndrome (/chaptercontent/65/325)
1537 Muir-Torre syndrome (/chaptercontent/65/313)
1539 Breast Tumours (5th ed.)
1540 1.
1543 Foreword with changes from the book, including corrigenda (/chaptercontent/32/148) ICD-O coding of breast tumours
1544 TNM staging of carcinomas of the breast (/chaptercontent/32/152) ICCR datasets: Breast (/chaptercontent/32/153)
1545 Introduction to tumours of the breast (/chaptercontent/32/1)
1546 2.
1547 Epithelial tumours of the breast
1548 Benign epithelial proliferations and precursors: Introduction (/chaptercontent/32/5)
1549 Usual ductal hyperplasia (/chaptercontent/32/4)
1550 Columnar cell lesions, including flat epithelial atypia (/chaptercontent/32/134) Atypical ductal hyperplasia (/chaptercontent/32/135)
1551 Adenosis and benign sclerosing lesions: Introduction (/chaptercontent/32/125)
1552 Sclerosing adenosis (/chaptercontent/32/6)
1553 Apocrine adenosis and adenoma (/chaptercontent/32/126) Microglandular adenosis (/chaptercontent/32/127)
1554 Radial scar / complex sclerosing lesion (/chaptercontent/32/128)
1555 Adenomas: Introduction (/chaptercontent/32/7) Tubular adenoma (/chaptercontent/32/130) Lactating adenoma (/chaptercontent/32/131)
1556 Ductal adenoma (/chaptercontent/32/133)
1557 Epithelial-myoepithelial tumours: Introduction (/chaptercontent/32/144)
1558 Pleomorphic adenoma (/chaptercontent/32/30) Adenomyoepithelioma (/chaptercontent/32/31)
1559 Malignant adenomyoepithelioma (/chaptercontent/32/32)
1560 Papillary neoplasms: Introduction (/chaptercontent/32/8)
1561 Intraductal papilloma (/chaptercontent/32/9)
1562 Papillary ductal carcinoma in situ (/chaptercontent/32/146) Encapsulated papillary carcinoma (/chaptercontent/32/10)
1563 Solid papillary carcinoma (in situ and invasive) (/chaptercontent/32/142) Invasive papillary carcinoma (/chaptercontent/32/143)
1564 Non-invasive lobular neoplasia: Introduction (/chaptercontent/32/11)
1565 Atypical lobular hyperplasia (/chaptercontent/32/12) Lobular carcinoma in situ (/chaptercontent/32/13)
1566 Ductal carcinoma in situ: Introduction (/chaptercontent/32/14)
1567 Ductal carcinoma in situ (/chaptercontent/32/15)
1568 Invasive breast carcinoma: General overview (/chaptercontent/32/18) Invasive breast carcinoma of no special type (/chaptercontent/32/141)
Microinvasive carcinoma (/chaptercontent/32/17)
1569 Invasive lobular carcinoma (/chaptercontent/32/19)
1570 Tubular carcinoma (/chaptercontent/32/20)
1571 Cribriform carcinoma (/chaptercontent/32/145) Mucinous carcinoma (/chaptercontent/32/22)
1572 Mucinous cystadenocarcinoma (/chaptercontent/32/139) Invasive micropapillary carcinoma (/chaptercontent/32/23)
1573 Carcinoma with apocrine differentiation (/chaptercontent/32/25) Metaplastic carcinoma (/chaptercontent/32/27)
1574 Rare and salivary gland-type tumours: Introduction (/chaptercontent/32/29)
1575 Acinic cell carcinoma (/chaptercontent/32/33)
1576 Adenoid cystic carcinoma (/chaptercontent/32/34) Secretory carcinoma (/chaptercontent/32/28) Mucoepidermoid carcinoma
Polymorphous adenocarcinoma (/chaptercontent/32/37)
1578 Tall cell carcinoma with reversed polarity (/chaptercontent/32/113)
1579 Neuroendocrine neoplasms: Introduction (/chaptercontent/32/119)
1581 Neuroendocrine carcinoma (/chaptercontent/32/46)
1582 3.
1583 Fibroepithelial tumours and hamartomas of the breast
1584 Fibroepithelial tumours and hamartomas of the breast: Introduction (/chaptercontent/32/120)
1585 Hamartoma (/chaptercontent/32/50) Fibroadenoma (/chaptercontent/32/51)
1586 Phyllodes tumour (/chaptercontent/32/52)
1587 4.
1588 Tumours of the nipple
1589 Tumours of the nipple: Introduction (/chaptercontent/32/121) Epithelial tumours
1590 Syringomatous tumour (/chaptercontent/32/57) Nipple adenoma (/chaptercontent/32/58)
1591 Paget disease of the breast (/chaptercontent/32/59)
1592 5.
1593 Mesenchymal tumours of the breast
1594 Mesenchymal tumours of the breast: Introduction (/chaptercontent/32/122) Vascular tumours
1595 Haemangioma (/chaptercontent/32/62) Angiomatosis (/chaptercontent/32/63)
1596 Atypical vascular lesions (/chaptercontent/32/64)
1597 Postradiation angiosarcoma of the breast (/chaptercontent/32/114) Primary angiosarcoma of the breast (/chaptercontent/32/65)
1598 Fibroblastic and myofibroblastic tumours Nodular fasciitis (/chaptercontent/32/67) Myofibroblastoma (/chaptercontent/32/68)
1599 Desmoid fibromatosis (/chaptercontent/32/69)
1600 Inflammatory myofibroblastic tumour (/chaptercontent/32/70)
1602 Schwannoma (/chaptercontent/32/72) Neurofibroma (/chaptercontent/32/73)
1603 Granular cell tumour (/chaptercontent/32/74)
1608 Angiolipoma (/chaptercontent/32/81) Liposarcoma (/chaptercontent/32/82)
1609 Other mesenchymal tumours and tumour-like conditions
1610 Pseudoangiomatous stromal hyperplasia (/chaptercontent/32/84)
1611 6.
1612 Haematolymphoid tumours of the breast
1613 Haematolymphoid tumours of the breast: Introduction (/chaptercontent/32/123) Lymphoma
1614 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) (/chaptercontent/32/89)
1615 Follicular lymphoma (/chaptercontent/32/90)
1616 Diffuse large B-cell lymphoma (/chaptercontent/32/91) Burkitt lymphoma (/chaptercontent/32/92)
1617 Breast implant-associated anaplastic large cell lymphoma (/chaptercontent/32/95)
1618 7.
1619 Tumours of the male breast
1620 Tumours of the male breast: Introduction (/chaptercontent/32/118) Epithelial tumours
1621 Gynaecomastia (/chaptercontent/32/98) Carcinoma in situ (/chaptercontent/32/99)
1622 Invasive carcinoma (/chaptercontent/32/100) Metastases to the breast (/chaptercontent/32/137)
1623 8.
1624 Genetic tumour syndromes of the breast
1625 Genetic tumour syndromes of the breast: Introduction (/chaptercontent/32/124) Syndromes
1626 BRCA1/2-associated hereditary breast and ovarian cancer syndrome (/chaptercontent/32/103) Cowden syndrome (/chaptercontent/32/105)
1627 Ataxia-telangiectasia (/chaptercontent/32/106)
1628 Li-Fraumeni syndrome, TP53-associated (/chaptercontent/32/107) Li-Fraumeni syndrome, CHEK2-associated (/chaptercontent/32/115)
1629 CDH1-associated breast cancer (/chaptercontent/32/116) PALB2-associated cancers (/chaptercontent/32/117)
1630 Peutz-Jeghers syndrome (/chaptercontent/32/138) Neurofibromatosis type 1 (/chaptercontent/32/109)
1631 The polygenic component of breast cancer susceptibility (/chaptercontent/32/147)
1633 Skin Tumours (5th ed.)
1634 1.
1635 Forewords and introductions
1638 Foreword with changes from the book, including corrigenda (/chaptercontent/64/394) ICD-O coding of skin tumours
1639 Introduction to skin tumours (/chaptercontent/64/1) ICCR datasets: Skin (/chaptercontent/64/390)
1640 2.
1641 Keratinocytic/epidermal tumours
1643 Carcinoma precursors and benign simulants (/chaptercontent/64/4)
1644 Premalignant keratoses and precursors (/chaptercontent/64/5) Actinic keratosis (/chaptercontent/64/6)
1645 Arsenical keratosis (/chaptercontent/64/7) PUVA keratosis (/chaptercontent/64/8)
1646 Squamous cell carcinoma in situ (Bowen disease) (/chaptercontent/64/34) Verrucae (/chaptercontent/64/9)
1647 Verruca vulgaris (/chaptercontent/64/10)
1648 Verruca plantaris and palmaris (/chaptercontent/64/11) Verruca plana (/chaptercontent/64/12)
1649 Benign acanthomas/keratoses (/chaptercontent/64/13) Seborrhoeic keratosis (/chaptercontent/64/14)
1650 Solar lentigo (/chaptercontent/64/15)
1651 Lichen planus-like keratosis (/chaptercontent/64/16) Clear cell acanthoma (/chaptercontent/64/17)
1652 Large cell acanthoma (/chaptercontent/64/18) Warty dyskeratoma (/chaptercontent/64/19) Other benign keratoses (/chaptercontent/64/20)
1653 Epidermal carcinomas (/chaptercontent/64/21)
1654 Basal cell carcinomas (/chaptercontent/64/22)
1655 Superficial basal cell carcinoma (/chaptercontent/64/24) Nodular basal cell carcinoma (/chaptercontent/64/23)
1656 Micronodular basal cell carcinoma (/chaptercontent/64/25) Infiltrating basal cell carcinoma (/chaptercontent/64/26)
1657 Sclerosing/morphoeic basal cell carcinoma (/chaptercontent/64/27) Basosquamous carcinoma (/chaptercontent/64/28)
1658 Basal cell carcinoma with sarcomatoid differentiation (/chaptercontent/64/29) Basal cell carcinoma with adnexal differentiation
(/chaptercontent/64/30) Fibroepithelial basal cell carcinoma (/chaptercontent/64/31)
1659 Keratoacanthomas (/chaptercontent/64/374) Keratoacanthoma (/chaptercontent/64/33)
1660 Squamous cell carcinomas (/chaptercontent/64/35)
1661 Verrucous squamous cell carcinoma (/chaptercontent/64/333) Acantholytic squamous cell carcinoma (/chaptercontent/64/397) Lymphoepithelial
1662 Clear cell squamous cell carcinoma (/chaptercontent/64/396)
1663 Spindle cell squamous cell carcinoma (/chaptercontent/64/399)
1664 Squamous cell carcinoma with sarcomatoid differentiation (/chaptercontent/64/401)
1665 Neuroendocrine neoplasms (/chaptercontent/64/37)
1666 Neuroendocrine carcinomas (/chaptercontent/64/38) Merkel cell carcinoma (/chaptercontent/64/39)
1667 3.
1668 Melanocytic neoplasms
1670 Genomic landscape of melanoma (/chaptercontent/64/357)
1671 Melanocytic neoplasms in intermittently sun-exposed skin (/chaptercontent/64/42)
1672 Naevi (/chaptercontent/64/43)
1673 Junctional, compound, and dermal naevi (/chaptercontent/64/44)
1674 Simple lentigo and lentiginous melanocytic naevus (/chaptercontent/64/56) Dysplastic naevus (/chaptercontent/64/45)
1675 Naevus spilus (/chaptercontent/64/46)
1676 Special-site naevi (of the breast, axilla, scalp, and ear) (/chaptercontent/64/47) Halo naevus (/chaptercontent/64/48)
1677 Meyerson naevus (/chaptercontent/64/49) Recurrent naevus (/chaptercontent/64/50) Combined naevus (/chaptercontent/64/335)
1678 Melanocytomas (/chaptercontent/64/403)
1679 WNT-activated deep penetrating/plexiform melanocytoma (naevus) (/chaptercontent/64/51) Pigmented epithelioid melanocytoma
BAP1-inactivated melanocytoma (/chaptercontent/64/53)
1681 MITF pathway-activated melanocytic tumours (/chaptercontent/64/402) Melanoma intermittently sun-exposed skin (/chaptercontent/64/54)
1682 Low-CSD melanoma (including superficial spreading melanoma) (/chaptercontent/64/55)
1683 Melanocytic neoplasms in chronically sun-exposed skin (/chaptercontent/64/57)
1684 Melanoma in chronically sun-exposed skin (/chaptercontent/64/58) Lentigo maligna melanoma (/chaptercontent/64/59)
1685 Desmoplastic melanoma (/chaptercontent/64/60)
1686 Spitz tumours (/chaptercontent/64/61)
1687 Spitz naevi (/chaptercontent/64/411)
1688 Pigmented spindle cell naevus (Reed naevus) (/chaptercontent/64/62) Spitz naevus (/chaptercontent/64/63)
1689 Spitz melanocytoma (/chaptercontent/64/412)
1690 Spitz melanocytoma (Atypical Spitz tumour) (/chaptercontent/64/336) Spitz melanoma (/chaptercontent/64/413)
1691 Spitz melanoma (/chaptercontent/64/64)
1692 Melanocytic tumours in acral skin (/chaptercontent/64/65)
1693 Acral naevi (/chaptercontent/64/66)
1694 Acral naevus (/chaptercontent/64/67) Acral melanomas (/chaptercontent/64/68)
1695 Acral melanoma (/chaptercontent/64/69)
1696 Genital and mucosal melanocytic tumours (/chaptercontent/64/70)
1697 Mucosal and genital naevi (/chaptercontent/64/71) Melanosis (/chaptercontent/64/337)
1698 Genital naevus (/chaptercontent/64/72) Mucosal melanomas (/chaptercontent/64/73)
1699 Mucosal melanomas (/chaptercontent/64/74)
1700 Blue naevus and related tumours (/chaptercontent/64/75)
1701 Blue naevi and melanocytoses (/chaptercontent/64/76)
1702 Naevus of Ito and naevus of Ota (/chaptercontent/64/77) Congenital dermal melanocytosis (/chaptercontent/64/78) Blue naevus
1703 Melanomas arising from blue naevi (/chaptercontent/64/80) Melanoma arising in blue naevus (/chaptercontent/64/81)
1704 Congenital melanocytic tumours (/chaptercontent/64/82)
1705 Congenital naevi (/chaptercontent/64/83)
1706 Congenital melanocytic naevus (/chaptercontent/64/84)
1707 Proliferative nodules in congenital melanocytic naevus (/chaptercontent/64/85) Melanomas arising in congenital naevi (/chaptercontent/64/86)
1708 Melanoma arising in giant congenital naevus (/chaptercontent/64/87)
1709 Ocular and CNS melanocytic tumours (/chaptercontent/64/88)
1710 Conjunctival melanocytic tumours (/chaptercontent/64/370) Conjunctival naevus (/chaptercontent/64/89)
1711 Conjunctival melanocytic intraepithelial lesions (/chaptercontent/64/90) Conjunctival melanoma (/chaptercontent/64/91)
1712 Uveal melanocytic tumours (/chaptercontent/64/371) Uveal melanocytoma (/chaptercontent/64/92)
1713 Uveal melanoma (/chaptercontent/64/93)
1714 CNS melanocytic tumours (/chaptercontent/64/406)
1715 Diffuse meningeal melanocytic neoplasms: melanocytosis and melanomatosis (/chaptercontent/64/334)
1716 Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma (/chaptercontent/64/389)
1717 Nodular, naevoid, and metastatic melanomas (/chaptercontent/64/94)
1718 Nodular and other melanomas (/chaptercontent/64/95) Nodular melanoma (/chaptercontent/64/96)
1719 Naevoid melanoma (/chaptercontent/64/97) Dermal melanoma (/chaptercontent/64/338)
1720 Metastatic melanomas (/chaptercontent/64/414)
1721 Melanoma metastatic to the skin (/chaptercontent/64/98) Melanoma metastatic to other organs (/chaptercontent/64/407)
1722 4.
1723 Appendageal tumours
1725 Tumours with apocrine and eccrine differentiation (/chaptercontent/64/101)
1726 Benign apocrine and eccrine tumours (/chaptercontent/64/102) Hidrocystoma/cystadenoma (/chaptercontent/64/103)
1727 Syringoma (/chaptercontent/64/104) Poroma (/chaptercontent/64/105)
1728 Syringofibroadenoma (/chaptercontent/64/106) Hidradenoma (/chaptercontent/64/107)
1729 Spiradenoma (/chaptercontent/64/108) Cylindroma (/chaptercontent/64/109)
1730 Tubular adenoma (/chaptercontent/64/110)
1731 Syringocystadenoma papilliferum (/chaptercontent/64/111) Mixed tumour (/chaptercontent/64/112)
1732 Myoepithelioma (/chaptercontent/64/113)
1733 Malignant apocrine and eccrine tumours (/chaptercontent/64/114) Adnexal adenocarcinoma, NOS (/chaptercontent/64/115) Microcystic adnexal
1734 Cribriform tumour (previously carcinoma) (/chaptercontent/64/129) Porocarcinoma (/chaptercontent/64/117)
1735 NUT carcinoma (/chaptercontent/64/339)
1736 Malignant neoplasms arising from spiradenoma, cylindroma, or spiradenocylindroma (/chaptercontent/64/118)
1737 Malignant mixed tumour (/chaptercontent/64/119) Hidradenocarcinoma (/chaptercontent/64/120)
1738 Endocrine mucin-producing sweat gland carcinoma (/chaptercontent/64/122) Mucinous carcinoma (/chaptercontent/64/121)
1739 Digital papillary adenocarcinoma (/chaptercontent/64/123) Adenoid cystic carcinoma (/chaptercontent/64/124)
1740 Apocrine carcinoma (/chaptercontent/64/125)
1741 Squamoid ductal eccrine carcinoma (/chaptercontent/64/126)
1742 Syringocystadenocarcinoma papilliferum (/chaptercontent/64/127) Secretory carcinoma (/chaptercontent/64/128)
1743 Signet-ring cell/histiocytoid carcinoma (/chaptercontent/64/130)
1744 Tumours with follicular differentiation (/chaptercontent/64/131)
1745 Benign tumours with follicular differentiation (/chaptercontent/64/132) Trichoblastoma (/chaptercontent/64/133)
1746 Pilomatricoma (/chaptercontent/64/134) Melanocytic matricoma (/chaptercontent/64/139) Trichilemmoma (/chaptercontent/64/135) Trichoadenoma
(/chaptercontent/64/388) Trichofolliculoma (/chaptercontent/64/136)
1747 Pilar sheath acanthoma (/chaptercontent/64/137)
1748 Tumour of the follicular infundibulum (/chaptercontent/64/138) Trichodiscomas and fibrofolliculomas (/chaptercontent/64/140)
1749 Malignant tumours with follicular differentiation (/chaptercontent/64/141) Proliferating trichilemmal tumour (/chaptercontent/64/143)
1750 Pilomatrical carcinoma (/chaptercontent/64/142)
1751 Trichoblastic carcinoma/carcinosarcoma (/chaptercontent/64/144) Trichilemmal carcinoma (/chaptercontent/64/145)
1752 Tumours with sebaceous differentiation (/chaptercontent/64/146)
1753 Benign tumours with sebaceous differentiation (/chaptercontent/64/147) Sebaceoma (/chaptercontent/64/148)
1754 Sebaceous adenoma (/chaptercontent/64/149)
1755 Malignant tumours with sebaceous differentiation (/chaptercontent/64/150) Sebaceous carcinoma (/chaptercontent/64/151)
1756 Site-specific appendageal tumours (/chaptercontent/64/152)
1757 Benign site-specific appendageal tumours (/chaptercontent/64/153) Hidradenoma papilliferum (/chaptercontent/64/154)
1758 Fibroadenoma and phyllodes tumour of anogenital mammary-like glands (/chaptercontent/64/155)
1759 Malignant site-specific appendageal tumours (/chaptercontent/64/156) Mammary Paget disease (/chaptercontent/64/157)
1760 Extramammary Paget disease (/chaptercontent/64/158)
1761 Adenocarcinoma of mammary-gland type (/chaptercontent/64/159)
1762 5.
1763 Tumours of the nail unit
1764 Nail bed epithelial tumours (/chaptercontent/64/351) Onychomatricoma (/chaptercontent/64/350) Onychopapilloma (/chaptercontent/64/349)
1765 Ungual fibrokeratoma (/chaptercontent/64/354) Onychocytic matricoma (/chaptercontent/64/373)
1766 Subungual keratoacathoma (/chaptercontent/64/348)
1767 6.
1768 Tumours of haematopoietic and lymphoid origin
1770 Myeloid proliferations and neoplasms (/chaptercontent/64/162)
1771 Mastocytosis (/chaptercontent/64/163) Mastocytosis (/chaptercontent/64/405) Mast cell sarcoma (/chaptercontent/64/166)
1772 Secondary cutaneous involvement in myeloid neoplasms (/chaptercontent/64/167) Cutaneous involvement in myeloid neoplasms, including
myeloid sarcoma (/chaptercontent/64/168)
1773 Histiocytic or dendritic cell neoplasms (/chaptercontent/64/169)
1774 Plasmacytoid dendritic cell neoplasms (/chaptercontent/64/170)
1775 Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm (/chaptercontent/64/171)
1776 Blastic plasmacytoid dendritic cell neoplasm (/chaptercontent/64/172) Langerhans cell neoplasms (/chaptercontent/64/173)
1777 Langerhans cell histiocytosis (/chaptercontent/64/174) Histiocytic tumours (/chaptercontent/64/175)
1778 Xanthelasma (/chaptercontent/64/376)
1779 Juvenile xanthogranuloma (/chaptercontent/64/176) Reticulohistiocytosis (/chaptercontent/64/218)
1780 Rosai-Dorfman Disease (/chaptercontent/64/178)
1781 Erdheim-Chester disease (/chaptercontent/64/177) ALK postive histiocytosis (/chaptercontent/64/179) Histiocytic sarcoma (/chaptercontent/64/180)
1782 Other dendritic cell neoplasms (/chaptercontent/64/181) Indeterminate dendritic cell tumour (/chaptercontent/64/182)
1783 Cutaneous B-cell lymphoproliferative disorders and neoplasms (/chaptercontent/64/183)
1784 Reactive B-cell rich lymphoid proliferations (/chaptercontent/64/341) Primary cutaneous mature B cell neoplasms (/chaptercontent/64/184)
1785 Primary cutaneous marginal zone lymphoma (/chaptercontent/64/185) Primary cutaneous follicle centre lymphoma (/chaptercontent/64/186)
1786 Primary cutaneous diffuse large B-cell lymphoma, leg type (/chaptercontent/64/187) Intravascular large B-cell lymphoma (/chaptercontent/64/188)
1787 Cutaneous involvement in primarily extracutaneous B-cell lymphomas and leukaemias (/chaptercontent/64/190)
1788 Mantle cell lymphoma (/chaptercontent/64/191) Burkitt lymphoma (/chaptercontent/64/192)
1789 Chronic lymphocytic leukaemia/small lymphocytic lymphoma (/chaptercontent/64/193) B-lymphoblastic leukaemia/lymphoma
Secondary lymphomatoid granulomatosis (/chaptercontent/64/210)
1791 Cutaneous T-cell and NK-cell lymphoproliferative disorders and neoplasms (/chaptercontent/64/195)
1792 Reactive T-cell rich lymphoid proliferations (/chaptercontent/64/342) Primary cutaneous T cell disorders (/chaptercontent/64/196)
1793 Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder (/chaptercontent/64/197)
1794 Mycosis fungoides (/chaptercontent/64/198)
1795 Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Lymphomatoid papulosis (/chaptercontent/64/199)
1796 Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma (/chaptercontent/64/219)
1797 Subcutaneous panniculitis-like T-cell lymphoma (/chaptercontent/64/200) Primary cutaneous gamma/delta T-cell lymphoma
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder (/chaptercontent/64/203) Primary cutaneous CD8-positive aggressive
epidermotropic cytotoxic T-cell lymphoma (/chaptercontent/64/202)
1799 Primary cutaneous peripheral T-cell lymphoma, NOS (/chaptercontent/64/204) Sezary syndrome (/chaptercontent/64/205)
1800 EBV-positive lymphoproliferative diseases of childhood (/chaptercontent/64/206) Severe mosquito bite allergy (/chaptercontent/64/207)
1801 Hydroa vacciniforme lymphoproliferative disorder (/chaptercontent/64/208)
1802 Secondary cutaneous involvement in T-cell and NK-cell lymphomas and leukaemias (/chaptercontent/64/209)
1803 Anaplastic large cell lymphoma (/chaptercontent/64/363)
1804 Nodal T follicular helper lymphoma, angioimmunoblastic type (/chaptercontent/64/211) T-cell prolymphocytic leukaemia (/chaptercontent/64/212)
1805 T-lymphoblastic leukaemia/lymphoma (/chaptercontent/64/213) Adult T cell leukaemia/lymphoma (/chaptercontent/64/216)
1806 Extranodal NK/T-cell lymphoma (/chaptercontent/64/215)
1807 Other cutaneous lymphoproliferative disorders (/chaptercontent/64/364)
1808 Lymphoproliferative disorders and lymphomas associated with immunodeficiency and dysregulation (/chaptercontent/64/366)
1809 EBV-positive mucocutaneous ulcer (/chaptercontent/64/189)
1810 Inborn error of immunity-associated lymphoproliferative disorders (/chaptercontent/64/365)
1811 7.
1814 Adipocytic tumours (/chaptercontent/64/222)
1815 Naevus lipomatosus superficialis (/chaptercontent/64/223) Lipoma (/chaptercontent/64/224)
1816 Angiolipoma (/chaptercontent/64/225)
1817 Spindle cell/pleomorphic lipoma (/chaptercontent/64/226) Atypical lipomatous tumour (/chaptercontent/64/227)
1818 Pleomorphic liposarcoma (/chaptercontent/64/228)
1819 Fibroblastic, myofibroblastic, and fibrohistiocytic tumours (/chaptercontent/64/229)
1820 Benign fibroblastic, myofibroblastic, and fibrohistiocytic neoplasms (/chaptercontent/64/230) Fibroma of tendon sheath (/chaptercontent/64/231)
1821 Calcifying aponeurotic fibroma (/chaptercontent/64/381) Sclerotic fibroma (/chaptercontent/64/382)
1822 Nuchal-type fibroma (/chaptercontent/64/383) Gardner fibroma (/chaptercontent/64/384)
1823 Pleomorphic fibroma (/chaptercontent/64/385) Elastofibroma (/chaptercontent/64/386)
1824 Desmoplastic fibroblastoma (/chaptercontent/64/387) Fibrous papule (/chaptercontent/64/310)
1825 Fibroblastic connective tissue naevus (/chaptercontent/64/308) Fibroosseous tumour of digits (/chaptercontent/64/307)
1826 Dermatofibroma (fibrous histiocytoma) (/chaptercontent/64/233) Superficial fibromatosis (/chaptercontent/64/234)
1827 Inclusion body fibromatosis (/chaptercontent/64/305)
1828 Plexiform fibrohistiocytic tumour (/chaptercontent/64/235) Superficial acral fibromyxoma (/chaptercontent/64/236)
1829 Cutaneous myxoma (superficial angiomyxoma) (/chaptercontent/64/237) Dermatomyofibroma (/chaptercontent/64/238)
1830 Multinucleate cell angiohistiocytoma (/chaptercontent/64/306) Plaque-like CD34+ dermal fibroma (/chaptercontent/64/240) Nodular fasciitis
1831 EWSR1::SMAD3 rearranged fibroblastic tumour (/chaptercontent/64/301)
1832 Intermediate fibroblastic, myofibroblastic, and fibrohistiocytic neoplasms (/chaptercontent/64/242) Dermatofibrosarcoma protuberans
1833 Myxoinflammatory fibroblastic sarcoma (/chaptercontent/64/244)
1834 Malignant fibroblastic, myofibroblastic, and fibrohistiocytic neoplasms (/chaptercontent/64/415) Myxofibrosarcoma (/chaptercontent/64/296)
1835 Vascular tumours (/chaptercontent/64/245)
1836 Haemangiomas (/chaptercontent/64/246)
1837 Cherry haemangioma (/chaptercontent/64/247)
1838 Sinusoidal haemangioma (/chaptercontent/64/248) Microvenular haemangioma (/chaptercontent/64/249) Hobnail haemangioma
(/chaptercontent/64/250) Glomeruloid haemangioma (/chaptercontent/64/251) Papillary haemangioma (/chaptercontent/64/302)
1839 Spindle cell haemangioma (/chaptercontent/64/252) Epithelioid haemangioma (/chaptercontent/64/253) Tufted haemangioma
Angiokeratoma (/chaptercontent/64/255) Infantile haemangioma (/chaptercontent/64/256)
1841 Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non- involuting congenital haemangioma
Lobular capillary haemangioma (/chaptercontent/64/258)
1843 Poikilodermatous plaque-like haemangioma (/chaptercontent/64/343) Acquired elastotic haemangioma (/chaptercontent/64/344)
1844 Verrucous venous malformation (/chaptercontent/64/259) Arteriovenous malformation (/chaptercontent/64/260)
1845 Other benign vascular tumours (/chaptercontent/64/261)
1846 Lymphangioma (superficial lymphatic malformation) (/chaptercontent/64/262) Cutaneous epithelioid angiomatous nodule (/chaptercontent/64/263)
1847 Post-radiation atypical vascular lesion (/chaptercontent/64/264) Intermediate vascular neoplasms (/chaptercontent/64/378)
1848 Pseudomyogenic haemangioendothelioma (/chaptercontent/64/356) Epithelioid haemangioendothelioma (/chaptercontent/64/368)
1849 Hobnail haemangioendotheliomas (/chaptercontent/64/369) Composite haemangioendothelioma (/chaptercontent/64/379) Kaposi sarcoma
1850 Malignant vascular sarcomas (/chaptercontent/64/267) Cutaneous angiosarcoma (/chaptercontent/64/269)
1851 Pericytic and perivascular tumours (/chaptercontent/64/270)
1852 Benign pericytic and perivascular neoplasms (/chaptercontent/64/271) Glomus tumour (/chaptercontent/64/272)
1853 Myopericytoma (/chaptercontent/64/273)
1854 Myofibroma and myofibromatosis (/chaptercontent/64/372) Angioleiomyoma (/chaptercontent/64/274)
1855 Smooth muscle tumours (/chaptercontent/64/275)
1856 Benign smooth muscle neoplasms (/chaptercontent/64/276) Smooth muscle hamartoma (/chaptercontent/64/309)
1857 Cutaneous leiomyomas (/chaptercontent/64/277)
1858 EBV-associated smooth muscle tumour (/chaptercontent/64/355) Intermediate smooth muscle neoplasms (/chaptercontent/64/278)
1859 Atypical intradermal smooth muscle neoplasm (/chaptercontent/64/279)
1860 Neural tumours (/chaptercontent/64/280)
1861 Benign neural neoplasms (/chaptercontent/64/281)
1862 Dermal hyperneury/Epithelial sheath neuroma (/chaptercontent/64/312) Solitary circumscribed neuroma (/chaptercontent/64/283)
1863 Dermal nerve sheath myxoma (/chaptercontent/64/284) Perineurioma (/chaptercontent/64/285)
1864 Neurofibroma (/chaptercontent/64/282)
1865 Schwannoma (/chaptercontent/64/287) Granular cell tumour (/chaptercontent/64/286)
1866 Hybrid nerve sheath tumours (/chaptercontent/64/315) Malignant neural neoplasms (/chaptercontent/64/288)
1868 Tumours of uncertain differentiation (/chaptercontent/64/290)
1869 Benign neoplasms of uncertain differentiation (/chaptercontent/64/291) Cellular neurothekeoma (/chaptercontent/64/292)
1870 Epithelioid fibrous histiocytoma (/chaptercontent/64/232) Non-neural granular cell tumour (/chaptercontent/64/358) PEComa
Intermediate neoplasms of uncertain differentiation (/chaptercontent/64/380) Angiomatoid fibrous histiocytoma (/chaptercontent/64/313)
1872 NTRK-rearranged spindle cell neoplasm (/chaptercontent/64/316) Atypical fibroxanthoma (/chaptercontent/64/293)
1873 Superficial CD34+ fibroblastic tumour (/chaptercontent/64/304) Malignant neoplasms of uncertain differentiation (/chaptercontent/64/300)
1874 Pleomorphic dermal sarcoma (/chaptercontent/64/295) Epithelioid sarcoma (/chaptercontent/64/297)
1875 CRTC1::TRIM11 cutaneous tumour (/chaptercontent/64/303) Dermal clear cell sarcoma (/chaptercontent/64/298)
1877 8.
1878 Metastases to skin
1879 Metastases to skin (/chaptercontent/64/217)
1880 Cancer of unknown primary site (/chaptercontent/64/367)
1881 9.
1882 Genetic tumour syndromes associated with skin malignancies
1883 Introduction (/chaptercontent/64/318) Familial melanoma (/chaptercontent/64/319)
1884 BAP1 tumour predisposition syndrome (/chaptercontent/64/323) Xeroderma pigmentosum (/chaptercontent/64/320)
1885 Naevoid basal cell carcinoma syndrome (Gorlin syndrome) (/chaptercontent/64/321) Carney complex (/chaptercontent/64/322)
1886 Muir-Torre syndrome (/chaptercontent/64/324)
1887 Brooke-Spiegler and related syndromes (/chaptercontent/64/325)
1889 Endocrine and Neuroendocrine Tumours (5th ed.)
1890 1.
1891 Forewords and introductions
1894 Foreword with changes from the book, including corrigenda (/chaptercontent/53/217) ICD-O coding of endocrine and neuroendocrine
tumours (/chaptercontent/53/218) TNM staging of endocrine and neuroendocrine tumours (/chaptercontent/53/219) ICCR datasets:
Endocrine organs (/chaptercontent/53/220)
1895 Introduction to endocrine and neuroendocrine tumours (/chaptercontent/53/1)
1896 2.
1897 Pituitary tumours
1898 Pituitary tumours: Introduction (/chaptercontent/53/3)
1899 Anterior pituitary neuroendocrine tumours (PitNETs)
1900 PitNETs of PIT1 lineage
1901 Somatotroph PitNET/adenoma (/chaptercontent/53/6) Mammosomatotroph PitNET/adenoma (/chaptercontent/53/200) Lactotroph
PitNET/adenoma (/chaptercontent/53/7)
1902 Thyrotroph PitNET/adenoma (/chaptercontent/53/8)
1903 Mature plurihormonal PIT1-lineage PitNET/adenoma (/chaptercontent/53/12) Immature PIT1-lineage PitNET/adenoma (/chaptercontent/53/205)
1904 Acidophil stem cell PitNET/adenoma (/chaptercontent/53/203)
1905 Mixed somatotroph-lactotroph PitNET/adenoma (/chaptercontent/53/206)
1906 PitNETs of TPIT lineage
1907 Corticotroph PitNET/adenoma (/chaptercontent/53/9)
1908 PitNETs of SF1 lineage
1909 Gonadotroph PitNET/adenoma (/chaptercontent/53/10)
1910 PitNETs without distinct lineage differentiation
1911 Null cell PitNET/adenoma (/chaptercontent/53/11)
1912 Plurihormonal PitNET/adenomas (/chaptercontent/53/13)
1913 Multiple PitNETs
1914 Multiple synchronous PitNET/adenomas of distinct lineages (/chaptercontent/53/207)
1915 Metastatic PitNETs
1916 Metastatic PitNET (/chaptercontent/53/15)
1917 Other anterior pituitary tumours
1918 Adamantinomatous craniopharyngioma (/chaptercontent/53/18) Papillary craniopharyngioma (/chaptercontent/53/19)
1919 Pituitary blastoma (/chaptercontent/53/17)
1920 Posterior pituitary and hypothalamic neoplasms
1921 Pituicyte-derived tumours
1922 Pituicytomas (/chaptercontent/53/22)
1923 Neuronal tumours
1924 Gangliocytoma and mixed gangliocytoma-PitNET/adenoma (/chaptercontent/53/24)
1925 Sellar neurocytoma (/chaptercontent/53/25)
1926 Other sellar tumours
1927 Meningiomas (/chaptercontent/53/29) Chordoma (/chaptercontent/53/30)
1928 3.
1929 Thyroid tumours
1930 Thyroid tumours: Introduction (/chaptercontent/53/32)
1931 Developmental abnormalities
1932 Thyroglossal duct cyst (/chaptercontent/53/34)
1933 Other congenital thyroid abnormalities (/chaptercontent/53/35)
1934 Follicular cell-derived neoplasms
1935 Benign tumours
1936 Thyroid follicular nodular disease (/chaptercontent/53/150) Follicular thyroid adenoma (/chaptercontent/53/38)
1937 Follicular thyroid adenoma with papillary architecture (/chaptercontent/53/194) Oncocytic adenoma of the thyroid (/chaptercontent/53/196)
1938 Low-risk neoplasms
1939 Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (/chaptercontent/53/42)
1940 Thyroid tumours of uncertain malignant potential (/chaptercontent/53/41) Hyalinizing trabecular tumour (/chaptercontent/53/39)
1941 Malignant neoplasms
1942 Follicular thyroid carcinoma (/chaptercontent/53/45)
1943 Invasive encapsulated follicular variant of papillary thyroid carcinoma (/chaptercontent/53/40) Papillary thyroid carcinoma (/chaptercontent/53/44)
1944 Oncocytic carcinoma of the thyroid (/chaptercontent/53/46)
1945 High-grade follicular cell-derived non-anaplastic thyroid carcinoma (/chaptercontent/53/47) Anaplastic thyroid carcinoma (/chaptercontent/53/48)
1946 Thyroid C cell-derived carcinoma
1947 Medullary thyroid carcinoma (/chaptercontent/53/50)
1948 Mixed medullary and follicular cell-derived carcinomas
1949 Mixed medullary and follicular cell-derived thyroid carcinomas (/chaptercontent/53/51)
1950 Salivary gland-type carcinomas of the thyroid Mucoepidermoid carcinoma (/chaptercontent/53/52) Secretory carcinoma
Thyroid tumours of uncertain histogenesis
1952 Sclerosing mucoepidermoid carcinoma with eosinophilia (/chaptercontent/53/53) Cribriform morular thyroid carcinoma (/chaptercontent/53/55)
1953 Thymic tumours within the thyroid
1954 Thymoma (/chaptercontent/53/63)
1955 Spindle epithelial tumour with thymus-like elements (/chaptercontent/53/64) Intrathyroidal thymic carcinoma (/chaptercontent/53/65)
1956 Embryonal thyroid neoplasms
1957 Thyroblastoma (/chaptercontent/53/57)
1958 4.
1959 Parathyroid tumours
1960 Parathyroid tumours: Introduction (/chaptercontent/53/67) Parathyroid hyperplasia (/chaptercontent/53/169)
1961 Parathyroid adenoma (/chaptercontent/53/68)
1962 Parathyroid lipoadenoma (/chaptercontent/53/69)
1963 Atypical parathyroid tumour (/chaptercontent/53/70) Parathyroid carcinoma (/chaptercontent/53/71)
1964 5.
1965 Adrenal gland tumours
1966 Adrenal gland tumours: Introduction (/chaptercontent/53/91)
1967 Lesions in the adrenal cortex
1968 Adrenal rests (/chaptercontent/53/87) Adrenal cysts (/chaptercontent/53/174)
1969 Adrenal myelolipoma (/chaptercontent/53/128)
1970 Adrenal cortical tumours
1971 Congenital adrenal hyperplasia (/chaptercontent/53/193) Adrenocortical nodular disease (/chaptercontent/53/171) Adrenal cortical adenoma
1972 Adrenal cortical carcinoma (/chaptercontent/53/95)
1973 Sex cord stromal and other tumours
1974 Adrenal sex cord stromal tumour (/chaptercontent/53/97) Adenomatoid tumour (/chaptercontent/53/98)
1975 Adrenal melanoma (/chaptercontent/53/195)
1976 6.
1977 Adrenal medulla and extra-adrenal paraganglia tumours
1978 Adrenal medulla and extra-adrenal paraganglia tumours: Introduction (/chaptercontent/53/100)
1979 Neuroblastic tumours
1980 Neuroblastoma (/chaptercontent/53/102) Ganglioneuroblastoma, intermixed (/chaptercontent/53/103) Ganglioneuroblastoma, nodular
(/chaptercontent/53/104) Ganglioneuroma (/chaptercontent/53/105)
1981 Paraganglioma and phaeochromocytoma
1982 Phaeochromocytoma (/chaptercontent/53/112)
1983 Sympathetic paraganglioma (/chaptercontent/53/109)
1984 Parasympathetic paraganglioma (/chaptercontent/53/110)
1985 Composite paraganglion tumours
1986 Composite phaeochromocytomas and paragangliomas (/chaptercontent/53/114)
1987 7.
1988 Pancreatic neuroendocrine neoplasms
1989 Pancreatic neuroendocrine neoplasms: Introduction (/chaptercontent/53/73)
1992 Non-functioning (non-syndromic) pancreatic neuroendocrine tumours (/chaptercontent/53/76) Insulinoma (/chaptercontent/53/77)
1993 Glucagonoma (/chaptercontent/53/78)
1994 Somatostatinoma (/chaptercontent/53/79) Gastrinoma (/chaptercontent/53/80)
1995 VIPoma (/chaptercontent/53/81)
1996 Serotonin-producing tumours with and without carcinoid syndrome (/chaptercontent/53/82) Other pancreatic neuroendocrine tumours with ectopic
hormone production (/chaptercontent/53/83)
1998 Pancreatic neuroendocrine carcinoma (/chaptercontent/53/85)
1999 Mixed neuroendocrine-non-neuroendocrine neoplasms
2000 Mixed ductal adenocarcinoma-neuroendocrine neoplasms (/chaptercontent/53/88) Mixed acinar-neuroendocrine carcinoma (/chaptercontent/53/89)
2001 8.
2002 Neuroendocrine neoplasms in non-endocrine organs
2003 Neuroendocrine neoplasms in non-endocrine organs: Introduction (/chaptercontent/53/173)
2006 Neuroendocrine tumours (/chaptercontent/53/119)
2008 Small cell neuroendocrine carcinoma (/chaptercontent/53/121) Large cell neuroendocrine carcinoma (/chaptercontent/53/122) Merkel cell
2009 Mixed neuroendocrine neoplasms
2010 Mixed neuroendocrine-non-neuroendocrine neoplasms (/chaptercontent/53/124)
2011 Paraganglioma-like neuroendocrine neoplasms
2012 Composite gangliocytoma/neuroma and neuroendocrine tumour (/chaptercontent/53/176) Cauda equina neuroendocrine tumour (previously
paraganglioma) (/chaptercontent/53/178)
2013 9.
2014 Mesenchymal and stromal tumours
2015 Mesenchymal and stromal tumours: Introduction (/chaptercontent/53/126)
2016 Lipocytic tumours
2018 Fibrous tumours
2019 Solitary fibrous tumour (/chaptercontent/53/130)
2021 Benign vascular tumours (/chaptercontent/53/132) PEComa (/chaptercontent/53/181)
2022 Glomangioma and glomus tumour (/chaptercontent/53/182) Angiosarcoma (/chaptercontent/53/133)
2028 Schwannoma (/chaptercontent/53/139) Neurofibroma (/chaptercontent/53/140)
2031 10.
2033 Haematolymphoid tumours: Introduction (/chaptercontent/53/142) IgG4-related disease (/chaptercontent/53/186)
2034 Extranodal marginal zone lymphoma (/chaptercontent/53/143) Diffuse large B-cell lymphoma (/chaptercontent/53/170) Langerhans cell
histiocytosis (/chaptercontent/53/144)
2035 Rosai-Dorfman disease (/chaptercontent/53/145) Erdheim-Chester disease (/chaptercontent/53/185)
2036 Follicular dendritic cell sarcoma (/chaptercontent/53/146)
2037 11.
2039 Germ cell tumours: Introduction (/chaptercontent/53/188)
2041 Germ cell tumours in endocrine organs (/chaptercontent/53/149) Teratomas with endocrine differentiation (/chaptercontent/53/187)
2042 12.
2043 Metastasis
2044 Metastasis: Introduction (/chaptercontent/53/192) Metastasis to the pituitary gland (/chaptercontent/53/175) Metastasis to the thyroid gland
(/chaptercontent/53/190) Metastasis to the adrenal gland (/chaptercontent/53/189)
2045 13.
2046 Genetic tumour syndromes associated with endocrine lesions and tumours
2047 Genetic tumour syndromes associated with endocrine lesions and tumours: Introduction (/chaptercontent/53/153)
2048 Multiple endocrine neoplasia type 1 (/chaptercontent/53/154) Multiple endocrine neoplasia type 2 (/chaptercontent/53/155) Multiple endocrine
neoplasia type 4 (/chaptercontent/53/156)
2049 Multiple endocrine neoplasia type 5 (MAX-related tumours) (/chaptercontent/53/163) Hyperparathyroidism-jaw tumour syndrome
Von Hippel-Lindau syndrome (/chaptercontent/53/158)
2051 SDH-deficient tumour syndromes (/chaptercontent/53/159)
2052 Neurofibromatosis type 1 (/chaptercontent/53/160) Carney complex (/chaptercontent/53/161)
2053 McCune-Albright syndrome (/chaptercontent/53/162) DICER1 syndrome (/chaptercontent/53/164)
2054 Glucagon cell hyperplasia and neoplasia (/chaptercontent/53/165) MAFA-related familial insulinomatosis (/chaptercontent/53/210)
2055 Syndromic familial follicular cell-derived thyroid tumours (/chaptercontent/53/167)
2056 Non-syndromic familial follicular cell-derived thyroid tumours (/chaptercontent/53/168)
2058 Soft Tissue and Bone Tumours (5th ed.)
2059 1.
2062 Foreword with changes from the book, including corrigenda (/chaptercontent/33/274) ICD-O coding of soft tissue and bone tumours
2063 TNM staging of soft tissue and bone tumours (/chaptercontent/33/281) ICCR datasets: Soft tissue & bone (/chaptercontent/33/282)
2064 2.
2066 Soft tissue tumours: Introduction (/chaptercontent/33/1) Adipocytic tumours
2067 Lipoma (/chaptercontent/33/4) Lipomatosis (/chaptercontent/33/213)
2068 Lipomatosis of nerve (/chaptercontent/33/214) Lipoblastoma and lipoblastomatosis (/chaptercontent/33/8) Angiolipoma (/chaptercontent/33/5)
2069 Myolipoma of soft tissue (/chaptercontent/33/9) Chondroid lipoma (/chaptercontent/33/6)
2070 Spindle cell lipoma and pleomorphic lipoma (/chaptercontent/33/10) Hibernoma (/chaptercontent/33/7)
2071 Atypical spindle cell / pleomorphic lipomatous tumour (/chaptercontent/33/223)
2072 Atypical lipomatous tumour / well-differentiated liposarcoma (/chaptercontent/33/12) Dedifferentiated liposarcoma (/chaptercontent/33/14)
2073 Myxoid liposarcoma (/chaptercontent/33/16)
2074 Pleomorphic liposarcoma (/chaptercontent/33/15)
2075 Myxoid pleomorphic liposarcoma (/chaptercontent/33/250)
2077 Nodular fasciitis (/chaptercontent/33/18)
2078 Proliferative fasciitis and proliferative myositis (/chaptercontent/33/20)
2079 Myositis ossificans and fibro-osseous pseudotumour of digits (/chaptercontent/33/19) Ischaemic fasciitis (/chaptercontent/33/21)
2080 Elastofibroma (/chaptercontent/33/22)
2081 Fibrous hamartoma of infancy (/chaptercontent/33/23) Fibromatosis colli (/chaptercontent/33/24)
2082 Juvenile hyaline fibromatosis (/chaptercontent/33/25) Inclusion body fibromatosis (/chaptercontent/33/26) Fibroma of tendon sheath
2083 Desmoplastic fibroblastoma (/chaptercontent/33/28) Myofibroblastoma (/chaptercontent/33/29)
2084 Calcifying aponeurotic fibroma (/chaptercontent/33/31)
2085 EWSR1-SMAD3-positive fibroblastic tumour (emerging) (/chaptercontent/33/253) Angiomyofibroblastoma (/chaptercontent/33/33)
2086 Cellular angiofibroma (/chaptercontent/33/34)
2087 Angiofibroma of soft tissue (/chaptercontent/33/251) Nuchal-type fibroma (/chaptercontent/33/35)
2088 Acral fibromyxoma (/chaptercontent/33/109) Gardner fibroma (/chaptercontent/33/36)
2089 Palmar fibromatosis and plantar fibromatosis (/chaptercontent/33/38) Desmoid fibromatosis (/chaptercontent/33/40)
2090 Lipofibromatosis (/chaptercontent/33/41)
2091 Giant cell fibroblastoma (/chaptercontent/33/42)
2092 Dermatofibrosarcoma protuberans (/chaptercontent/33/46) Solitary fibrous tumour (/chaptercontent/33/37)
2093 Inflammatory myofibroblastic tumour (/chaptercontent/33/43) Low-grade myofibroblastic sarcoma (/chaptercontent/33/50)
2094 Superficial CD34-positive fibroblastic tumour (/chaptercontent/33/249) Myxoinflammatory fibroblastic sarcoma (/chaptercontent/33/44) Infantile
fibrosarcoma (/chaptercontent/33/48)
2095 Adult fibrosarcoma (/chaptercontent/33/47) Myxofibrosarcoma (/chaptercontent/33/49)
2096 Low-grade fibromyxoid sarcoma (/chaptercontent/33/51)
2097 Sclerosing epithelioid fibrosarcoma (/chaptercontent/33/52)
2098 So-called fibrohistiocytic tumours
2099 Tenosynovial giant cell tumour (/chaptercontent/33/57) Deep fibrous histiocytoma (/chaptercontent/33/54)
2100 Plexiform fibrohistiocytic tumour (/chaptercontent/33/55) Giant cell tumour of soft tissue (/chaptercontent/33/56)
2102 Haemangiomas
2103 Synovial haemangioma (/chaptercontent/33/269) Intramuscular angioma (/chaptercontent/33/270)
2104 Arteriovenous malformation/haemangioma (/chaptercontent/33/271) Venous haemangioma (/chaptercontent/33/272)
2105 Anastomosing haemangioma (/chaptercontent/33/252) Epithelioid haemangioma (/chaptercontent/33/215)
2106 Lymphangioma and lymphangiomatosis (/chaptercontent/33/67)
2107 Tufted angioma and kaposiform haemangioendothelioma (/chaptercontent/33/211) Retiform haemangioendothelioma (/chaptercontent/33/71)
2108 Papillary intralymphatic angioendothelioma (/chaptercontent/33/210) Composite haemangioendothelioma (/chaptercontent/33/209)
2109 Kaposi sarcoma (/chaptercontent/33/70)
2110 Pseudomyogenic haemangioendothelioma (/chaptercontent/33/72) Epithelioid haemangioendothelioma (/chaptercontent/33/73)
2113 Glomus tumour (/chaptercontent/33/79)
2114 Myopericytoma, including myofibroma (/chaptercontent/33/78) Angioleiomyoma (/chaptercontent/33/77)
2116 Leiomyoma (/chaptercontent/33/99)
2118 Inflammatory leiomyosarcoma (/chaptercontent/33/255) Leiomyosarcoma (/chaptercontent/33/100)
2121 Embryonal rhabdomyosarcoma (/chaptercontent/33/104) Alveolar rhabdomyosarcoma (/chaptercontent/33/105)
2122 Pleomorphic rhabdomyosarcoma (/chaptercontent/33/107)
2123 Spindle cell / sclerosing rhabdomyosarcoma (/chaptercontent/33/106) Ectomesenchymoma (/chaptercontent/33/94)
2125 Gastrointestinal stromal tumour (/chaptercontent/33/216)
2127 Soft tissue chondroma (/chaptercontent/33/96)
2128 Extraskeletal osteosarcoma (/chaptercontent/33/97)
2130 Schwannoma (/chaptercontent/33/81) Neurofibroma (/chaptercontent/33/83) Perineurioma (/chaptercontent/33/84)
2132 Dermal nerve sheath myxoma (/chaptercontent/33/86) Solitary circumscribed neuroma (/chaptercontent/33/87)
2133 Ectopic meningioma and meningothelial hamartoma (/chaptercontent/33/88) Benign triton tumour / neuromuscular choristoma
Hybrid nerve sheath tumour (/chaptercontent/33/91)
2135 Malignant peripheral nerve sheath tumour (/chaptercontent/33/92) Malignant melanotic nerve sheath tumour (/chaptercontent/33/82)
2136 Tumours of uncertain differentiation Intramuscular myxoma (/chaptercontent/33/110) Juxta-articular myxoma (/chaptercontent/33/111)
2137 Deep (aggressive) angiomyxoma (/chaptercontent/33/112) Atypical fibroxanthoma (/chaptercontent/33/115)
2138 Angiomatoid fibrous histiocytoma (/chaptercontent/33/116) Ossifying fibromyxoid tumour (/chaptercontent/33/117)
2139 Myoepithelioma, myoepithelial carcinoma, and mixed tumour (/chaptercontent/33/118) Pleomorphic hyalinizing angiectatic tumour of soft parts
2140 Haemosiderotic fibrolipomatous tumour (/chaptercontent/33/119) Phosphaturic mesenchymal tumour (/chaptercontent/33/120)
2141 NTRK-rearranged spindle cell neoplasm (emerging) (/chaptercontent/33/254) Synovial sarcoma (/chaptercontent/33/121)
2142 Epithelioid sarcoma (/chaptercontent/33/127)
2144 Clear cell sarcoma of soft tissue (/chaptercontent/33/124)
2145 Extraskeletal myxoid chondrosarcoma (/chaptercontent/33/125) Desmoplastic small round cell tumour (/chaptercontent/33/126) Extrarenal
rhabdoid tumour (/chaptercontent/33/128)
2146 PEComa (/chaptercontent/33/130) Intimal sarcoma (/chaptercontent/33/131)
2147 Undifferentiated sarcoma (/chaptercontent/33/133)
2148 3.
2149 Undifferentiated small round cell sarcomas of bone and soft tissue
2151 Round cell sarcoma with EWSR1-non-ETS fusions (/chaptercontent/33/244) CIC-rearranged sarcoma (/chaptercontent/33/230)
2152 Sarcoma with BCOR genetic alterations (/chaptercontent/33/231)
2153 4.
2154 Bone tumours
2155 Bone tumours: Introduction (/chaptercontent/33/261)
2157 Subungual exostosis (/chaptercontent/33/140)
2158 Bizarre parosteal osteochondromatous proliferation (/chaptercontent/33/256) Periosteal chondroma (/chaptercontent/33/258)
2159 Enchondroma (/chaptercontent/33/137) Osteochondroma (/chaptercontent/33/136) Chondroblastoma (/chaptercontent/33/142)
2160 Chondromyxoid fibroma (/chaptercontent/33/138) Osteochondromyxoma (/chaptercontent/33/139)
2161 Synovial chondromatosis (/chaptercontent/33/141)
2162 Central atypical cartilaginous tumour / chondrosarcoma, grade 1 (/chaptercontent/33/241) Secondary peripheral atypical cartilaginous tumour /
chondrosarcoma, grade 1 (/chaptercontent/33/267)
2163 Central chondrosarcoma, grades 2 and 3 (/chaptercontent/33/143)
2164 Secondary peripheral chondrosarcoma, grades 2 and 3 (/chaptercontent/33/266) Periosteal chondrosarcoma (/chaptercontent/33/242)
2165 Clear cell chondrosarcoma (/chaptercontent/33/146) Mesenchymal chondrosarcoma (/chaptercontent/33/145) Dedifferentiated chondrosarcoma
2166 Osteogenic tumours
2167 Osteoma (/chaptercontent/33/148) Osteoid osteoma (/chaptercontent/33/149) Osteoblastoma (/chaptercontent/33/150)
2168 Low-grade central osteosarcoma (/chaptercontent/33/152) Osteosarcoma (/chaptercontent/33/153)
2169 Parosteal osteosarcoma (/chaptercontent/33/156) Periosteal osteosarcoma (/chaptercontent/33/157)
2170 High-grade surface osteosarcoma (/chaptercontent/33/158) Secondary osteosarcoma (/chaptercontent/33/232)
2171 Fibrogenic tumours
2172 Desmoplastic fibroma of bone (/chaptercontent/33/168) Fibrosarcoma of bone (/chaptercontent/33/169)
2173 Vascular tumours of bone
2174 Haemangioma of bone (/chaptercontent/33/234)
2175 Epithelioid haemangioma of bone (/chaptercontent/33/235)
2176 Epithelioid haemangioendothelioma of bone (/chaptercontent/33/236) Angiosarcoma of bone (/chaptercontent/33/237)
2177 Osteoclastic giant cell-rich tumours
2178 Aneurysmal bone cyst (/chaptercontent/33/247) Giant cell tumour of bone (/chaptercontent/33/161) Non-ossifying fibroma (/chaptercontent/33/163)
2179 Notochordal tumours
2180 Benign notochordal cell tumour (/chaptercontent/33/165) Conventional chordoma (/chaptercontent/33/166)
2181 Dedifferentiated chordoma (/chaptercontent/33/257)
2182 Poorly differentiated chordoma (/chaptercontent/33/218)
2183 Other mesenchymal tumours of bone
2184 Chondromesenchymal hamartoma of chest wall (/chaptercontent/33/172) Osteofibrous dysplasia (/chaptercontent/33/181)
2185 Adamantinoma of long bones (/chaptercontent/33/177) Simple bone cyst (/chaptercontent/33/179)
2186 Fibrocartilaginous mesenchymoma (/chaptercontent/33/259) Fibrous dysplasia (/chaptercontent/33/180)
2187 Lipoma and hibernoma of bone (/chaptercontent/33/239) Leiomyosarcoma of bone (/chaptercontent/33/238)
2188 Undifferentiated pleomorphic sarcoma (/chaptercontent/33/178) Bone metastases (/chaptercontent/33/187)
2189 Haematopoietic neoplasms of bone
2190 Solitary plasmacytoma of bone (/chaptercontent/33/191)
2191 Primary non-Hodgkin lymphoma of bone (/chaptercontent/33/192) Langerhans cell histiocytosis (/chaptercontent/33/193)
2192 Erdheim-Chester disease (/chaptercontent/33/194) Rosai-Dorfman disease (/chaptercontent/33/195)
2193 5.
2194 Genetic tumour syndromes of soft tissue and bone
2195 Genetic tumour syndromes of soft tissue and bone: Introduction (/chaptercontent/33/197) Enchondromatosis (/chaptercontent/33/200)
2196 Li-Fraumeni syndrome (/chaptercontent/33/202) McCune-Albright syndrome (/chaptercontent/33/203) Multiple osteochondromas
(/chaptercontent/33/204) Neurofibromatosis type 1 (/chaptercontent/33/205)
2197 Rothmund-Thomson syndrome (/chaptercontent/33/264) Werner syndrome (/chaptercontent/33/265)
2199 Haematolymphoid Tumours (5th ed.)
2200 1.
2204 Foreword with changes from the book, including corrigenda (/chaptercontent/63/388) ICD-O coding of haematolymphoid tumours
2205 ICCR datasets: Haemopoietic (/chaptercontent/63/382) General Introduction (/chaptercontent/63/310)
2206 2.
2207 Myeloid proliferations and neoplasms
2208 Myeloid precursor lesions
2209 Clonal Haematopoiesis
2211 Clonal haematopoiesis (/chaptercontent/63/5)
2212 Clonal cytopenias of undetermined significance (/chaptercontent/63/6)
2213 Myeloproliferative neoplasms
2216 Chronic myeloid leukaemia (/chaptercontent/63/10)
2217 Chronic neutrophilic leukaemia (/chaptercontent/63/11) Chronic eosinophilic leukaemia (/chaptercontent/63/12) Polycythaemia vera
Essential thrombocythaemia (/chaptercontent/63/14) Primary myelofibrosis (/chaptercontent/63/15)
2219 Juvenile myelomonocytic leukaemia (/chaptercontent/63/33) Myeloproliferative neoplasm, NOS (/chaptercontent/63/16)
2220 Mastocytosis
2222 Cutaneous mastocytosis (/chaptercontent/63/19) Systemic mastocytosis (/chaptercontent/63/20) Mast cell sarcoma (/chaptercontent/63/21)
2223 Myelodysplastic neoplasms
2225 Myelodysplastic neoplasms, with defining genetic abnormalities
2226 Myelodysplastic neoplasm with low blasts and 5q deletion (/chaptercontent/63/24) Myelodysplastic neoplasm with low blasts and SF3B1 mutation
(/chaptercontent/63/23) Myelodysplastic neoplasm with biallelic TP53 inactivation (/chaptercontent/63/277)
2227 Myelodysplastic neoplasms, morphologically defined
2228 Myelodysplastic neoplasm with low blasts (/chaptercontent/63/314) Myelodysplastic neoplasm, hypoplastic (/chaptercontent/63/345)
Myelodysplastic neoplasm with increased blasts (/chaptercontent/63/29)
2229 Myelodysplastic neoplasms of childhood
2230 Childhood myelodysplastic neoplasm with low blasts (/chaptercontent/63/272)
2231 Childhood myelodysplastic neoplasm with increased blasts (/chaptercontent/63/30)
2232 Myelodysplastic/myeloproliferative neoplasms
2234 Chronic myelomonocytic leukaemia (/chaptercontent/63/31) Myelodysplastic/myeloproliferative neoplasm with neutrophilia (/chaptercontent/63/32)
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis (/chaptercontent/63/273)
2235 Myelodysplastic/myeloproliferative neoplasm, NOS (/chaptercontent/63/34)
2236 Acute myeloid leukaemia
2238 Acute myeloid leukaemia with defining genetic abnormalities
2239 Acute promyelocytic leukaemia with PML::RARA fusion (/chaptercontent/63/38) Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion
(/chaptercontent/63/39) Acute myeloid leukaemia with CBFB::MYH11 fusion (/chaptercontent/63/40)
2240 Acute myeloid leukaemia with DEK::NUP214 fusion (/chaptercontent/63/42) Acute myeloid leukaemia with RBM15::MRTFA fusion
(/chaptercontent/63/44) Acute myeloid leukaemia with BCR::ABL1 fusion (/chaptercontent/63/45)
2241 Acute myeloid leukaemia with KMT2A rearrangement (/chaptercontent/63/41) Acute myeloid leukaemia with MECOM rearrangement
(/chaptercontent/63/43) Acute myeloid leukaemia with NUP98 rearrangement (/chaptercontent/63/46) Acute myeloid leukaemia with NPM1
mutation (/chaptercontent/63/318)
2242 Acute myeloid leukaemia with CEBPA mutation (/chaptercontent/63/346) Acute myeloid leukaemia, myelodysplasia-related (/chaptercontent/63/47)
2243 Acute myeloid leukaemia with other defined genetic alterations (/chaptercontent/63/280)
2244 Acute myeloid leukaemia, defined by differentiation
2245 Acute myeloid leukaemia with minimal differentiation (/chaptercontent/63/51) Acute myeloid leukaemia without maturation (/chaptercontent/63/52)
2246 Acute myeloid leukaemia with maturation (/chaptercontent/63/53) Acute basophilic leukaemia (/chaptercontent/63/54)
2247 Acute myelomonocytic leukaemia (/chaptercontent/63/55) Acute monocytic leukaemia (/chaptercontent/63/56)
2248 Acute erythroid leukaemia (/chaptercontent/63/58)
2249 Acute megakaryoblastic leukaemia (/chaptercontent/63/59)
2250 Myeloid sarcoma
2252 Myeloid neoplasms, secondary
2253 Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions
2255 Myeloid neoplasm post cytotoxic therapy (/chaptercontent/63/27)
2256 Myeloid neoplasms associated with germline predisposition (/chaptercontent/63/28) Myeloid proliferations associated with Down syndrome
2257 Myeloid/lymphoid neoplasms
2258 Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement
2260 Myeloid/lymphoid neoplasm with PDGFRA rearrangement (/chaptercontent/63/72) Myeloid/lymphoid neoplasm with PDGFRB rearrangement
(/chaptercontent/63/73) Myeloid/lymphoid neoplasm with FGFR1 rearrangement (/chaptercontent/63/74) Myeloid/lymphoid neoplasm with JAK2
rearrangement (/chaptercontent/63/75)
2261 Myeloid/lymphoid neoplasm with FLT3 rearrangement (/chaptercontent/63/335) Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion
(/chaptercontent/63/370) Myeloid/lymphoid neoplasms with other tyrosine kinase gene fusions (/chaptercontent/63/371)
2262 Acute leukaemias of mixed or ambiguous lineage
2264 Acute leukaemia of ambiguous lineage with defining genetic abnormalities
2265 Mixed-phenotype acute leukaemia with BCR::ABL1 fusion (/chaptercontent/63/78) Mixed-phenotype acute leukaemia with KMT2A rearrangement
(/chaptercontent/63/79) Acute leukaemia of ambiguous lineage with other defined genetic alterations (/chaptercontent/63/363)
2266 Acute leukaemia of ambiguous lineage, immunophenotypically defined Mixed-phenotype acute leukaemia, B/myeloid (/chaptercontent/63/80)
Mixed-phenotype acute leukaemia, T/myeloid (/chaptercontent/63/81) Mixed-phenotype acute leukaemia, rare types (/chaptercontent/63/365)
Acute leukaemia of ambiguous lineage, NOS (/chaptercontent/63/82) Acute undifferentiated leukaemia (/chaptercontent/63/366)
2267 3.
2268 Histiocytic/Dendritic cell neoplasms
2270 Plasmacytoid dendritic cell neoplasms
2271 Plasmacytoid dendritic cell neoplasms
2272 Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm (/chaptercontent/63/87)
2273 Blastic plasmacytoid dendritic cell neoplasm (/chaptercontent/63/88)
2274 Langerhans cell and other dendritic cell neoplasms
2275 Langerhans cells neoplasms
2276 Langerhans cell histiocytosis (/chaptercontent/63/92) Langerhans cell sarcoma (/chaptercontent/63/93)
2277 Other dendritic cell neoplasms
2278 Indeterminate dendritic cell tumour (/chaptercontent/63/103) Interdigitating dendritic cell sarcoma (/chaptercontent/63/104)
2279 Histiocyte/macrophage neoplasms
2280 Histiocytic neoplasms
2281 Juvenile xanthogranuloma (/chaptercontent/63/282) Erdheim-Chester disease (/chaptercontent/63/97) Rosai-Dorfman Disease
ALK-positive histiocytosis (/chaptercontent/63/279) Histiocytic sarcoma (/chaptercontent/63/99)
2283 4.
2284 B-cell lymphoid proliferations and lymphomas
2285 Introduction to B-cell lymphoproliferative disorders and neoplasms (/chaptercontent/63/287)
2286 Tumour like lesions with B-cell predominance
2288 Reactive B-cell rich lymphoid proliferations that can mimic lymphoma (/chaptercontent/63/322)
2289 IgG4-related disease (/chaptercontent/63/285)
2290 Unicentric Castleman disease (/chaptercontent/63/284)
2291 Idiopathic multicentric Castleman disease (/chaptercontent/63/355)
2292 KSHV/HHV8-associated multicentric Castleman disease (/chaptercontent/63/356)
2293 Precursor B-cell neoplasms
2294 B-lymphoblastic leukaemias/lymphomas
2296 B-lymphoblastic leukaemia/lymphoma (/chaptercontent/63/385)
2297 B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy (/chaptercontent/63/292) B-lymphoblastic leukaemia/lymphoma with hypodiploidy
2298 B-lymphoblastic leukaemia/lymphoma with iAMP21 (/chaptercontent/63/337)
2299 B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion (/chaptercontent/63/288)
2300 B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features (/chaptercontent/63/110) B lymphoblastic leukaemia/lymphoma with KMT2A
rearrangement (/chaptercontent/63/289) B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion (/chaptercontent/63/290)
2301 B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features (/chaptercontent/63/338) B lymphoblastic leukaemia/lymphoma with
TCF3::PBX1 fusion (/chaptercontent/63/339)
2302 B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion (/chaptercontent/63/340)
2303 B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion (/chaptercontent/63/348) B-lymphoblastic leukaemia/lymphoma with other defined
genetic alterations (/chaptercontent/63/344)
2304 B-lymphoblastic leukaemia/lymphoma, NOS (/chaptercontent/63/111)
2305 Mature B-cell neoplasms
2306 Pre-neoplastic and neoplastic small lymphocytic proliferations
2308 Monoclonal B-cell lymphocytosis (/chaptercontent/63/115)
2309 Chronic lymphocytic leukaemia/small lymphocytic lymphoma (/chaptercontent/63/116)
2310 Splenic B-cell lymphomas and leukaemias
2312 Hairy cell leukaemia (/chaptercontent/63/119)
2313 Splenic marginal zone lymphoma (/chaptercontent/63/129)
2314 Splenic diffuse red pulp small B-cell lymphoma (/chaptercontent/63/123)
2315 Splenic B-cell lymphoma/leukaemia with prominent nucleoli (/chaptercontent/63/122)
2316 Lymphoplasmacytic lymphoma
2317 Lymphoplasmacytic lymphoma (/chaptercontent/63/294)
2318 Marginal zone lymphoma
2320 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (/chaptercontent/63/127)
2321 Primary cutaneous marginal zone lymphoma (/chaptercontent/63/326) Nodal marginal zone lymphoma (/chaptercontent/63/128)
2322 Paediatric nodal marginal zone lymphoma (/chaptercontent/63/361)
2323 Follicular lymphoma
2325 In situ follicular B-cell neoplasm (/chaptercontent/63/295) Follicular lymphoma (/chaptercontent/63/132)
2326 Paediatric-type follicular lymphoma (/chaptercontent/63/133) Duodenal-type follicular lymphoma (/chaptercontent/63/296)
2327 Cutaneous follicle centre lymphoma
2328 Primary cutaneous follicle centre lymphoma (/chaptercontent/63/327)
2329 Mantle cell lymphoma
2331 In situ mantle cell neoplasm (/chaptercontent/63/137) Mantle cell lymphoma (/chaptercontent/63/138)
2332 Leukaemic non-nodal mantle cell lymphoma (/chaptercontent/63/139)
2333 Transformations of indolent B-cell lymphomas
2335 Transformations of indolent B-cell lymphomas (/chaptercontent/63/329)
2336 Large B-cell lymphomas
2338 Diffuse large B-cell lymphoma, NOS (/chaptercontent/63/157)
2339 T-cell/histiocyte-rich large B-cell lymphoma (/chaptercontent/63/143)
2340 Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements (/chaptercontent/63/161)
2341 ALK-positive large B-cell lymphoma (/chaptercontent/63/153)
2342 Large B-cell lymphoma with IRF4 rearrangement (/chaptercontent/63/134) High grade B-cell lymphoma with 11q aberrations
(/chaptercontent/63/162) Lymphomatoid granulomatosis (/chaptercontent/63/180)
2343 EBV-positive diffuse large B-cell lymphoma (/chaptercontent/63/149)
2344 Diffuse large B-cell lymphoma associated with chronic inflammation (/chaptercontent/63/150) Fibrin-associated large B-cell lymphoma
2345 Fluid overload-associated large B-cell lymphoma (/chaptercontent/63/300) Plasmablastic lymphoma (/chaptercontent/63/154)
2346 Primary large B-cell lymphoma of immune-privileged sites (/chaptercontent/63/155) Primary cutaneous diffuse large B-cell lymphoma, leg type
(/chaptercontent/63/171) Intravascular large B-cell lymphoma (/chaptercontent/63/152)
2347 Primary mediastinal large B-cell lymphoma (/chaptercontent/63/166) Mediastinal grey zone lymphoma (/chaptercontent/63/164)
2348 High-grade B-cell lymphoma, NOS (/chaptercontent/63/163)
2349 Burkitt lymphoma
2350 Burkitt lymphoma (/chaptercontent/63/160)
2351 KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas
2353 Primary effusion lymphoma (/chaptercontent/63/175)
2354 KSHV/HHV8-positive diffuse large B-cell lymphoma (/chaptercontent/63/176)
2355 KSHV/HHV8-positive germinotropic lymphoproliferative disorder (/chaptercontent/63/177)
2356 Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation
2358 Hyperplasias arising in immune deficiency/dysregulation (/chaptercontent/63/124)
2359 Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation (/chaptercontent/63/352)
2360 EBV-positive mucocutaneous ulcer (/chaptercontent/63/353)
2361 Lymphomas arising in immune deficiency / dysregulation (/chaptercontent/63/354) Inborn error of immunity-associated lymphoid proliferations and
lymphomas (/chaptercontent/63/301)
2362 Hodgkin lymphoma
2364 Classic Hodgkin lymphoma (/chaptercontent/63/146)
2365 Nodular lymphocyte predominant Hodgkin lymphoma (/chaptercontent/63/142)
2366 Plasma cell neoplasms and other diseases with paraproteins
2368 Monoclonal gammopathies
2369 Cold agglutinin disease (/chaptercontent/63/349)
2370 IgM monoclonal gammopathy of undetermined significance (/chaptercontent/63/184)
2371 Non-IgM monoclonal gammopathy of undetermined significance (/chaptercontent/63/185) Monoclonal gammopathy of renal significance
2372 Diseases with monoclonal immunoglobulin deposition
2373 Immunoglobulin-related (AL) amyloidosis (/chaptercontent/63/188) Monoclonal immunoglobulin deposition disease (/chaptercontent/63/189)
2374 Heavy chain diseases
2376 Mu heavy chain disease (/chaptercontent/63/192) Gamma heavy chain disease (/chaptercontent/63/193) Alpha heavy chain disease
2377 Plasma cell neoplasms
2379 Plasmacytoma (/chaptercontent/63/197)
2380 Plasma cell myeloma / multiple myeloma (/chaptercontent/63/198)
2381 Plasma cell neoplasms with associated paraneoplastic syndrome (/chaptercontent/63/199)
2382 5.
2383 T-cell and NK-cell lymphoid proliferations and lymphomas
2385 Tumour-like lesions with T-cell predominance
2386 Kikuchi-Fujimoto disease (/chaptercontent/63/303)
2387 Autoimmune lymphoproliferative syndrome (/chaptercontent/63/156) Indolent T-lymphoblastic proliferation (/chaptercontent/63/234)
2388 Precursor T-cell neoplasms
2389 T-lymphoblastic leukaemia / lymphoma
2390 T-lymphoblastic leukaemia / lymphoma, NOS (/chaptercontent/63/204)
2391 Early T-precursor lymphoblastic leukaemia / lymphoma (/chaptercontent/63/205)
2392 Mature T-cell and NK-cell neoplasms
2393 Mature T-cell and NK-cell leukaemias
2395 T-prolymphocytic leukaemia (/chaptercontent/63/209)
2396 T-large granular lymphocytic leukaemia (/chaptercontent/63/210) NK-large granular lymphocytic leukaemia (/chaptercontent/63/256) Adult T-cell
leukaemia/lymphoma (/chaptercontent/63/211)
2397 Sezary syndrome (/chaptercontent/63/212)
2398 Aggressive NK-cell leukaemia (/chaptercontent/63/257)
2399 Primary cutaneous T-cell lymphoid proliferations and lymphomas
2400 Introduction to primary cutaneous T-cell neoplasms (/chaptercontent/63/214)
2401 Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder (/chaptercontent/63/304)
2402 Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder (/chaptercontent/63/221)
2404 Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis (/chaptercontent/63/216)
2405 Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma (/chaptercontent/63/350)
2406 Subcutaneous panniculitis-like T-cell lymphoma (/chaptercontent/63/218) Primary cutaneous gamma/delta T-cell lymphoma
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma (/chaptercontent/63/220)
2408 Primary cutaneous peripheral T-cell lymphoma, NOS (/chaptercontent/63/236)
2409 Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas
2411 Indolent T-cell lymphoma of the gastrointestinal tract (/chaptercontent/63/227)
2412 Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract (/chaptercontent/63/244) Enteropathy-associated T-cell lymphoma
2413 Monomorphic epitheliotropic intestinal T-cell lymphoma (/chaptercontent/63/225) Intestinal T-cell lymphoma, NOS (/chaptercontent/63/332)
2414 Hepatosplenic T-cell lymphoma
2415 Hepatosplenic T-cell lymphoma (/chaptercontent/63/229)
2416 Anaplastic large cell lymphoma
2418 ALK-positive anaplastic large cell lymphoma (/chaptercontent/63/232) ALK-negative anaplastic large cell lymphoma (/chaptercontent/63/233)
2419 Breast implant-associated anaplastic large cell lymphoma (/chaptercontent/63/235)
2420 Nodal T-follicular helper (TFH) cell lymphoma
2422 Nodal TFH cell lymphoma, angioimmunoblastic-type (/chaptercontent/63/240) Nodal TFH cell lymphoma, follicular-type (/chaptercontent/63/239)
2423 Nodal TFH cell lymphoma, NOS (/chaptercontent/63/241)
2424 Other peripheral T-cell lymphomas
2425 Peripheral T-cell lymphoma, NOS (/chaptercontent/63/247)
2426 EBV-positive NK-cell and T-cell lymphomas
2427 EBV-positive nodal T- and NK-cell lymphoma (/chaptercontent/63/246) Extranodal NK/T-cell lymphoma (/chaptercontent/63/258)
2428 EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood
2430 Severe mosquito bite allergy (/chaptercontent/63/250)
2431 Hydroa vacciniforme lymphoproliferative disorder (/chaptercontent/63/251) Systemic chronic active EBV disease (/chaptercontent/63/252)
2432 Systemic EBV-positive T-cell lymphoma of childhood (/chaptercontent/63/253)
2433 6.
2434 Stroma-derived neoplasms of lymphoid tissues
2436 Mesenchymal dendritic cell neoplasms
2437 Follicular dendritic cell neoplasms
2438 Follicular dendritic cell sarcoma (/chaptercontent/63/265)
2439 EBV-positive inflammatory follicular dendritic cell sarcoma (/chaptercontent/63/266) Fibroblastic reticular cell tumour (/chaptercontent/63/267)
2440 Myofibroblastic tumours
2441 Myofibroblastic tumour
2442 Intranodal palisaded myofibroblastoma (/chaptercontent/63/334)
2443 Spleen-specific vascular-stromal tumours
2444 Splenic vascular-stromal tumours
2445 Littoral cell angioma (/chaptercontent/63/270) Splenic hamartoma (/chaptercontent/63/368)
2446 Sclerosing angiomatoid nodular transformation (SANT) of spleen (/chaptercontent/63/369)
2447 7.
2448 Genetic tumour syndromes
2449 Introduction (/chaptercontent/63/306) Fanconi anaemia (/chaptercontent/63/305) Bloom syndrome (/chaptercontent/63/307)
2450 Ataxia-telangiectasia syndrome (/chaptercontent/63/308) RASopathies (/chaptercontent/63/309)
2452 Paediatric Tumours (5th ed.)
2453 1.
2457 Foreword with changes from the book, including corrigenda (/chaptercontent/44/534) ICD-O coding of paediatric tumours
2458 TNM staging of paediatric tumours (/chaptercontent/44/553) Introduction to paediatric tumours (/chaptercontent/44/1)
2459 2.
2460 Haematolymphoid disorders
2461 Haematolymphoid disorders: Introduction (/chaptercontent/44/3)
2462 Myeloid neoplasms
2464 Chronic myeloid leukaemia (CML) (/chaptercontent/44/466) Juvenile myelomonocytic leukaemia (/chaptercontent/44/17)
2465 Myelodysplastic syndromes
2466 Refractory cytopenia of childhood (/chaptercontent/44/22) Myelodysplastic syndrome with excess blasts (/chaptercontent/44/21)
2467 Acute myeloid leukaemia (AML)
2468 Acute myeloid leukaemias (AMLs) defined by differentiation (/chaptercontent/44/469)
2469 Acute myeloid leukaemias (AMLs) with defining genetic abnormalities (/chaptercontent/44/468)
2470 Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions Myeloid neoplasms associated with germline
predisposition (/chaptercontent/44/470) Myeloid proliferations associated with Down syndrome (/chaptercontent/44/10)
2471 Mast cell neoplasia
2472 Mastocytosis (/chaptercontent/44/32)
2473 Lymphoid neoplasms
2474 Precursor lymphoid neoplasms
2475 B-lymphoblastic leukaemia/lymphoma (/chaptercontent/44/35)
2476 T- and NK-lymphoblastic leukaemia/lymphoma (/chaptercontent/44/403)
2477 Mature B-cell neoplasms
2478 Primary mediastinal large B-cell lymphoma (/chaptercontent/44/41) Diffuse large B-cell lymphoma NOS (/chaptercontent/44/42)
2479 EBV-positive diffuse large B-cell lymphoma (/chaptercontent/44/393) Large B-cell lymphoma with IRF4 rearrangement (/chaptercontent/44/43)
Paediatric-type follicular lymphoma (/chaptercontent/44/44)
2480 Paediatric nodal marginal zone lymphoma (/chaptercontent/44/45) ALK-positive large B-cell lymphoma (/chaptercontent/44/46) Lymphomatoid
granulomatosis (/chaptercontent/44/48)
2481 Plasmablastic lymphoma (/chaptercontent/44/50) Mediastinal grey zone lymphoma (/chaptercontent/44/54) Burkitt lymphoma
Large B-cell lymphoma with 11q aberration (/chaptercontent/44/489)
2483 Mature T/NK-cell neoplasms
2484 Peripheral T-cell lymphoma NOS (/chaptercontent/44/490) Aggressive NK-cell leukaemia (/chaptercontent/44/53)
2485 Primary cutaneous T-cell neoplasms
2487 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders (/chaptercontent/44/59) Subcutaneous panniculitis-like T-cell lymphoma
2488 Anaplastic large cell lymphoma
2489 ALK-positive anaplastic large cell lymphoma (/chaptercontent/44/57)
2490 Hepatosplenic T-cell lymphoma
2491 Hepatosplenic T-cell lymphoma (/chaptercontent/44/58)
2492 EBV-positive lymphoproliferative diseases of childhood
2493 Systemic EBV-positive T-cell lymphoma of childhood (/chaptercontent/44/60) Hydroa vacciniforme lymphoproliferative disorder
Hodgkin lymphoma
2495 Classic Hodgkin lymphoma (/chaptercontent/44/65)
2496 Nodular lymphocyte-predominant Hodgkin lymphoma (/chaptercontent/44/511)
2497 Histiocytic and dendritic cell neoplasms
2498 Langerhans cell histiocytosis and related disorders (/chaptercontent/44/68)
2499 Immunodeficiency-associated lymphoproliferative disorders
2500 Primary immunodeficiency-associated lymphoproliferative disorders (/chaptercontent/44/71) Posttransplant lymphoproliferative disorders
2501 HIV-associated lymphoproliferative disorders (/chaptercontent/44/408)
2502 3.
2503 CNS tumours
2504 CNS tumours: Introduction (/chaptercontent/44/75) Gliomas, glioneuronal tumours, and neuronal tumours
2505 Gliomas, glioneuronal tumours, and neuronal tumours: Introduction (/chaptercontent/44/364)
2506 Paediatric-type diffuse low-grade gliomas
2507 Diffuse astrocytoma, MYB- or MYBL1-altered (/chaptercontent/44/429) Angiocentric glioma (/chaptercontent/44/397)
2508 Polymorphous low-grade neuroepithelial tumour of the young (/chaptercontent/44/405) Diffuse low-grade glioma, MAPK pathway-altered
2509 Paediatric-type diffuse high-grade gliomas
2510 Diffuse midline glioma, H3 K27-altered (/chaptercontent/44/78)
2511 Diffuse hemispheric glioma, H3 G34-mutant (/chaptercontent/44/79)
2512 Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype (/chaptercontent/44/99) Infant-type hemispheric glioma
Circumscribed astrocytic gliomas
2514 Pilocytic astrocytoma (/chaptercontent/44/80)
2515 High-grade astrocytoma with piloid features (/chaptercontent/44/477) Pleomorphic xanthoastrocytoma (/chaptercontent/44/82)
2516 Subependymal giant cell astrocytoma (/chaptercontent/44/81) Astroblastoma, MN1-altered (/chaptercontent/44/83)
2517 Glioneuronal and neuronal tumours
2518 Ganglioglioma (/chaptercontent/44/94)
2519 Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma (/chaptercontent/44/86) Dysembryoplastic neuroepithelial tumour
2520 Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (/chaptercontent/44/85)
2521 Diffuse leptomeningeal glioneuronal tumour (/chaptercontent/44/97) Multinodular and vacuolating neuronal tumour (/chaptercontent/44/404)
2522 Ependymal tumours
2523 Ependymal tumours: Introduction (/chaptercontent/44/437) Supratentorial ependymoma (/chaptercontent/44/90)
2524 Supratentorial ependymoma, ZFTA fusion-positive (/chaptercontent/44/438) Supratentorial ependymoma, YAP1 fusion-positive
(/chaptercontent/44/439) Posterior fossa ependymoma (/chaptercontent/44/91)
2525 Posterior fossa group A (PFA) ependymoma (/chaptercontent/44/95) Posterior fossa group B (PFB) ependymoma (/chaptercontent/44/440) Spinal
ependymoma, MYCN-amplified (/chaptercontent/44/436) Myxopapillary ependymoma (/chaptercontent/44/471)
2526 Choroid plexus tumours
2527 Choroid plexus papilloma (/chaptercontent/44/100)
2528 Atypical choroid plexus papilloma (/chaptercontent/44/101) Choroid plexus carcinoma (/chaptercontent/44/102)
2529 CNS embryonal tumours
2530 Medulloblastoma: Introduction (/chaptercontent/44/476)
2531 Medulloblastomas, molecularly defined
2532 Medulloblastoma, WNT-activated (/chaptercontent/44/105)
2533 Medulloblastoma, SHH-activated and TP53-wildtype (/chaptercontent/44/106) Medulloblastoma, SHH-activated and TP53-mutant
(/chaptercontent/44/107) Medulloblastoma, non-WNT/non-SHH (/chaptercontent/44/108)
2534 Medulloblastomas, histologically defined
2535 Medulloblastoma, histologically defined (/chaptercontent/44/442)
2536 Other CNS embryonal tumours
2537 Other CNS embryonal tumours: Introduction (/chaptercontent/44/501) Atypical teratoid/rhabdoid tumour (/chaptercontent/44/110)
2538 Cribriform neuroepithelial tumour (/chaptercontent/44/465)
2539 Embryonal tumour with multilayered rosettes (/chaptercontent/44/111) CNS neuroblastoma, FOXR2-activated (/chaptercontent/44/113)
2540 CNS tumour with BCOR internal tandem duplication (/chaptercontent/44/114) CNS embryonal tumour NEC/NOS (/chaptercontent/44/446)
2541 Pineal tumours
2542 Pineal tumours
2543 Pineal tumours: Introduction (/chaptercontent/44/502) Pineoblastoma (/chaptercontent/44/117)
2544 Melanocytic CNS tumours
2545 Melanocytic CNS tumours: Introduction (/chaptercontent/44/503)
2546 Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis (/chaptercontent/44/119)
2547 Tumours of the sellar region
2548 Tumours of the sellar region: Introduction (/chaptercontent/44/504)
2549 Pituitary endocrine tumours
2550 Pituitary adenoma / pituitary neuroendocrine tumour (/chaptercontent/44/310) Pituitary blastoma (/chaptercontent/44/311)
2551 Craniopharyngiomas
2552 Adamantinomatous craniopharyngioma (/chaptercontent/44/122)
2553 4.
2554 Peripheral neuroblastic tumours
2555 Peripheral neuroblastic tumours: Introduction (/chaptercontent/44/401) Ganglioneuroma (/chaptercontent/44/453)
2556 Ganglioneuroblastoma, intermixed (/chaptercontent/44/451) Neuroblastoma (/chaptercontent/44/326)
2557 Ganglioneuroblastoma, nodular (and other composite neuroblastic tumours) (/chaptercontent/44/452)
2558 5.
2559 Eye tumours
2560 Eye tumours: Introduction (/chaptercontent/44/124)
2561 Conjunctival neoplasms
2562 Hamartomas
2563 Epibulbar choristoma (/chaptercontent/44/127)
2564 Epibulbar osseous choristoma (/chaptercontent/44/128) Phakomatous choristoma (/chaptercontent/44/398)
2566 Conjunctival junctional, compound, and subepithelial naevi (/chaptercontent/44/130) Inflamed juvenile conjunctival naevus
Uveal neoplasms
2568 Diffuse choroidal neurofibroma and ganglioneuroma (/chaptercontent/44/133) Lisch nodule (iris hamartoma) (/chaptercontent/44/134)
2569 Retinal and neuroepithelial tumours
2570 Retinocytoma (/chaptercontent/44/137) Retinoblastoma (/chaptercontent/44/138)
2571 Medulloepithelioma (/chaptercontent/44/399)
2572 Optic nerve tumours
2573 Pilocytic astrocytoma and other gliomas of the optic nerve (/chaptercontent/44/140)
2574 6.
2575 Soft tissue and bone tumours
2576 Soft tissue and bone tumours: Introduction (/chaptercontent/44/142)
2579 Lipomatosis (/chaptercontent/44/145) Lipoblastoma/lipoblastomatosis (/chaptercontent/44/146) Liposarcoma (/chaptercontent/44/193)
2581 Fasciitis/myositis (/chaptercontent/44/149)
2582 Fibrodysplasia ossificans progressiva (/chaptercontent/44/520) Fibroma of tendon sheath (/chaptercontent/44/493)
2583 Gardner fibroma (/chaptercontent/44/150)
2584 Fibrous hamartoma of infancy (/chaptercontent/44/480) Lipofibromatosis (/chaptercontent/44/485)
2585 Inclusion body infantile digital fibromatosis (/chaptercontent/44/481)
2586 Juvenile hyaline fibromatosis (hyaline fibromatosis syndrome) (/chaptercontent/44/482) Fibromatosis colli (/chaptercontent/44/483)
2587 Calcifying aponeurotic fibroma (/chaptercontent/44/484) Sinonasal angiofibroma (/chaptercontent/44/300)
2588 Plantar/palmar fibromatoses (/chaptercontent/44/152)
2589 Dermatofibrosarcoma protuberans (/chaptercontent/44/367) Desmoid fibromatosis (/chaptercontent/44/492)
2590 EWSR1::SMAD3-positive fibroblastic tumour (/chaptercontent/44/153) Infantile fibrosarcoma (/chaptercontent/44/160)
2591 Paediatric NTRK-rearranged spindle cell neoplasm (/chaptercontent/44/155)
2592 Low-grade fibromyxoid sarcoma / sclerosing epithelioid fibrosarcoma (/chaptercontent/44/156) Inflammatory myofibroblastic tumour
2593 Low-grade myofibroblastic sarcoma (/chaptercontent/44/157)
2594 So-called fibrohistiocytic tumours
2595 Fibrous histiocytoma (/chaptercontent/44/409)
2596 Plexiform fibrohistiocytic tumour (/chaptercontent/44/159) Tenosynovial giant cell tumour (/chaptercontent/44/410)
2598 Capillary malformations (/chaptercontent/44/526) Venous malformations (/chaptercontent/44/528)
2599 Arteriovenous malformations (/chaptercontent/44/529) Intramuscular vascular anomalies (/chaptercontent/44/164) Lymphatic anomalies
2600 Congenital haemangioma (/chaptercontent/44/162) Infantile haemangioma (/chaptercontent/44/505)
2601 Haemangioma of placenta (/chaptercontent/44/427)
2602 Lobular capillary haemangioma (pyogenic granuloma) (/chaptercontent/44/411) Epithelioid haemangioma (/chaptercontent/44/462)
2603 Tufted angioma and kaposiform haemangioendothelioma (/chaptercontent/44/163) Papillary intralymphatic angioendothelioma and retiform
haemangioendothelioma (/chaptercontent/44/165)
2604 Pseudomyogenic haemangioendothelioma (/chaptercontent/44/412) Kaposi sarcoma (/chaptercontent/44/413)
2605 Epithelioid haemangioendothelioma (/chaptercontent/44/414) Angiosarcoma (/chaptercontent/44/478)
2607 Myofibroma and myopericytoma (/chaptercontent/44/168)
2608 Glomus tumour and glomuvenous malformation (/chaptercontent/44/169)
2614 Ectomesenchymoma (/chaptercontent/44/178)
2616 Paediatric gastrointestinal stromal tumour (/chaptercontent/44/217)
2618 Schwannoma (/chaptercontent/44/184) Neurofibroma (/chaptercontent/44/536) Perineurioma (/chaptercontent/44/537)
2619 Hybrid nerve sheath tumour (/chaptercontent/44/538) Granular cell tumour (/chaptercontent/44/539)
2620 Solitary circumscribed neuroma (/chaptercontent/44/189)
2621 Ectopic meningioma and meningothelial hamartoma (/chaptercontent/44/190) Benign triton tumour / neuromuscular choristoma
(/chaptercontent/44/191) Malignant peripheral nerve sheath tumour (/chaptercontent/44/192)
2622 Tumours of uncertain derivation
2623 Intramuscular/juxta-articular myxoma (/chaptercontent/44/507) Superficial angiomyxoma (/chaptercontent/44/508)
2624 Deep angiomyxoma (/chaptercontent/44/509)
2625 Angiomatoid fibrous histiocytoma (/chaptercontent/44/201) Clear cell sarcoma of soft tissue (/chaptercontent/44/195) Alveolar soft part sarcoma
2626 Extrarenal rhabdoid tumour (/chaptercontent/44/197) PEComa (/chaptercontent/44/188)
2627 Synovial sarcoma (/chaptercontent/44/187) Epithelioid sarcoma (/chaptercontent/44/198)
2628 Myoepithelial tumours of soft tissue (/chaptercontent/44/199) Phosphaturic mesenchymal tumour (/chaptercontent/44/200)
2629 Desmoplastic small round cell tumour (/chaptercontent/44/203) Undifferentiated sarcomas (/chaptercontent/44/463)
2630 Undifferentiated small round cell sarcomas of soft tissue and bone
2632 Round cell sarcoma with EWSR1::non-ETS fusions (/chaptercontent/44/207) CIC-rearranged sarcoma (/chaptercontent/44/208)
2633 Sarcoma with BCOR genetic alterations (/chaptercontent/44/209)
2634 Bone tumours
2635 Osteogenic tumours
2636 Subungual exostosis (/chaptercontent/44/204)
2637 Bizarre parosteal osteochondromatous proliferation (/chaptercontent/44/202) Osteoblastoma (/chaptercontent/44/212)
2638 Osteoid osteoma (/chaptercontent/44/213)
2639 Chondromesenchymal hamartoma of the chest wall (/chaptercontent/44/214) Osteosarcoma (/chaptercontent/44/215)
2641 Chondroblastoma (/chaptercontent/44/224) Osteochondroma (/chaptercontent/44/221)
2642 Chondromyxoid fibroma (/chaptercontent/44/225)
2643 Enchondroma and enchondromatosis (/chaptercontent/44/222) Chondrosarcoma (/chaptercontent/44/226)
2644 Mesenchymal chondrosarcoma (/chaptercontent/44/540)
2645 Other bone tumours
2646 Vascular tumours of bone (/chaptercontent/44/228) Aneurysmal bone cyst (/chaptercontent/44/516) Giant cell tumour of bone
(/chaptercontent/44/517) Non-ossifying fibroma (/chaptercontent/44/518)
2647 Notochordal tumours (/chaptercontent/44/230) Simple bone cyst (/chaptercontent/44/512)
2648 Adamantinoma (/chaptercontent/44/513) Osteofibrous dysplasia (/chaptercontent/44/514) Fibrous dysplasia (/chaptercontent/44/515)
2649 7.
2651 Germ cell tumours: Introduction (/chaptercontent/44/233)
2653 Non-invasive germ cell neoplasia
2654 Intratubular germ cell neoplasia (male gonadal) (/chaptercontent/44/236) Gonadoblastoma (/chaptercontent/44/425)
2655 Germinoma-family tumours
2656 Germinoma/dysgerminoma/seminoma (/chaptercontent/44/237)
2657 Non-germinomatous germ cell tumours
2658 Non-germinomatous germ cell tumours: Introduction (/chaptercontent/44/506) Mature cystic teratoma (/chaptercontent/44/240)
2659 Extragonadal teratoma (/chaptercontent/44/444)
2660 Monodermal teratomas (female gonadal) (/chaptercontent/44/241) Immature teratoma (female gonadal) (/chaptercontent/44/242)
2661 Prepubertal-type testicular teratoma (/chaptercontent/44/238) Postpubertal-type teratoma (/chaptercontent/44/243)
2662 Embryonal carcinoma (/chaptercontent/44/245) Yolk sac tumour (/chaptercontent/44/246) Fetus in fetu (/chaptercontent/44/186)
2663 Choriocarcinoma (non-gestational) (/chaptercontent/44/247) Malignant mixed germ cell tumours (/chaptercontent/44/248)
2664 8.
2665 Renal and male genital tumours
2666 Renal and male genital tumours: Introduction (/chaptercontent/44/250)
2667 Renal tumours
2668 Nephroblastic and related tumours
2669 Paediatric cystic nephroma (/chaptercontent/44/256) Nephroblastoma (/chaptercontent/44/257)
2670 Molecularly defined renal tumours
2671 Renal cell carcinoma with MiT translocations (/chaptercontent/44/185) ALK-rearranged renal cell carcinoma (/chaptercontent/44/181)
2672 Eosinophilic solid and cystic renal cell carcinoma (/chaptercontent/44/177) SMARCB1-deficient renal medullary carcinoma (/chaptercontent/44/223)
2673 Metanephric tumours
2674 Metanephric adenoma (/chaptercontent/44/486) Metanephric adenofibroma (/chaptercontent/44/487) Metanephric stromal tumour
2675 Mesenchymal renal tumours
2676 Ossifying renal tumour of infancy (/chaptercontent/44/259) Mesoblastic nephroma (/chaptercontent/44/255)
2677 Clear cell sarcoma of the kidney (/chaptercontent/44/416) Malignant rhabdoid tumour of the kidney (/chaptercontent/44/258) Anaplastic sarcoma of
the kidney (/chaptercontent/44/417)
2678 Renal Ewing sarcoma (/chaptercontent/44/415)
2679 Testicular tumours
2680 Non-germ cell testicular tumours: Introduction (/chaptercontent/44/419) Juvenile granulosa cell tumour of the testis (/chaptercontent/44/420)
2681 9.
2682 Female genital tumours
2683 Non-germ cell tumours of the female genital tract: Introduction (/chaptercontent/44/261)
2684 Ovarian tumours
2685 Sex cord stromal tumours
2686 Ovarian fibroma (/chaptercontent/44/264)
2687 Sclerosing stromal tumour (/chaptercontent/44/422)
2688 Juvenile granulosa cell tumour of the ovary (/chaptercontent/44/265) Sex cord tumour with annular tubules (/chaptercontent/44/266)
2689 Papillary cystadenoma (/chaptercontent/44/423)
2690 Sertoli-Leydig cell tumour (/chaptercontent/44/424) Gynandroblastoma (/chaptercontent/44/269)
2691 Other ovarian tumours
2692 Small cell carcinoma of the ovary, hypercalcaemic type (/chaptercontent/44/270)
2693 Lower female genital tract tumours
2695 Mesonephric remnants and hyperplasia (/chaptercontent/44/278) Mullerian papilloma (/chaptercontent/44/277)
2697 Peritoneal tumours
2699 Peritoneal inclusion cysts (/chaptercontent/44/274)
2700 10.
2701 Breast tumours
2702 Breast tumours: Introduction (/chaptercontent/44/281)
2703 Breast tumours
2704 Fibroepithelial tumours (/chaptercontent/44/283) Juvenile fibroadenoma (/chaptercontent/44/284) Juvenile papillomatosis (/chaptercontent/44/428)
2705 11.
2706 Digestive system tumours
2707 Digestive system tumours: Introduction (/chaptercontent/44/286)
2708 Liver tumours
2710 Hepatoblastoma (/chaptercontent/44/289)
2711 Fibrolamellar variant of hepatocellular carcinoma (/chaptercontent/44/290) Paediatric hepatocellular carcinoma (/chaptercontent/44/430)
2712 Mesenchymal tumours unique to the liver
2713 Mesenchymal hamartoma (/chaptercontent/44/292)
2714 Calcifying nested stromal-epithelial tumour (/chaptercontent/44/293) Embryonal sarcoma of the liver (/chaptercontent/44/295)
2715 Hepatic congenital haemangioma (/chaptercontent/44/522) Hepatic infantile haemangioma (/chaptercontent/44/431)
2716 Hepatic angiosarcoma (/chaptercontent/44/523)
2717 Pancreatic tumours
2719 Pancreatoblastoma (/chaptercontent/44/298)
2720 Pancreatic acinar cell carcinoma (/chaptercontent/44/299) Solid pseudopapillary neoplasm (/chaptercontent/44/305)
2721 Gastrointestinal tumours
2723 Gastroblastoma (/chaptercontent/44/303)
2724 Appendiceal neuroendocrine tumours (/chaptercontent/44/304)
2725 12.
2726 Endocrine tumours
2727 Endocrine tumours: Introduction (/chaptercontent/44/307)
2728 Thyroid tumours
2729 Thyroid epithelial tumours
2730 Follicular adenoma of the thyroid (/chaptercontent/44/314) Papillary thyroid carcinoma (/chaptercontent/44/315) Medullary thyroid carcinoma
2731 Spindle epithelial tumour with thymus-like elements (/chaptercontent/44/317)
2732 Parathyroid tumours
2733 Parathyroid endocrine tumours
2734 Parathyroid adenoma (/chaptercontent/44/320)
2735 Adrenal tumours
2736 Adrenocortical tumours
2737 Adrenal cortical tumours (/chaptercontent/44/323)
2738 Tumours of the adrenal medulla and extra-adrenal paraganglia
2739 Sympathetic paraganglioma (/chaptercontent/44/325)
2740 Parasympathetic paraganglioma (head and neck paraganglioma) (/chaptercontent/44/472) Phaeochromocytoma (/chaptercontent/44/455)
2741 Composite phaeochromocytoma/paraganglioma (/chaptercontent/44/456)
2744 Other neuroendocrine tumours (/chaptercontent/44/329)
2745 13.
2746 Head and neck tumours
2747 Head and neck tumours: Introduction (/chaptercontent/44/331)
2748 Benign tumours
2749 Squamous cell papilloma of the larynx (/chaptercontent/44/337) White sponge naevus (/chaptercontent/44/338)
2750 Congenital granular cell epulis (/chaptercontent/44/339) Central giant cell granuloma (/chaptercontent/44/335) Odontogenic tumours
(/chaptercontent/44/334) Ossifying fibroma (/chaptercontent/44/348)
2751 Sinonasal tract myxoma (/chaptercontent/44/542) Nasal dermoid cyst (/chaptercontent/44/342)
2752 Nasopharyngeal dermoid (/chaptercontent/44/343)
2753 Sinonasal chondromesenchymal hamartoma (/chaptercontent/44/344) Pleomorphic adenoma (/chaptercontent/44/443)
2754 Malignant tumours
2755 Mucoepidermoid carcinoma (/chaptercontent/44/457) Acinic cell carcinoma (/chaptercontent/44/458)
2756 Sialoblastoma (/chaptercontent/44/459)
2757 Nasopharyngeal carcinoma (/chaptercontent/44/349) NUT carcinoma (/chaptercontent/44/351)
2758 Melanotic neuroectodermal tumour of infancy (/chaptercontent/44/350)
2759 14.
2760 Thoracic tumours
2761 Lung tumours
2762 Fetal lung interstitial tumour (/chaptercontent/44/432)
2763 Congenital peribronchial myofibroblastic tumour (/chaptercontent/44/433) Pleuropulmonary blastoma (/chaptercontent/44/355)
2764 Heart tumours
2765 Cardiac rhabdomyoma (/chaptercontent/44/357)
2766 15.
2767 Skin tumours
2768 Skin tumours: Introduction (/chaptercontent/44/359)
2769 Hamartomas
2770 Hamartomas (/chaptercontent/44/360)
2771 Epithelial neoplasms
2772 Squamous neoplasms
2773 Angiokeratoma (/chaptercontent/44/363) Epidermal naevi (/chaptercontent/44/434) Pilomatricoma (/chaptercontent/44/499)
2775 Naevi
2776 Congenital naevi (/chaptercontent/44/370)
2777 Junctional, compound, and dermal naevi (/chaptercontent/44/371)
2778 Blue naevus (/chaptercontent/44/372) Spitz naevus (/chaptercontent/44/373)
2779 Pigmented spindle cell naevus (Reed naevus) (/chaptercontent/44/510)
2780 Melanoma
2781 Melanoma (/chaptercontent/44/375)
2782 16.
2783 Genetic tumour syndromes
2784 Selected tumour predisposition syndromes: Introduction (/chaptercontent/44/402)
2785 Syndromes predisposing primarily to neural tumours Neurofibromatosis type 1 (/chaptercontent/44/385) Neurofibromatosis type 2
(/chaptercontent/44/386) Tuberous sclerosis (/chaptercontent/44/379)
2786 Naevoid basal cell carcinoma syndrome (Gorlin syndrome) (/chaptercontent/44/384) Retinoblastoma syndrome (/chaptercontent/44/387)
2787 Syndromes predisposing primarily to endocrine tumours
2788 Von Hippel-Lindau syndrome (/chaptercontent/44/449)
2789 Hereditary phaeochromocytoma-paraganglioma syndromes (/chaptercontent/44/388)
2790 Syndromes predisposing primarily to Wilms tumours
2791 WAGR syndrome (/chaptercontent/44/460)
2792 Beckwith-Wiedemann and related overgrowth syndromes (/chaptercontent/44/435)
2793 Syndromes predisposing primarily to gastrointestinal tumours Familial adenomatous polyposis (/chaptercontent/44/383) Lynch syndrome
2794 Other syndromes
2795 Xeroderma pigmentosum (/chaptercontent/44/391)
2796 Rothmund-Thomson syndrome (/chaptercontent/44/390) Li-Fraumeni syndrome (/chaptercontent/44/380)
2797 DICER1 syndrome (/chaptercontent/44/389)
2798 BAP1 tumour predisposition syndrome (/chaptercontent/44/500)
2799 Constitutional mismatch repair deficiency syndrome (/chaptercontent/44/382) Rhabdoid tumour predisposition syndrome (/chaptercontent/44/381)

Daftar Isi WHO 2

Uploaded by

Copyright:

Available Formats

Daftar Isi WHO 2

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Daftar Isi WHO 2

Uploaded by

Copyright:

Available Formats

1 Central Nervous System Tumours (5th ed.

You might also like